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Abstract
Interactions between adenosine A2 A and dopamine D2  receptors are thought to be 
involved in morphine and cocaine-induced addictive responses. The aim o f this thesis 
was to further investigate the involvement of the adenosine A2 A receptor in morphine 
and cocaine addiction.
Using electrophysiology, D2  receptor function was studied in ventral tegmental area 
dopamine cells in GDI wildtype and A2 A receptor knockout mice. Responses to the 
D2  receptor agonist, quinpirole, were significantly reduced in A2 A receptor knockout 
mice
Gonditioning, extinction and reinstatement to morphine or cocaine were studied in 
GDI wildtype and A2A receptor knockout mice and G57BL/6 mice. Reliable 
conditioning to either morphine or cocaine could not be established in GDI mice; 
however significant conditioning, extinction and reinstatement could be induced 
following morphine or cocaine treatment in G57BL/6 mice. No significant difference 
in the qualitative binding or functional activation o f p-opioid receptors in the ventral 
tegmental area and substantia nigra of GDI and G57BL/6 mice were observed.
The dopaminergic profile was studied in the brains o f the GDI mice that responded or 
did not respond to cocaine-induced conditioning studies. There was no difference in 
dopamine transporter binding and dopamine D2  G-protein activity between responders 
and non-responders. Significantly lower levels of D% and D2 receptor binding was 
observed in the caudate-putamen of responders.
Chronic ‘binge’ cocaine administration was studied in wildtype and A%A receptor 
knockout mice. Data collection and sample analysis were compromised in these 
studies allowing only qualitative comparisons. The results obtained indicated that 
wildtype mice treated with cocaine for 14 days showed an increase in ambulatory 
activity as well as an increase in extracellular dopamine released from the nucleus 
accumbens.
These findings confirm the importance o f interactions between the adenosinergic and 
dopaminergic systems during addictive processes and also highlight the importance of 
strain differences when studying behavioural responses.
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Chapter 1 : Introduction
1.1 Understanding drug addiction
Addiction to drugs of abuse is a widespread social, economic and medical burden. To 
date, 200 million people globally use drugs of abuse each year and 5% of the 
population aged between 16 and 64 use illicit drugs each year, but only 0.6% of these 
are considered “problem drug users” (ONDCP 2004). The economic cost o f drug 
abuse in 2002 was estimated at $180.9 billion (ONDCP 2004) and the cost in England 
and Wales for class A drug abuse was estimated at £3.5 billion (Godfrey et al. 2002). 
One of the major problems associated with long term drug use and treatment o f drug 
dependence is the high incidence of relapse following long periods o f abstinence. For 
a review see Dackis and O’Brien (2005).
Over the years many different and somewhat conflicting explanations, definitions and 
theories about drug abuse, dependence and addiction have been published. It is 
difficult to define drug addiction in a single statement, as it is not a simple concept but 
one which involves both physical and behavioural factors. The emphasis on behaviour 
in addiction arises from the compulsive nature of drug seeking. An addict is driven by 
the strong urge to take the drug, which is known as craving, reviewed by Wise (1988). 
Drug addiction can also be considered a chronic relapsing disorder, as addicts remain 
addicted for long periods of time and periods of remission are often followed by the 
re-occurrence of drug use, commonly known as relapse (Koob et a l 1997; Hyman et 
al 2001). Furthermore, drug use persists despite the serious and harmful 
consequences to the addict; the compulsive use of the drug becomes uncontrollable 
(Nestler 1992; Leshner 1997; Hyman et a l 2001). These factors all fuel what can be
16
described as the continuum of drug use; this has been represented in a number of 
models which emphasise different phases in addiction. For a review see Dackis and 
O’Brien (2005).
The physical dependence to drugs of abuse is often linked to the withdrawal 
symptoms; unpleasant withdrawal symptoms such as dysphoria, anxiety and 
irritability promote drug taking for relief. This is known as negative reinforcement, 
defined as the reinforcement of a drug by removal of an undesired stimulus or 
negative emotional state (Koob et al. 1998), which can also result in relapse.
Craving is a critical aspect o f physical dependence; studies show that craving can be 
dramatically amplified by cues associated with a drug (O'Brien et al. 1998). Drug 
craving is also associated with conditioned withdrawal, where withdrawal symptoms 
can be triggered by exposure to conditioned stimuli, for example where the drug is 
taken. Therefore, environmental stimuli associated with withdrawal can trigger 
conditioned withdrawal and drug craving, which motivates relapse (Koob et al. 1998). 
This explanation of addiction is only relevant for drugs of abuse that lead to physical 
dependence such as opiates and alcohol. Furthermore, it does not account for the early 
stages o f drug use.
Drugs of abuse also elicit a state o f positive reinforcement due to the rewarding and 
reinforcing effects. Positive reinforcement can be measured in vivo using self- 
administration and conditioned lever pressing; in both cases the drug acts as a 
reinforcer (see section 1.2). These in vivo models help to demonstrate how drugs o f
17
abuse interact with reward mechanisms in the brain, as reviewed by Koob (1998) and 
Wise (1996).
The described state of reinforcement does not, however, take into account the fact that 
drug users tend to display greater drug craving after many doses rather than a few. 
This increase in drug craving does not correlate with the drug high, which tends to be 
less after many doses due to the development of drug-induced tolerance, as reviewed 
by van Ree (1999) and Hyman and Malenka (2001).
Drug addiction has also been identified in terms of an ‘incentive-sensitisation’ 
approach, which takes into account the neurobiological effects of drugs o f abuse. This 
model highlights the distinction between drug liking (the high of the drug) and drug 
wanting (craving). In the development of addiction there is an increase in the drug 
wanting despite the fact that there is little or no change in the pleasurable effect o f the 
drug, as reviewed by Robinson and Berridge (1993). This is due to the fact that 
different brain mechanisms are responsible for the two components of drug reward 
and repeated drug use. Repeated drug use causes sensitisation o f the “wanting” 
system but no sensitisation or tolerance of the “liking” system. Pathways within the 
brain have been identified to play a role in this aspect of addiction (see section 1.3 for 
more detail). Neuro-adaptive changes within specific brain regions can also explain 
the compulsive and escalating drug use seen as an addiction develops (Koob et a l 
1988; Koob 1992; Koob et a l 1997). These changes are often long lasting, which 
explains why addicts find it difficult to abstain from drug use and as a result, often 
relapse.
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Finally, it has been hypothesised that repeated drug use sensitises the primary 
affective response, which is the pleasure experienced upon drug consumption. 
However, over time the level of pleasure experienced decreases such that the user 
begins to experience dysphoria, which in turn results in relapse. For a review see 
Koob and Le Moal (1997).
All these explanatory models are vital in the understanding of drug addiction and no 
one model can be applied to all drugs of abuse or all aspects of drug addiction. It is 
important to also consider that there is a major psychoanalytical contribution to 
understanding addiction, the discussion of which is not within the scope of this thesis.
ADDICTIVE AGENT DRUG EUPHORIA
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Figure 1.1: A summary of the various inputs to addiction
The cycle of addiction is positively reinforced by the drug euphoria and the activation 
of reward pathways. This is followed by negative reinforcement, which manifests 
itself in withdrawal and tolerance and the resultant dysregulation of the reward 
pathways. Negative reinforcement is enhanced further by drug related cues and stress, 
which increase craving. Neuronal mechanisms for these components have been 
increasingly delineated with animal models. Adapted from Dackis et al. (2005)
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1.2 Behavioural paradigms to study the addictive properties of drugs of abuse
The addictive response to drugs of abuse has been shown through the use of in vivo 
behavioural models. In rodent studies, enhanced arousal is observed as an increase in 
locomotor activity and stereotypic behaviours. Experimental paradigms have been 
designed to study these and various aspects of animal behaviour in response to the 
different stages of the addiction cycle (Shaham et al. 2003; Koob et al. 2005). For 
example, the behavioural sensitisation model involves the progressive increase in 
motor stimulatory effects of the drug following repeated intermittent administration, 
this is thought to represent the transition from drug liking to drug wanting (Robinson 
et al. 1993).
The reinforcing and rewarding properties of drugs of abuse have been widely studied 
using rat and mouse animal models. The model of self-administration is the most 
closely related to human drug taking. It is an operant paradigm where animals learn to 
perform a task (lever press, nose poke or wheel turn) in exchange for either a drug, 
administered intravenously or orally, or an electrical stimulation o f a neural pathway 
(de Wit et al. 1981; Nestler 1992). This model can also be used to examine a number 
of different aspects of drug addiction, for example, acquisition rates, stability o f drug 
intake, dose-response properties, the effects o f receptor-selective agonists and 
antagonists and the role o f specific gene products in self-administration (Pich et al. 
1998).
Conditioned place preference (CPP) is a conditioning paradigm, commonly used to 
measure the rewarding and reinstating properties of drugs but can also be used to 
assess various other effects o f abused drugs such as extinction and relapse. Animals
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learn to associate the experience o f a drug with a particular context, for example, a 
distinctive stimulating environment (Nestler 1992; Anderson et a l 2005; Koob et al 
2005). The self-administration and CPP paradigms are both designed to assess 
reinforcement and reward but measure different aspects o f drug reinforcement and 
reward. In self-administration, the injection of a drug is a consequence o f lever- 
pressing, therefore the addictive drug is reinforcing the lever pressing behaviour. The 
CPP paradigm however creates an association of the environmental cues with the 
effects of the drug.
The use o f these in vivo models has contributed to the identification of the 
involvement of a number of neurotransmitters in the brain, in particular dopamine 
(DA) and dopaminergic (DAergic) pathways, in the reinforcing and rewarding effects 
of many abused drugs. For comprehensive reviews see Wise and Bozarth (1987) and 
Pierce and Kumaresan (2006).
1.3 The neurobiology of drug addiction
Complex changes in the brain, specifically in the basal ganglia, have been shown to 
underlie addiction. The basal ganglia is composed of a dorsal and ventral division; the 
dorsal division consists of the following brain regions; caudate-putamen (CPu), 
globus pallidus (GP), entopeduncular nucleus (EPN) and the subthalamic nucleus 
(STN). The ventral division consists of the nucleus accumbens (NAc), the ventral 
pallidum (VP) and ventral tegmental area (VTA). The CPu, NAc and olfactory 
tubercule (OT) also form what is known as the striatum (STr). Over 90% of striatal 
neurons are medium spiny neurons and they can be divided into two subtypes: 
striatopallidal neurons, which contain the peptides enkephalins; and striatonigral and
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striato-entopeduncular neurons, which contain the peptides substance P and 
dynorphins (for further details see section 1.6.1, Fig. 1.4). The main 
neurotransmitter/neuromodulator systems, implicated in drug addiction, within the 
basal ganglia include DA (DAergic cell bodies are concentrated in the VTA), opioid 
peptides, y-aminobutyric acid (GABA) and glutamate (Schultz 1998; Kalivas et a l 
1999; Koob et a l 2001).
Several dense clusters of DAergic neuronal cell bodies are located near the base of the 
mesencephalon in the midbrain. The ascending DAergic pathways can be divided into 
three pathways; the nigrostriatal pathway, the mesolimbic pathway and the 
mesocortical pathway (Fig. 1.2).
The axons of the DAergic neurons in the substantia nigra (SN) ascend to the CPu, 
forming the nigrostriatal pathway. This is a key pathway associated with 
neurodegenerative disorders such as Parkinson’s disease, where destruction of 
DAergic neurons is evident and results in deficits in motor function (Carlsson 1959; 
Kalivas cr <3 /. 1999).
Two ascending DAergic systems originate from the cells of the VTA. The DA 
containing neurons of the mesolimbic DA pathway run from the VTA and innervate 
various limbic structures such as the NAc, hippocampus, lateral septum and 
amygdala. The mesocortical DAergic pathway, also originating from the VTA, 
innervates the cerebral cortex, particularly the pre-frontal area. The brain regions 
within the mesolimbic and mesocortical pathways, or mesocorticolimbic pathway.
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operate in parallel, interaeting with eaeh other and other areas within the brain via 
various neuronal connections (Carr fl/. 1999; Kalivas a/. 1999).
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Figure 1.2: Three ascending DAergic systems in the basal ganglia
The nigrostriatal pathway, illustrated in blue, originates in the SN an innervates the 
CPu. The mesolimbic pathway, illustrated in green originates in the VTA and 
innervates the NAc, hippocampus and GP. The mesocorticolimbic pathway, 
illustrated in red also originates from the VTA and innervates the cortex.
In addition to DAergic neurotransmission both GABAergie and glutamatergic 
neurotransmission play a key role in the neurobiology of addiction. 
Immunoeytochemistry and in situ hybridisation studies have identified a population of 
GABA-containing cells in the VTA (Bayer et al. 1991; Kalivas 1993; Kalivas et al. 
1993). GABAergie neurons project from the NAc to the VTA/SN and VP, forming 
the main outputs of the NAc (Walaas et al. 1980) (Fig. 1.2). In addition, the VTA has 
GABAergie projections which innervate the NAc and medial pre-frontal cortex 
(mPFC) (Thierry et al. 1980; Van Boekstaele et al. 1995; Steffensen et al. 1998; Carr 
et al. 2000). GABAergie efferents also project from the VP to the thalamus (Fig. 1.3).
23
GABAergic neurons play a significant role in the regulation of DAergic neurons of 
the VTA. It has been observed that GABAergic terminals form synapses with 
DAergic cells in the VTA (Bayer et al. 1991). Extracellular GAB A is released in the 
VTA and its influence over DAergic neurons is exerted via G ABA receptors; GABAa 
and GAB As which are expressed on VTA neurons (Churchill et al 1992; Schwarzer 
et al. 2001; Wirtshafter et al. 2001). Antagonists for both receptors appear to enhance 
local DA release, which suggests that these receptors exert a tonic inhibitory control 
over somatodendritic release o f DA.
Glutamatergic neurons are the major excitatory input to the midbrain area, projecting 
mainly from the mPFC to the NAc but also from the amygdala and hippocampus to 
the NAc (Fig. 1.3). Increased glutamate-mediated transmission in the NAc may 
contribute to the relapse o f drug taking behaviour during abstinence (Dawson et al. 
1988). There are additional glutamatergic projections which run from the thalamus to 
the mPFC and NAc (Hyman et a l 2001; Heimer 2003; Pierce et al 2006).
Excitatory glutamatergic synaptic inputs from the mPFc are found in GABAergic and 
DAergic cells within the VTA (Bonci et a l 1999) (Fig. 1.2). These excitatory effects 
are mediated by ionotropic, a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
(AMPA) and N-methyl-D-aspartic acid (NMDA) receptors and metabotropic 
glutamate receptors, both of which are present in the VTA (Albin et al. 1992; Paquet 
et al. 1997). Electrophysiological evidence revealed that AMP A and NMDA receptors 
are also present on non-DAergic neurons in the VTA (Wang et al. 1995). AMP A 
receptors are, however, more abundant in DAergic neurons o f the VTA compared to 
the NMDA receptors (Martin et al. 1993; Paquet et al. 1997). The stimulation of
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AMP A receptors on DAergic neurons in the VTA increases cell firing (Wang et al 
1993) and DA release in the NAc (Westerink et al. 1996) and mPFC (Westerink et al. 
1998), which is associated with an increase in DA in the VTA. The perfusion of 
AMP A receptor antagonists in the VTA reduces the release of DA in the mPFC 
(Takahata et a l 1998; Westerink et a l 1998) but does not alter DAergic firing pattern, 
DA release in the VTA or basal DA release in the NAc, suggesting that mesocortical 
DAergic neurons are under a tonic excitatory control by AMP A receptors (Adell et al.
2004).
The stimulation of NMDA receptors in the VTA, causes alterations in the firing 
patterns of DAergic neurons (Wang et al 1993) and like AMP A receptors, increases 
DAergic cell firing and DA release in the VTA (Kretschmer 1999), NAc (Karreman et 
al. 1996b; Westerink et al. 1996) and mPFC (Westerink et al. 1998). The 
administration of competitive NMDA receptor antagonists does not alter the firing 
pattern of DAergic neurons so no change in DA release is observed in the VTA and 
NAc (French et al. 1993; Kretschmer 1999). The administration o f non-competitive 
NMDA receptor antagonists does, however, alter the firing pattern o f DAergic 
neurons (French et al. 1993; French 1994) as well as DA release in the VTA, NAc 
and mPFC (Kretschmer 1999; Mathe et al. 1999). The effect o f non-competitive 
NMDA receptor antagonists maybe due to the activation of glutamate inputs to the 
mPFC (Murase et al. 1993), increasing the release of glutamate in the VTA which in 
turn could act on AMP A receptors (Mathe et al. 1998).
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Figure 1.3: Limbic circuitry involved in drug addiction
DAergic pathways from the VTA innervate the VP, NAe, Hip, mPFC and Amy. 
GABAergic neurons project from the VTA to the NAc and from the NAe to the VTA, 
mPFC and VP. Glutamatergic projections from the Amy, mPFC, Hip and Thai 
innervate the NAe; the Thai also innevates the mPFC via glutamatergic projections. 
Red arrows indicate glutamatergic pathways, blue arrows indicate GABAergic 
pathways and green arrows indicate dopaminergic pathways. Abbreviations: Amy, 
amygdala; Hip, hippocampus; mPFC, medial prefrontal cortex; NAe, nucleus 
aeeumbens; Thai, thalamus; VP, ventral pallidum; VTA, ventral tegmental area. 
Adapted from Pierce et al. (2006)
1.3.1 Dopamine and its receptors
There is a great deal of experimental evidence which identifies DA as the main 
neurotransmitter involved in reward and reinforcement. DAergic effects in the 
mesocortieolimbic system have been shown to play a crucial role in the modulation of 
the reward-related process of addiction (Koob 1996; Di Chiara 2002; Houchi et al.
2005). One common feature shared by all drugs of abuse is the enhancement o f DA
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activity within the mescorticolimbic pathway, as reviewed by Wise (1996). DA 
signalling is mediated through two major subtypes of G-protein coupled DA 
receptors; the D l family (Di and D 5) and the D2 family (the D2 , D3 and D4 ), for a 
review see Berke and Hyman (2000). The DA Di receptor and DA D2  receptor are of 
specific interest due to their high density in the brain regions involved in addiction, in 
particular the striatum.
DA Dl receptors are coupled to Gg/Goif and stimulate adenylyl cyclase (AC) activity 
to produce intracellular second messenger cyclic adenosine monophosphate (cAMP). 
cAMP in turn activates protein kinase A (PKA) which phosphorylates cAMP 
response element binding protein (CREB) and DA and cAMP regulated 
phosphoprotein 32 KDa (DARPP-32) at threonine-34 (Naim et al. 2004; 
Svenningsson et al. 2005). DA Di receptors are predominantly localised in the 
terminals of striatonigral and striato-entopenducular GABAergic neurons, which is 
also where the highest concentration o f DARPP-32 is located. The phosphorylation 
o f DARPP-32 at the threonine-34 residue inhibits protein-phosphatase 1 (PP-1), 
which would otherwise dephosphorylate CREB. The resultant increase in CREB may 
mediate the behavioural symptoms of addiction, decreasing the animal’s sensitivity to 
dmg-induced and natural rewards (Nestler 2004).
DA Dl receptors are highly abundant in the NAc, with moderate to low density in the 
VTA (Dawson et al. 1988) and DA Di receptor mRNA has been identified in a 
moderate to high proportion of cells projecting from the forebrain areas to the VTA 
(Cameron et al. 1993; Lu et al. 1997). This supports functional studies indicating that 
DA Dl receptor stimulation in the prefrontal cortex and NAc provides feedback
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activity for the regulation of the activity of DA neurons in the VTA (Grace et al. 
1985; Karreman et al. 1996a). Furthermore, the data support the possible presence of 
presynaptic DA Di receptors in the VTA, which would allow somatodendritically 
released DA to regulate the release of glutamate and G ABA from the forebrain 
(Cameron et al. 1993; Lu et al. 1997).
DA D2  receptors are coupled to Gj/Go which inhibits AC and cAMP production. In 
addition, DA D2  receptors activate the phospholipase C (PLC) signal transduction 
pathway, which activates protein phophatase 2B (PP-2B) or (caleineurin). PP-2B in 
turn inactivates the L-type voltage dependent Ca^”^ channels, which prevents the 
depolarisation of neuronal plasma membrane, reducing the probability o f cell firing 
(Vallar et al. 1989; Ferre et al. 2004) (for further details see section 1.6.1, Fig 1.5). 
Unlike DA Di receptors DA D2  receptors are highly expressed in the VTA and NAc 
of rodents (Bouthenet et al. 1987; Wamsley et al. 1989).
DA is somatodendritically released by DAergic neurons in the VTA and also by the 
terminal boutons of the cell. DA D2  receptors are present on DAergic neurons and act 
as autoreceptors; a receptor for the same neurotransmitter as that released from the 
neuron (Wamsley et al. 1989; Sibley et al. 1993). The somatodendritic release o f DA 
is likely to modulate the activity of the DAergic neurons via the interaction with 
inhibitory autoreceptors. The perfusion o f a DA D2  agonist into the VTA decreases 
DAergic neuronal firing whereas a DA D2  antagonist increases DAergic neuronal 
firing (Kalivas et al. 1991; Chen et al. 2000b). The presence and activation of DA D 2 
autoreceptors has been confirmed in mice lacking DA D2  receptors that do not show 
autoreeeptor mediated inhibition of firing of DAergic neurons (Mercuri et al. 1997;
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Centonze et al. 2002). Two isoforms of DA D2  receptors have been identified, D2 L 
and D2 S, which display different affinities for inhibitory G-proteins and are expressed 
at different levels within brain regions (Montmayeur et al. 1991; Guiramand et al.
1995). In addition, Centonze et al. (2002) identified that the D2 L receptors do not play 
a major role in the presynaptic action of somatodendritic autoreceptors, which 
suggests that D2 S receptors are the main impulse-regulating DA autoreceptors.
Despite the significant involvement of GAB A, glutamate, opioid peptide and 
endoeannabinoid systems in the acute reinforcing effects of drugs o f abuse, the 
majority of evidence identifies the mesolimbic DA system as the key modulatory 
system with regards to addiction. For a review see Feltenstein and See (2008). The 
administration of nicotine, ethanol, amphetamine, cocaine and opioids was found to 
cause an increase in DA release in the NAc using in vivo microdialysis (Di Chiara et 
al. 1988). For example, increased extracellular DA was detected in the NAc during 
intravenous cocaine self-administration (Pettit et al. 1989). Furthermore, lesions of 
the NAc and VTA using the neurotoxin 6 -hydroxydopamine (6 -OHDA), to destroy 
DAergic neurons, markedly attenuate cocaine self-administration (Roberts et al. 1980; 
Roberts et al. 1982; Pettit et al. 1984; Gerrits et al. 1996). In addition, the 
administration of DA Di, D2  and D 3 receptor antagonists decreased the reinforcing 
effects of cocaine (Woolverton et al. 1992; Caine et al. 1995; Koob et al. 1997; 
Epping-Jordan et al. 1998).
1.4 Morphine and addiction
Morphine is a drug which is part of a group of drugs known as opioids. Opioids 
produce their effects by mimicking the action of the endogenous substanees P-
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endorphin, leu- and met-enkephalin. Opioids act on three opioid receptor subtypes, 
the p opioid receptor (MOPr), the k  opioid receptor (KOPr) and the 6  opioid receptor 
(DOPr) (Martin et al. 1976; Lord et al. 1977). These receptors belong to a family o f 
seven transmembrane G-protein coupled receptors. The MOPr, which mediates the 
effect of morphine, is the most closely associated with drug dependence (Martin et al. 
1976). The MOPr’s are also widely dispersed aeross a number o f brain regions 
including the cortex, STr, thalamus, hippocampus, locus coruleus (LC), VTA, NAc 
and amygdala. The interaction of the opioids with the MOPr in these brain regions is 
thought to mediate their behavioural and reinforcing effects, which has also been 
linked to the DAergic system. For a comprehensive review see Van Ree et al. (1999).
Evidence suggests that the rewarding action of opioids are mediated in the VTA, for 
example, infusions o f morphine directly into the VTA, wherein the cell bodies o f the 
mesolimbic DA system are located, encourages intravenous (i.v.) self-administration, 
which can be reduced by the central and systemic administration of opioid antagonists 
(Bozarth et al. 1981). The infusion of opioids into the VTA also induced place 
preference (Bozarth 1987), which further highlights the importance o f the VTA in the 
rewarding action o f opioids. In addition, the infusion of morphine to the cell body 
regions of DAergic neurons in the VTA reinstates self-administration o f cocaine or 
heroin, suggesting that opioid receptors in the VTA are also able to activate circuits 
controlling potential relapse (Stewart 1983). Furthermore, morphine-induced GPP was 
completely abolished in DA D2 receptor knockout mice, which implies that these 
receptors play a crucial role in the rewarding effects of morphine (Maldonado et al.
1997). The reinforcing effect o f opioids in the NAc persists following the complete 
destruction of all DAergic neurons. This suggests that the reinforcing action o f opiates
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may involve both a DA dependent mechanism in the VTA and an unknown 
independent mechanism which may include the NAc (Ettenberg et al. 1982; Dworkin 
et al. 1988; Koob 1988; Pettit er a/. 1989; van Ree a/. 1999).
DA is shown to be involved in the rewarding effeets of opioids as self-administered 
doses of opioids dis-inhibit the DA system (Johnson et al. 1992a) causing an increase 
in DA in the NAc (Wise et al. 1995). This increase in DAergic signals to the NAc is 
via the activation of VTA DA neurons, which occurs indirectly through the activation 
of inhibitory MOPr located on GABAergic intemeurons (Johnson et al. 1992a) in the 
VTA or GABAergic projection neurons (Tepper et al. 1995). Under normal 
conditions G ABA inhibits DA cell-firing, however, upon MOPr activation the 
inhibitory GABAergic effect on VTA DA neurons is reduced thereby increasing the 
DA cell firing and the amount of DA released into the NAc (Johnson et al. 1992a).
Opiates also target the NAc neurons independently o f DA, via the activation of 
postsynaptic opioid receptors expressed in the NAc (Di Chiara et al. 1988; Nestler
1996). Hnasko et al. (2005) demonstrated that transgenic DA deficient mice displayed 
robust GPP for morphine and therefore DA is not essential for mice to experience the 
rewarding effects of morphine. This supports the suggestion that opiates may mediate 
their rewarding effects in regions such as the NAc (Olds 1982). In addition, there is 
evidence to suggest that the pedunculopontine tegmental nucleus located in the brain 
stem may also mediate the rewarding properties o f morphine as lesions o f this region 
block the reinforcing effects o f morphine (Bechara et al. 1989).
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The MOPr largely mediates the reinforcing actions of opioids. The repeated 
microinjection of jx-opioids into the VTA, but not the NAc, results in behavioural 
sensitisation to peripherally administered morphine, which is blocked by the opioid 
antagonist, naltrexone, thereby decreasing opioid reinforcement (Kalivas et a l 1987; 
Vezina et a l 1987; Negus et a l 1993). Mice with an increased number o f MOPr show 
a significant enhancement in the efficacy of morphine to aet as a reinforcer when 
eompared to wildtype mice (Elmer et al. 1996).
These findings were reinforced by the development of mice lacking opioid receptors 
or opioid peptides using gene targeting technology. MOPr deficient mice have been 
generated in a number of laboratories and have been used to investigate the biological 
actions of morphine (Matthes et al. 1996; Sora et al. 1997; Tian et al. 1997; Loh et al.
1998). The study of the euphorie and addictive nature of morphine identified that 
morphine conditioning did not induce place preference in the MOPr deficient mice 
(Matthes et al. 1996). All signs of withdrawal, sueh as jumping, sniffing, tremor, 
diarrhoea, weight loss and hyperthermia, were also absent following chronic 
morphine treatment in MOPr deficient mice (Matthes et al. 1996).
Acute morphine has been shown to inhibit the cAMP signal transduction pathway 
whereas chronic exposure to morphine causes what is thought to be compensatory 
upregulation of the cAMP pathway, shown by increased levels o f AC and PKA in the 
NAc (Self et a l 1995). This is regarded as the basis of the development of drug 
tolerance, sensitisation, dependence and onset of withdrawal (Nestler 1997). This was 
confirmed in MOPr deficient mice as the upregulation of AC did not develop 
following chronic treatment (Matthes et al. 1996). This reveals that the absence o f the
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MOPr prevents morphine withdrawal and therefore reinforcement at a biochemical 
and behavioural level. For a comprehensive review of the effects of opioids in the 
MOPr deficient mice see Kieffer (1999).
There is evidence to show a potential role for the endoeannabinoid system in opioid 
reward. The genetic deletion of the cannabionoid (CBi) receptor in mice (Ledent et al. 
1999) resulted in reduced opioid intake which represents a reduction in opiate 
reinforcement (Caille et a l 2003). In addition, microdialysis studies of the NAc in 
mice lacking the CBi receptor showed that mesolimbic DA release in response to 
morphine was reduced compared to the wildtype mice (Mascia et al. 1999). This 
suggests that the link between the cannabinoid and opioid systems is not entirely 
dependent on MOPr mechanisms but also involves CBi receptor mechanisms 
(Lichtermann et al. 2000).
1.5 Cocaine and addiction
Cocaine is one of a group o f drugs of abuse known as psychostimulants; cocaine acts 
on monoamine transporters to block the re-uptake of DA, noradrenaline (NA) and 5- 
hydroxytryptamine (5-HT) into pre-synaptic neurons, thereby increasing synaptic 
concentrations of DA, NA and 5-HT whieh acutely increases aetivity at DAergic, 
adrenergic and 5-HT receptors (Heikkila et al. 1975; Koe 1976; Raiteri et al. 1977; 
Torres et al. 2003). Deficits in extracellular 5-HT and DA levels in the NAc have 
been shown following withdrawal from cocaine (Parsons et al. 1995), suggesting that 
the same neurotransmitter systems that are activated by acute cocaine treatment may 
underlie the symptoms o f cocaine withdrawal (Parsons et al. 1995). Repeated cocaine 
administration has also been shown to induce changes in G-protein coupled receptor
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systems in the brain, which include opioid, adenosine, glutamate and G ABA receptor 
systems (Unterwald et al. 1992; Turchan et al. 1999; Sharpe et al. 2000; Xi et al. 
2002; Toda et al. 2003; Xi et al. 2003).
Neuropharmacological studies have established an important role for the DAergic 
system in the reinforcing effects of cocaine (Woolverton et al. 1992), primarily due to 
the increased levels of DA in the NAc. For example, self-administration studies have 
shovm that the i.v. infusion o f cocaine causes an increase in extracellular DA in the 
NAc, measured using in vivo microdialysis (Pettit et al. 1989; Czoty et al. 2000). In 
addition, 6 -OHDA lesions in the NAc (Roberts et al. 1980; Pettit et al. 1984; Zito et 
al. 1985; Caine et al. 1994) and in the VTA (Roberts et al. 1982) disrupt cocaine self­
administration. Liao et al. (2000) demonstrated that the infusions o f cocaine into the 
NAc shell but not the core produced GPP, which suggests that the effects of cocaine 
may be region specific (Anderson et al. 2005). Furthermore, pretreatment with drugs 
inhibiting noradrenergic or serotonergic re-uptake did not inhibit cocaine self­
administration, suggesting that DA may be the primary catecholamine involved in the 
reinforeing effects of cocaine (De Wit et al. 1977; Woolverton 1992). However, the 
blockade of either DA Di or DA D2  receptors by administration o f selective 
antagonists directly into the NAc increases the rate of cocaine self-administration 
(Phillips et al. 1983), and the selective destruction of mesolimbic DA neurons in the 
NAc and/or central and peripheral noradrenergic systems, using 6 -OHDA, had no 
significant affect on cocaine place conditioning (Spyraki et al. 1982). These studies 
therefore suggest that cocaine may also ellicit its rewarding effects through non- 
DAergic mechanisms (Spyraki et al. 1982).
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Evidence supporting the role o f DAergic mechanisms in the rewarding effects of 
cocaine was shown following the administration of a DA uptake inhibitor which 
induced CPP, as would cocaine (Le Pen et al. 1996). The lesion o f presynaptic DA 
terminals o f the mPFC, using 6 -OHDA, depleted DA and NA in the mPFC but there 
were no significant reductions in the NAc or CPu compared to controls and no change 
in 5-HT levels in any of the regions (Hemby et al. 1992). Furthermore, the lesions 
failed to attenuate place conditioning induced by the administration of cocaine and no 
differences in spontaneous activity were observed between the lesioned and control 
mice during the pre-conditioning and test phase. This suggests that the depletion of 
DA and NA in the mPFC do not affect the rewarding efficacy of cocaine (Hemby et 
1992).
In transgenic mice, in which the gene for dopamine transporters (DAT) was disrupted, 
cocaine did not induce behavioural effects, such as enhanced locomotor activity and 
stereotypy, despite the lack of any increase in extracellular DA in the dorsal striatum 
(Giros et al. 1996; Carboni et al. 2001). However, cocaine-induced self- 
administration and CPP was maintained in DAT knockout mice (Carboni et al. 2001). 
Coeaine also induced increases in DA dialysate in the NAc, which suggests that the 
noradrenergic transporters expressed by noradrenergic terminals o f the NAc could, 
because of the absence o f DAT, act as an alternative site for DA clearance from the 
extracellular compartment (Carboni et al. 2001).
There is no doubt that DAergic mechanisms are involved in the mediation o f the 
rewarding effects o f cocaine but the influenee o f the DAergic receptors, particularly 
the DA D2  receptor, is uncertain, for example DA D2  receptor antagonists fail to
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influence cocaine-induced CPP whereas DA Di receptor antagonists block cocaine- 
induced place preference, which suggests that DA Di but not DA D2  are involved in 
the primary rewarding properties of cocaine (Cervo et al. 1995; Pruitt et al. 1995; 
Liao et al. 1998; Nazarian et al. 2004). In contrast, the injection of selective DA Di or 
DA D2  receptor antagonists into the NAc increased cocaine self-administration which 
suggests therefore that both DA Di and DA D2  reeeptors are involved in mediating the 
reinforcing actions of cocaine (Phillips et al. 1983; Maldonado et al. 1993). 
Interestingly, Baker et al. (1996) found that infusions of a low dose o f DA D2  
antagonist sulpride, that occupied over 42% of DA D2  receptors in the NAc, did not 
alter CPP but did attenuate cocaine-induced locomotion. In addition, a higher dose of 
sulpiride completely reversed cocaine-induced locomotion and occupied over 96% of 
sulpiride binding sites but still had no effect on CPP, further suggesting that perhaps 
DA D2  receptors in the NAc are not involved in cocaine-induced CPP but may be 
involved in cocaine-induced locomotion (Baker et al. 1996).
There is much evidence to show that eocaine can cause modifications in DA receptor 
function. The activity of NAc neurons is markedly inhibited by cocaine and Henry et 
al. (1989) identified that NAc neurons become supersensitive to these inhibitory 
effects of DA following chronic cocaine administration. Further studies showed 
significant increases in the inhibitory responses o f NAc neurons to a DA Di receptor 
agonist rather than DA D2  receptor agonist, which was maintained up to one month 
following withdrawal from cocaine (Henry et al. 1991; Henry et al. 1995). This 
response is thought to be mediated by the supersensitivity o f DA Di receptors (Henry 
et al. 1991; Xu et al. 1994a; Henry et al. 1998). This change in DA Di receptor 
sensitivity may participate in the development o f behavioural sensitisation seen
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following chronic exposure to cocaine (Henry et al. 1991). The repeated 
administration of cocaine, however, caused subsensitivity o f somatodendritic DA D% 
autoreceptors in the VTA (Henry et al. 1989; Ackerman et al. 1990; Lee et al. 1997). 
A similar effect is seen following DA D% receptor stimulation with the DA D] agonist, 
quinpirole (Henry et al. 1998).
The alteration in the sensitivity of the DA receptors in the VTA and NAc may be due 
to alterations in signal transduction mechanisms, as repeated exposure to cocaine 
upregulates the cAMP-signalling pathway in the NAc via the activation of DA Di 
receptors (Terwilliger et al. 1991; Unterwald et al. 1996; Freeman et al. 2001; Lu et 
al. 2003). Chronic but not acute cocaine treatment in rats produced a significant 
decrease in Gia and Goa protein levels in the VTA (Nestler et al. 1990; Striplin et al. 
1992), NAc (Nestler et al. 1990; Terwilliger et al. 1991) and LC (Nestler et al. 1990). 
Chronic cocaine administration had no effect on G-protein activity in any other brain 
regions; the changes were specific to the NAc, VTA and LC, which suggests that the 
regulation o f G-proteins may underlie the chronic effects of cocaine in these brain 
regions.
Synaptic plasticity in the VTA has been shown to play a role in the behavioural 
response of in vivo cocaine exposure. The potentiation o f excitatory synapses in the 
VTA is similar following acute and chronic exposure to cocaine (Ungless et al. 2001; 
Borgland et al. 2004), which suggests that the VTA plays an essential but transient 
role in behavioural sensitisation to cocaine. There was however an increase in 
locomotor activity following chronic treatment with cocaine (Borgland et al. 2004) 
which is thought to be due to adaptations responsible for sensitisation to cocaine.
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shifting from its initiation site in the VTA to its site of expression in the NAc over 
time (Wolf 1998; Vanderschuren et al. 2000).
Locomotor activity and stereotypic behaviour produced by cocaine is thought to be 
mediated by mesolimbic and nigrostriatal pathways. For example, lesions o f the NAc 
and CPu disrupt cocaine-induced locomotion and stereotypic behaviours (Kelly et al. 
1976). Moreover, loeomotor activity is increased after intra-accumbens administration 
of cocaine (Delfs et al. 1990) and the administration of DA D2 -selective antagonist 
into the NAc reverses cocaine-induced locomotion (Neisewander et al. 1995). 
Antagonists of DAergic, glutamatergic and GABAergic systems blocked cocaine- 
induced stereotypy whereas the agonists of all three systems induced stereotypic 
behaviour when administered into the striatum (Karler et al. 1995). This evidence 
implies that cocaine-induced stereotypy involves not only DA but also GABA and 
glutamate, and it has been postulated that the DAergic system activates the 
glutamatergic system which in turn activates the GABAergic system (Karler et al. 
1995), confirming that the interaction of all three systems is involved in coeaine 
addiction.
1.6 Adenosine and adenosine À2a receptors
Adenosine is an endogenous purine nucleoside involved in the modulation of several 
CNS activities; adenosine can be formed intraeellularly and extracellularly. 
Intracellular adenosine is formed by the enzymatic degradation of adenosine 
monophosphate (AMP) by 5 'nucleotidase, which can be transported into the 
extracellular space via specific bi-directional transporters (Zimmermann et al. 1998). 
Extracellular adenosine can be produeed by the degradation of adenosine triphosphate
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(ATP) by ectonucleotidases or by the metabolism of intracellular cAMP to AMP by 
extracellular phosphodiesterases and cAMP is subsequently despohosphorylated by 
5'nucelotidase to adenosine (Dunwiddie et al. 1997; Zimmermann et al. 1998). Its 
action is exerted via four cell surface adenosine receptors (Ai, A2 A, A 2 B, A3) 
(Fredholm et al. 1994), all o f which belong to the large family of G-protein coupled 
receptors (Linden et al. 1991). The adenosine Ai and A3 receptors are coupled to Gi/o 
heterotrimeric G-proteins. The binding of an agonist to the receptor induces a 
conformational change allowing the receptor to interact with and activate G-proteins, 
which inhibits AC and enhances the activation of phospholipases (Fredholm et al. 
1999).
The adenosine A2A and A2 B receptors are coupled to Gg-proteins and Goif proteins. The 
activation of these, results in an increase in cAMP through the stimulation o f AC 
activity (Fredholm et al. 1999). CGS 21680 (2-[p-(caboxyethyl)-phenyl-ethylamino]- 
5 ’ -N-ethylcarboxyamindoadenosine) is a relatively selective agonist for adenosine 
A2 A receptors, with little activity at adenosine A2 B sites (Lupica et al. 1990). 
Downstream from the formation of cAMP the striatum-enriched phosphoprotein, 
DARPP-32 becomes involved and activation of adenosine A2A receptors leads to a 
protein kinase A (PKA)-dependent phosphorylation o f DARPP-32 (Fig. 1.5) 
(Svenningsson et al. 1998b). Increasing evidence highlights the role o f adenosine in 
mediating responses induced by various drugs of abuse, including opioids and 
psychostimulants (Chen et al. 2000a). For a review see Ferre (2007).
39
1.6.1 Adenosine A2A receptors and dopamine interactions
The brain regions which constitute the basal ganglia are highly involved in the 
function of adenosine and DA reeeptors. Within the basal ganglia direct and indirect 
pathways connect the striatum to output structures, as reviewed by Ferre (1992) and 
Gerfen (1992). The direet pathway eonsists of the striatonigral and striato- 
entopeduncular neurons, which contain the peptides substance P and dynorphin while 
the indirect pathway consists of striatopallidal neurons, containing enkephalin (Fig. 
1.4) (Gerfen 1992).
The activation of adenosine A2 A receptors has a similar effect to the activation o f DA 
Dl receptors; upon activation, cAMP production is stimulated, activating PKA which 
promotes the phosphorylation of CREB and DARPP-32 and the inhibition of PP-1 
(Fig. 1.4) (Ferre et ah 2004; Salmi et al. 2005). Increased interest in adenosine A 2 A 
and DA D2  receptor interactions began following observations in binding assays, 
where the stimulation o f adenosine A2 A reeeptors caused a reduction in the affinity of 
DA D2  receptor agonist binding sites in membrane preparations from rat striatum 
(Ferre et ah 1991; Ferre et al. 1993), on signal transduction (Kull et al. 1999) and 
behaviourally (Fink et al. 1992; Fredholm et al. 1999; Svenningsson et al. 1999b). 
The interaction between adenosine A2 A receptors and DA D2  receptors is further 
supported by evidence of co-localisation in the striatum, NAc and tuberculum 
olfactorium. For reviews see Ongini and Fredholm (1996) and Svenningsson (1998a). 
In the striatum, adenosine A2A receptors are restricted to the GABAergic 
striatopallidal neurons, where DA D2  receptors are also expressed, as revealed by in 
situ hybridisation and immunohistochemistry (Schiffmann et al. 1991; Fink et al. 
1992).
40
INDIRECT
SINGPENK
STRIA TUM
SN
DYN
DIRECT
Figure 1.4: A diagram showing direct and indirect striatal efferent pathways 
involving both adenosine and DA receptors
The cortex provides excitatory inputs (+) to the striatum. The GABAergie-enkephalin 
(ENK) striatal neurons, that constitute the indirect pathway, contain DA D2 receptors 
(D2 ), adenosine Ai (Ai) and A2A (A2A) receptors and provide an inhibitory input (-) to 
the GP. Pallidal neurons inhibit the STN which provides an excitatory input to the SN. 
The GABA-ergic-substance P (SP)-dynorphin (DYN) striatal neurons which 
constitute the direct pathway express DA Di receptors (Di) and adenosine Ai 
receptors (Ai) and provide an inhibitory input to the SN. Adapted from Gerfen (1992) 
and Ferre et a/.(1992).
The administration of a DA D2 receptor antagonist or the lesion of DAergic neurons, 
using 6 -OHDA, enhanced activity in neurons that expressed adenosine A2 A receptors, 
which could be abolished by blocking the adenosine A2 A receptors; this confirms that 
adenosine A2 A receptors and DA D2 receptors interact in an antagonistic manner 
(Ongini et al. 1996; Ferre et al. 1997; Svenningsson et al. 1998a; Svenningsson et al. 
1999a). Furthermore, the binding of DA D2  antagonists was not affected by adenosine 
A2 A receptor activation, whieh suggests a possible interaction at the receptor/G- 
protein coupling level (Ferre et al. 1991).
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There is extensive evidence which strongly supports the hypothesis that the 
interaction between adenosine A2 A and DA D2  receptors is a direct intra-membrane 
receptor-receptor interaction (Zoli et al. 1993) most likely related to the formation of 
heterodimers (Zoli et al. 1993; Fuxe et al. 1998; Hillion et al. 2002; Canals et al. 
2003; Fuxe et al. 2003). It was postulated that the formation of adenosine A2A and DA 
D2  receptor heterodimers caused allosteric changes which modified ligand affinity, as 
well as G-protein coupling, and therefore the efficacy to control the target proteins in 
the membrane (Fuxe et al. 1998; Hillion et al. 2002; Torvinen et al. 2004; Torvinen et 
al. 2005).
Due to the antagonistic DA D2  and adenosine A2 A receptor interaction at the AC level, 
DA D2 receptor stimulation inhibits the products of adenosine A2A receptor-mediated 
cAMP accumulation and PKA activation such as the phosphorylation o f DARPP-32 
and the phosphorylation of CREB. DA D2  receptor activation does not only inhibit 
AC but also activates PLC, which then activates PP-2B which in turn activates L-type 
voltage dependent calcium channels (Fig. 1.5) (Ferre et al. 2004; Salmi et al. 2005). 
Interestingly, DARPP-32 phosphorylation and immediate early gene expression in the 
striatum was abolished in adenosine A2 A receptor knockout mice, which indicates that 
perhaps adenosine A2A receptors are capable o f DA D2  dependent and independent 
signalling (Svenningsson et al. 2000; Dassesse et al. 2001). Adenosine A2 A receptor 
agonists and antagonists elicited similar behavioural and cellular effects in the DA D2  
receptor knockout mice and wildtype mice (Aoyama et al. 2000; Zahniser et al. 2000; 
Chen et al. 2001), further strengthening the hypothesis that adenosine A2 A and DA D2  
receptors may have opposing but independent actions (Svenningsson et al. 1999b).
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The activation of adenosine A2 A receptors in the brain has been shown to induce 
catalepsy in mice (Ferre et al. 1991), modulate rotational behaviour following 
DAergic stimulation of the striatum in rats (Popoli et al. 1994) and regulate 
apomorphine-induced turning in rats with unilateral striatal DA innervation (Vellucci 
et al. 1993). These motor effects are thought to be due to the activation o f the highly 
abundant adenosine A2 A receptors in the striatum and may also be due to the 
interaction of adenosine A2A and DA D2 receptors.
The adenosine A2 A receptor was the first adenosine receptor to be genetically deleted 
in mice (Ledent et al. 1997) providing a valuable in vivo method of research. Four 
adenosine A2A receptor knockout mouse lines in three genetic backgrounds have been 
developed, CDl (Ledent et al. 1997), 129-steel x C57BL/6 (Chen et al. 2000a), pure 
129-Steel (Chen et al. 1999) and pure C57BL/6 (Bastia et al. 2005). Physiological and 
behavioural changes such as reduced exploratory behaviour and increased anxiety in a 
novel environment were recorded (Ledent et al. 1997). It is thought that these 
behavioural changes may be related, for example the reduced exploratory behaviour 
may be a result o f increased anxiety. An increase in aggressive behaviour was also 
observed and was confirmed by the resident intruder test, in which the adenosine A2 A 
knockout mice were more aggressive to intruders than wildtypes (Ledent et al. 1997).
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Figure 1.5: Mechanisms involved in biochemical reaction between DA D% and 
adenosine À2a receptors in striatopallidal neurons. As a consequence of the 
antagonistic DA D2 and adenosine A2 A interaction at the AC level, DA D2 receptor 
stimulation inhibits the products of adenosine A2 A receptor-mediated cAMP 
accumulation and PKA activation, such as phosphorylation o f DARPP-32 and CREB. 
DA D2 receptor also aetivates PLC, which activates PP-2B, which inactivates L-type 
VDCCs. Solid black arrows represent stimulatory effects and broken arrows represent 
inhibitory effects. Adapted from Ferre et al. (2004) and Svenningsson et al. (1999b).
The adenosine A2 A receptor agonist, CGS 21680, had no significant effect on 
adenosine A2A knockout mice, as expected. The adenosine A2 A receptor antagonist, 
caffeine, exhibited a strong depressant effect in adenosine A2 A receptor knockout 
mice suggesting that adenosine A2A receptors are required to produee the stimulatory 
locomotor effect seen in wildtype mice (Ledent et al. 1997). Adenosine A2 A receptor 
knockout mice also had increased blood pressure (Ledent et al. 1997).
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Using in vivo microdialysis, Dassesse et al (2001) showed a decrease in DA and an 
increase in glutamate extracellular levels in the striatum of adenosine A2 A receptor 
knockout mice. This was associated with an up-regulation of DA Di and DA D2  
receptor expression (Dassesse et al., 2001). These findings particularly highlight the 
importance of adenosine A2 A receptors in the DAergic system, as the absence of 
adenosine A 2A receptors leads to a functional hypo-DAergic state (Dassesse et al 
2001)
Adenosine Ai receptors have a widespread distribution throughout the brain but are 
mainly localised in the DA Di receptor rich striatonigral and striato-entopeduncular 
GABAergic neurons (Gerfen 1992; Hersch et al 1995; Yung et al 1995; Ferre et a l 
1997). Antagonistic Ai/Di receptor interactions appear to exist in striatal membranes 
and in vivo microdialysis studies have shown that the infusion of an adenosine Ai 
receptor agonist in the CPu counteracted the effect of a DA Di receptor agonist in 
increasing GABA levels (Ferre et a l 1996). The striatal infusion o f the NMDA 
antagonist, MK801, partially counteracted the effect o f the DA Di receptor agonist 
suggesting that NMDA receptors may also be involved in the antagonistic Ai/Di 
receptor interaction (Ferre et a l 1996; Ferre 1997). It has been postulated that the 
adenosine Ai receptor-mediated modulation of DA release might play some role in 
behavioural effects of adenosine receptor agonists (Popoli et a l 1994).
Adenosine Ai and A2 A receptor agonists inhibit the motor activating effects induced 
by DA Dl and D2  receptor agonists, respectively (Ferre et a l 1994). Selective 
adenosine Ai receptor antagonists potentiate DA Di receptor agonist-induced motor
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activation. However, adenosine A 2A receptor antagonists also potentiate DA Di 
receptor agonist-mediated motor effects, as shovm by a potentiation o f turning 
behaviour in rats with unilateral striatal DA innervation (Popoli et al. 1994; Pinna et 
al. 1996; Popoli et al. 1996; Fenu et al. 1997). These behavioural responses correlate 
well with the proposed adenosine-DA receptor interactions. Although adenosine A2 A 
and DA Di receptors are not located on the same striatal neurons the interactions 
could be explained by a synergistic effect between the direct and indirect pathways 
(Ferre cr a/. 1997).
Adenosine A2A receptors are preferentially Goif coupled in the striatum and are 
expressed on GABAergic striatopallidal neurons, but are also present at a much lower 
level in the cortex, amygdala, OT, hippocampus, hypothalamus, thalamus and 
cerebellum (Cunha et al. 1994; Johansson et al. 1995). The adenosine A2 A receptors 
show a postsynaptic distribution similar to that of postsynaptic DA Di and D2  
receptors (Boyson et al. 1986; Alexander et al. 1989). This localisation o f adenosine 
A2A receptors in DA rich areas o f the brain is thought to have implications in 
addiction.
1.7 Involvement of the adenosine A2A receptor in responses to morphine
The role o f adenosine in opioid addiction, specifically withdrawal, has been an area of 
much interest. Pharmacological studies using the selective adenosine A2 A agonist, 
CGS21680, identified a reduction in some of the signs o f morphine withdrawal, 
whereas antagonists produced the opposite effect (Kaplan et al. 1996; Salem et al. 
1997). Added to this, the blockade o f adenosine metabolism via adenosine kinase 
inhibitors reduced the extent of morphine withdrawal (Kaplan et al. 1998).
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An increase in the breakdown products of adenosine, hypoxanthine and inosine, are 
also seen in the NAc dialysate of morphine withdrawn rats (Salem et al. 1999), 
suggesting that adenosine may modulate the expression of withdrawal behaviour 
through the involvement of the adenosine A%A receptor (Salem et al. 1997). Salem and 
Hope (1999) postulated that endogenous adenosine released during morphine 
withdrawal produces an inhibitory tone and when this tone is blocked or interrupted 
the severity o f morphine withdrawal increases.
To study withdrawal, adenosine A2 A receptor knockout mice and wildtype controls 
were injected with morphine for a period of six days (Berrendero et al. 2003) or 
implanted with a mini pump for seven days (Bailey et al. 2004) and then injected with 
naloxone on the final day. The expression o f morphine withdrawal was enhanced in 
the knockout mice (Berrendero et al. 2003; Bailey et al. 2004). Due to the effect of 
morphine withdrawal on the DAergic system in the striatal and limbic regions o f the 
brain it is likely that the adenosine and DA interaction is involved in the morphine 
withdrawal syndrome (Di Chiara 1995). Despite this, no changes in DA D2  receptor 
binding were observed in morphine withdravm adenosine A2 A receptor knockout mice 
(Bailey et al. 2004). This would therefore suggest that changes in DA D2  receptor 
expression may not be involved in the modulation o f locomotor signs in opioid 
withdrawn adenosine A2 A receptor knockout mice. This, however, does not 
necessarily suggest a lack o f DAergic involvement as Dassesse et al. (2001) 
demonstrated a decrease in extracellular DA in adenosine A2 A receptor knockout mice 
which could be reflected in the decrease in locomotor activity seen in morphine 
withdrawn adenosine A2 A receptor knockout mice (Bailey et al. 2004).
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To add to this, no change in MOPr binding was observed in morphine withdrawn 
adenosine A2 A knockout mice (Bailey et a l 2002; Bailey et a l 2004), suggesting that 
the enhancement in morphine withdrawal is not related to any alteration in the MOPr 
expression (Bailey et a l 2004). However, a significant increase in the levels o f MOPr 
stimulated G-protein activity in morphine withdrawn adenosine A2 A knockout mice 
was observed in the NAc but not the CPu (Bailey et a l, 2004). The activation of 
MOPr has been shown to increase DA release and transmission in the NAc (Nestler et 
al 1993; Di Chiara 1995) and therefore the increase in MOPr G-protein activity may 
be a compensatory mechanism to increase the levels of already low DA in morphine 
withdrawn adenosine A%A receptor knockout mice (Bailey et a l 2004).
Deletion of the adenosine A2 A receptor abolished the rewarding responses o f 
morphine at both 5 and 10 mg/kg, shovm using a CPP paradigm (Castane et a l 2008; 
Brovm et a l 2009). In addition, the absence of the adenosine A2 A receptor reduced 
the self-administration of morphine, a response shown to be specific to drug 
reinforcers as no genotype difference was shown during sucrose self-administration 
(Brown et a l 2009). This also suggests that the lack of CPP and self-administration is 
unlikely to be due to a learning impairment. Wang et ah (2003) demonstrated that 
CDl adenosine A2 A receptor knockout mice display enhanced spatial recognition 
memory and should therefore have no learning impairment in a CPP paradigm. This 
evidence suggests that morphine may have a decreased reward value to mice deficient 
in the adenosine A2A receptor; perhaps adenosine A 2A receptor knockout mice 
represent a phenotype o f low vulnerability to drug addiction and the absence of the
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adenosine A2 A receptor may provide resistance against the addictive properties of 
drugs o f abuse (Brown et al. 2009).
Adenosine A%A receptor knockout mice are hypo-DAergic and an increase in the 
expression of DA Di and DA D2  mRNA in the striatum of adenosine A2 A receptor 
knockout mice was shown (Dassesse et al. 2001), a finding which is consistent with 
models of decreased DAergic function (Fang et al. 1997; Smith et al. 1997). 
Therefore, a decreased DAergic state correlates with decreased reward in adenosine 
A2 A receptor knockout mice. In contrast, Castane et al. (2008) demonstrated that the 
administration of morphine had no effect on extracelluar DA levels in the NAc of 
adenosine A 2A receptor knockout or wildtype mice compared with saline-treated 
groups, as did Rethy et al. (1971), Gupta et al. (1988) and Castane et al. (2006). 
Others have shown morphine-induced DA release in C57BL/6 strain o f mouse 
(Chefer et al. 2003) suggesting that DA response may be altered in different strains of 
mice (Castane et al. 2008).
The interactions between adenosine A 2A receptors and DAergic systems are complex 
and have been shown to involve second messenger systems (see section 1 .6 . 1 ). 
DARPP-32, which is involved in DA transmission, is altered in mice lacking 
adenosine A2 A receptors (Svenningsson et al. 2000) and a large body of evidence 
supports a role for DARPP-32 dependent signalling in mediating the action o f drugs 
of abuse, including morphine (Svenningsson et al. 2005).
Despite the fact that the rewarding properties of morphine seem impaired in adenosine 
A2 A receptor knockout mice the acute motor responses were preserved (Castane et al.
49
2008; Brown et al. 2009) suggesting that the adenosine A2 A receptor may not be 
involved in mediating the psychomotor responses to morphine. Activation o f DA Di 
receptors on striatal medium spiny neurons is involved in psychomotor effects of 
morphine as morphine-induced locomotion can be inhibited by the systemic 
administration of the DA Di receptor antagonist, SCH23390 (Jeziorski et al. 1995; 
Serrano et al. 2002; Brown et al. 2009). Adenosine A2A receptors are not expressed 
on the same striatal neurons as DA Di, which could explain the absence of adenosine 
A2A receptor involvement in the mediation of locomotor activity in response to 
morphine (Brown et al. 2009).
Adenosine A2 A receptor knockout mice also sensitised to morphine (Brown et al. 
2009) indicating that the adenosine A2A receptor is not necessary for the development 
of morphine sensitisation. This is consistent with evidence that an adenosine A% 
receptor antagonist was able to inhibit the development of sensitisation to morphine in 
mice (Weisberg et al. 1999). The role of adenosine in morphine-induced sensitisation 
may therefore be through the adenosine Ai rather than adenosine A2 A receptor.
These results suggest that adenosine A2A receptors play a crucial role in the rewarding 
effects of morphine and are required for modulating the negative motivational effects 
associated with morphine withdrawal (Berrendero et al. 2003; Bailey et al. 2004; 
Castane et al. 2008; Brown et al. 2009).
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1.8 Involvement of adenosine A2A receptors in responses to cocaine
There is ample evidence to show an interaction between cocaine and the 
adenosinergic system. The selective adenosine A2 A receptor agonist CGS21680 and 
the adenosine A2 /A 1 receptor agonist 5’-N-ethylcarboxamidoadenosine (NECA) 
inhibit the initiation of cocaine-induced self-administration (Knapp et a l 2001) and 
partly reverse cocaine-induced locomotion (Poleszak et a l 2002a). These results 
could be due to the involvement of DA D2  receptors in cocaine-induced responses 
(Ushijima et a l 1995; Kita et a l 1999; Adams et a l 2001; Schindler et a l 2002) and 
by the existence of adenosine A2a/DA D2  heterodimeric complexes in which 
adenosine A2 A receptor activation inhibits DA D2  receptor signalling by a reduction in 
the affinity of DA D2  receptors and G-protein coupling (Fuxe et al 1998; Hillion et 
al 2002; Canals et a l 2003; Fuxe et a l 2003).
There is also evidence to suggest that adenosine A2A receptors are involved in the 
process of cocaine-induced sensitisation. CGS 21680, was found to attenuate both the 
development and expression of cocaine induced sensitisation (Filip et a l 2006); this 
was also the case for the psychotimulant methamphetamine (Shimazoe et a l 2000). 
Adenosine A2 A receptors are also likely to be involved in cocaine-induced 
withdrawal. Mice were trained to associate reward with an electrical brain 
stimulation, with the current threshold indicative o f a measure o f reward. Mice 
withdrawn from cocaine produced an elevation in threshold which suggested a 
reduction in the rewarding properties of the electrical brain stimulation. The threshold 
elevation produced by cocaine withdrawal was reversed by an adenosine A2 A receptor 
antagonist, increasing the rewarding properties o f the electrical brain stimulation. In 
addition, the infusion of an adenosine A2 A receptor agonist directly into the NAc
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produced an elevation in threshold, shown during cocaine withdrawal (Baldo et al.
1999). These findings suggest that adenosine via adenosine A2 A receptors may inhibit 
central reward processes during chronic drug-induced neuronal activation (Baldo et 
al. 1999).
Adenosine A2 A receptors have been shown to be involved in the various aspects of 
cocaine addiction, making it difficult to identify the specific role o f adenosine A2 A 
receptors. The development of adenosine A2A receptor knockout mice provides a 
genetic model for the specific study of adenosine A2 A receptors and cocaine 
interactions in vivo. Chen et al. (2000a) were able to show that cocaine-induced 
locomotion was attenuated (rather than enhanced) in adenosine A2 A receptor knockout 
mice compared to wildtypes. This effect was selective to cocaine as both DA Di and 
D2  receptor agonists produced the same effects in the adenosine A2 A receptor 
knockout and wildtype mice (Chen et al. 2000a). In addition, there was no change in 
the expression of striatal DA Di and D2  receptors between the adenosine A 2 A receptor 
knockout and wildtype mice (Chen et al. 2000a). The results shown here conflict with 
the principle that adenosine A2 A and DA D2  receptors have an antagonistic 
relationship. The reason remains unknown although a possible explanation could be 
the difference between genetic and pharmacological studies of adenosine A2 A receptor 
studies (Chen et al. 2000a).
In contrast to the findings above, Soria et al. (2006) revealed a similar locomotor 
sensitisation in the adenosine A2 A receptor knockout mice and wildtype mice. It has 
been suggested that the discrepancies between the findings of Chen et al. (2000a) and 
Soria et al. (2006) may be due to the difference in the genetic background (C57BL/6 x
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129-Steel vs CD l) in addition to the different experimental conditions employed in 
each experiment (Soria et a l 2006). Mice lacking adenosine A2 A receptors also show 
a decrease in self-administration and motivation for cocaine but there was no change 
in the acute rewarding effects of cocaine, measured using CPP, compared to wildtypes 
(Soria et a l 2006).
Despite the availability of an adenosine A2 A receptor knockout model the specific 
influence o f adenosine A2A receptors on cocaine addiction is unknown. In particular 
little is known about the role of extra-striatal adenosine A2 A receptors in modulating 
psychomotor activity. The development of two brain region specific adenosine A2 A 
receptor knockouts; striatum-specific adenosine A2 A receptor knockout and the 
forebrain adenosine A2 A receptor knockout, which includes the deletion of adenosine 
A2A receptors from the striatum, cerebral cortex and hippocampus (Shen et a l 2008) 
enabled this. Cocaine-induced psychomotor activity was attenuated in the forebrain 
adenosine A2 A receptor knockouts, which is consistent with the results reported by 
Chen et a l  (2000a). In the striatal adenosine A2 A receptor knockout mice, however, 
cocaine-induced psychomotor activity was enhanced (Shen et a l 2008), most likely 
due to the antagonistic adenosine A2A and DA D2  interaction at striatopallidal neurons 
(Ferre et a l 1997). The opposite cocaine-induced responses in the two knockout mice 
provide the first evidence that extra-striatal neurons are in fact critically involved in 
the modulation o f psychomotor activity (Shen et a l 2008).
In addition, Shen et a l  (2008) reported that a combined treatment with an adenosine 
A2 A receptor antagonist and cocaine caused an enhancement in psychomotor activity 
in wildtype and forebrain adenosine A2A receptor knockout mice but an attenuation in
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the striatum specific adenosine A%A receptor knockout mice, which reiterates the 
opposing phenotypes created by the two knockouts (Shen et a l 2008). The attenuation 
in psychomotor activity seen in the striatal adenosine A2 A receptor knockout mice is 
likely to be due to the fact that the adenosine A2 A receptor antagonist blocks the 
receptors in the extra-striatal neurons therefore reducing the activity induced by 
cocaine (Shen et a l 2008).
1.9 Thesis hypothesis and aims
There is evidence to support the role of adenosine and adenosine A2A receptors in 
morphine and cocaine addiction. The co-expression of adenosine A2 A and DA D2  
receptors in striatopallidal neurons and their antagonistic interactions are thought to 
mediate different phases of morphine- and cocaine-induced addictive responses. The 
general aim of this thesis was to further explore the links between adenosine A2A and 
DA D2  receptors and morphine and cocaine addiction using the CDl strain o f 
adenosine A2 A receptor knockout mouse. The individual aims are as follows:
1) To investigate, using single cell electrophysiology, DA D2  receptor function in 
VTA DA cells in CDl wildtype and adenosine A2 A receptor knockout mice
2) To study conditioning, extinction and reinstatement to morphine and cocaine 
in CDl wildtype and adenosine A2A receptor knockout mice and C57BL/6 
mice using a conditioned place preference paradigm.
3) To determine, using quantitative autoradiography, the distribution of MOP 
receptors in the VTA of CDl and C57BL/6 mice. To further study the 
functionality of the MOP receptors in the VTA and SN in these mice using 
MOP receptor-stimulated [^^S]GTPyS quantitative autoradiography
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4) To identify, using quantitative autoradiography, whether there is a relationship 
between the responsiveness of CDl mice to cocaine and the density o f DA Di 
receptors, DA D2  receptors, DAT and the functionality of DA D2  receptors 
using DA D2  receptor-stimulated [^^S] GTPyS.
5) To evaluate the role of adenosine A2A receptors in chronic cocaine addiction 
using CDl adenosine A2A receptor knockout mice following the 14 day 
administration of cocaine using in vivo microdialysis to measure DA release in 
the NAc.
6) To investigate whether the absence of the adenosine A 2A receptors alters the 
effect o f a 14 day chronic ‘binge’ cocaine treatment on the locomotor activity.
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Chapter 2
Dopamine D% receptor function in dopamine cells in the VTA in CDl 
wildtype and adenosine A%A receptor knockout mice
2.1 Introduction
The application o f extracellular electrophysiology to tissue from various regions 
within the brain has greatly advanced our understanding of the influence o f 
transmitters on midbrain DA cell function (Kalivas 1993; Lacey 1993). Historically, 
studies have focused on DAergic neurons in the SN, as they are well characterised 
(Kalivas 1993). However, increased interest has focused on the DAergic neurons o f 
the VTA where two ascending DAergic pathways, mesolimbic and mesocortical 
pathways, originate and which is a key brain region involved in the modulation of 
reward processes of addiction. DA D2  receptors are present in high density in the 
VTA (Bouthenet et a l 1987; Wamsley et a l 1989) and the majority o f DA D2  
receptors are located on DAergic neurons (Bouthenet et a l 1987; Chen et a l 1991; 
Adell et a l 2004). The main role o f DA D2  receptors in the VTA is the regulation of 
DA release; the perfusion of a DA D2 receptor agonist into the VTA decreased 
DAergic neuronal firing whereas a DA D2 antagonist increased DAergic neuronal cell 
firing. DA is somatodendritically released by DAergic neurons in the VTA and the 
DA D2  receptors present on the DAergic neurons act as autoreceptors (Wamsley et a l 
1989; Sibley et a l 1993). The release of DA is likely to modulate the activity of 
DAergic neurons via the interaction with inhibitory autoreceptors (Mercuri et a l 
1997; Adell et a l 2004).
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Adenosine A2A receptors are highly expressed in DAergic pathways in the brain and 
are co-localised with DA D2  receptors in the striatum (Ferre et al. 1997). These 
receptors have opposing roles within the striatum, the DA D2  receptor decreases 
cAMP levels whereas the adenosine A2 A receptor increases cAMP levels (Ferre et al.
1997). This interaction may be an underlying mechanism for the involvement of 
adenosine A2A receptors in the reward process of addiction, which has prompted 
much research into the action of these receptors in the striatum. To date, there are no 
adenosine A2 A receptors found or identified in the VTA (Sebastiao et al. 1996; 
Moreau et al. 1999), however the nucleus accumbal region of the striatum is known to 
send negative feedback projections to the VTA (Kalivas 1993; Kalivas et al. 1993; 
Pierce et al. 2006) therefore interactions between adenosine A2 A receptors and DA D2  
receptors in the striatum may have an indirect effect on DAergic neuronal activity and 
cell firing in the VTA.
It was hypothesised that DAergic neuronal firing in the VTA may be altered in CDl 
adenosine A2 A receptor knockout mice. To test this hypothesis, in vitro brain slice 
preparation, optimised to evaluate the effects o f chemical compounds on DAergic 
systems in the VTA was used to take electrophysiological recordings. The VTA is 
known to contain two major types of neurons, DAergic neurons and GABAergic 
neurons, which can be identified by their well-defined electrophysiological properties 
(Grace et al. 1989; Johnson et al. 1992b; Chen et al. 2003). Single VTA DA neuron 
firing ranges between 0.5 and 4 Hz with an action potential of approximately 3 ms in 
duration whereas GABAergic neurons exhibit short duration action potentials o f less 
than 2 ms and high firing rates greater than 4 Hz. Upon the identification o f a VTA
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DA cell in the brain slice, the firing rate was recorded and the effect of various 
agonists and antagonists on the rate of DAgeric cell firing was assessed.
2.2 Methods
2.2.1 Maintenance and genotyping of the adenosine Aia receptor knockout 
mouse colony
The CDl adenosine A2 A receptor knockout mice were originally created by Ledent et 
al (1997) and generously supplied in order to maintain a breeding colony within the 
University of Surrey. In these mice the coding region of the adenosine A 2A receptor 
gene is disrupted.
A breeding colony of these mice has been maintained at the University o f Surrey 
experimental biology unit (EBU) for approximately 10 years. The mice were bred 
from heterozygote breeding pairs. These breeding pairs originated from the individual 
crossing of a number of heterozygote males from the existing colony each with a 
wildtype female from an external supplier (Charles River, Margate, Kent). The male 
and female heterozygotes from the litters of the newly created breeding pairs were 
paired and these formed the main breeding colonies which were maintained for 
approximately a year before new breeding pairs were created. The mice are housed in 
groups of approximately 4-5 mice per cage, in a temperature-controlled environment 
on a 12 h light/dark cycle and fed a pellet diet with water available ad libitum. All 
experimental procedures were conducted in accordance with the UK Animal 
Scientific Procedures Act 1986.
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A polymerase chain reaction (PCR) based method was used to genotype the mice at 
weaning, three weeks old. Tail tip samples were taken from which DNA was 
extracted using the DNeasy tissue kit (Qiagen, Hilden, Germany) following the 
manufacturer’s protocol.
In brief, all samples were incubated in a water bath at 55°C with proteinase K (Sigma- 
Aldrich, Dorset, UK) and left overnight to break down. The following day the cells in 
the sample were lysed with ethanol and transferred to individual spin columns, 
composed of a silica-gel membrane allowing DNA to selectively bind. Two 
centrifugation steps with washes followed, removing any contaminants and binding 
the DNA to the column. The spin columns were transferred to collection tubes and the 
DNA extracted upon the addition of a buffer, releasing the DNA from the membrane. 
The extracted DNA was then subjected to PCR amplification, using puReTaq Ready- 
To-Go PCR beads (GE Healthcare, Buckinghamshire, UK) and three custom primers 
(Sigma-Genosys, Suffolk, UK):
1) The common forward primer: AGTCATGGTTTCGGGAGATG
2) The wild-type reverse primer ACC AT GAT GTAC ACCGAGG AG
3) Adenosine A 2A receptor knockout reverse primer: 
AAGGAAGGGTGAGAACAGAG
These were used to selectively amplify fragments of different sizes from the wildtype 
and adenosine A2 A receptor knockout alleles. Primers 1 and 2 amplified a 229 base 
pair band from the wildtype allele, whereas primers 1 and 3 amplified a 572 base pair 
from the mutated allele. Heterozygous mice carrying a copy of both alleles resulted in 
2 bands, enabling the identification of three genotypes (Fig. 2.1). A total volume o f 25
59
pi per reaction was made up of 2 pi of each primer, 6 pi of DNA sample and 13 pi o f 
MilliQ water. The cycle parameters for the PCR were as follows:
1) Pre-cycle for 2 min at 94®C
2) Dénaturation for 30 s at 94°C
3) Annealing for 1 minute at 56°C
4) Elongation for 1 minute 15 s at 72°C
5) Post-cycle for 5 min at 72°C 
This process was repeated for 40 cycles.
The PCR products were separated by gel electrophoresis using 2% agarose double 
comb e-gels (Invitrogen, Carlsbad, CA, USA) allowing the identification o f the 
genotypes by comparison to the HyperLadder I DNA ladder (Bioline, London, UK) 
(Fig. 2.1).
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Figure 2.1: A representation (A) and an example (B) of how the PCR products of 
the genotyping reaction were separated by gel electrophoresis Lane 1 : DNA 
Ladder, Lane 2: +/+ wild type allele, 229 bp. Lane 3: -/- knockout allele, 572 bp. Lane 
4: +/- heterozygote, 229 and 572 bp.
2.2.2 Electrophysiological experiments
Physiological buffer solutions
Sucrose-containing buffer was necessary to maintain tissue homeostasis during the 
sectioning of the brain. 1 L of sucrose-containing buffer was prepared using: 200 mM 
sucrose, 10 mM 4-(2-hydroxyethyl)-1 -piperazineethanesulfonic acid (HEPES), 25 
mM NaHCOg, 10 mM MgS0 4 , 2.5 mM KCl, 1.2 mM NaH2 ? 0 4 , 0.5 mM CaCl]. The 
sucrose-containing buffer was stored at 4°C, with additional 50 ml aliquots frozen and 
stored at -20°C for use during sectioning.
Artificial cerebro-spinal fluid (aCSF) was formulated to mimic cerebral spinal fluid 
and maintain the spontaneous activity of neurons within the brain sections. The final 
concentrations of aCSF consisted of: 2.5 mM CaCL, 10 mM glucose, 25 mM
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NaHCOs, 1.25 mM NaH2P 0 4 , 3.75 mM KCl and 1.2 mM MgS0 4 . A five times 
concentrate stock solution of aCSF lacking CaCh and glucose was prepared in 
advance and stored at 4°C. Prior to experimentation, the aCSF was prepared by 
diluting the stock solution in distilled water and adding CaCl2  and glucose.
Preparation and sectioning o f  the brain
Mice were killed by cervical dislocation, immediately dissected and the brains were 
immersed in ice cold sucrose-containing buffer and bubbled with 95% 02/5% CO2 . 
The brain was then trimmed to form a block, containing the midbrain, which was 
mounted and fixed with cyanoarylic gel to a glass cutting stage o f a vibratome (Series 
1000 Vibratome, St. Louis, Missouri, USA). The vibratome also contained ice cold 
sucrose-containing buffer, bubbled with 95% 02/5% CO2 . Coronal sections (300 pm) 
were cut and the VTA and SN identified in the sections using a dissection microscope 
and a mouse brain atlas (Franklin et a l 1997). The sections containing the VTA were 
collected and placed in an incubation chamber containing aCSF supplied with 95% 
0 2 /5 % CO2 , for 1-3 h, at room temperature.
Electrophysiological recordings
A  single brain section was placed in the recording chamber, maintained at 32 ± 0.5°C 
and continuously perfused with oxygenated aCSF at a flow rate of 2 ml/min. In the 
recording chamber the VTA area was identified, visually, as a grey area medial to the 
SN and lemniscus. Borosilicate glass microelectrodes with a tip of approximately 1 
pm, pulled with a P-97 Flaming/Brown micropipette puller (Sutter Instrument 
Company, Novato, California, USA), were filled with aCSF to give an impedance o f 
3-6 MQ and lowered into the VTA. Extracellular recordings of action potentials from
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single cells in the VTA were amplified 1000 times and digitised using CED 1401 
Micro Mark 2 (Cambridge Electronic Design Ltd, Cambridge, UK). The signals were 
recorded in 10 s bins and captured with Spike 2 Software Version 5.2 (Cambridge 
Electronic Design Ltd, Cambridge, UK).
DAergic cells were identified by their characteristic firing pattern and data were 
recorded if  a stable baseline could be maintained for 2-3 h. The solution perfusing the 
brain section in the recording chamber was switched between aCSF alone and aCSF 
containing a drug. Drug applications were for approximately 5 min. A period of 
approximately 140 s was required for the perfusion solution to reach the tissue.
2.2.3 Materials
The sucrose was purchased from Fisher Scientific Ltd (Loughborough, Leicestershire, 
UK) and all other reagents were supplied by BDH Chemicals Ltd (Poole, Dorset, UK) 
and VWR International Ltd (Lutterworth, Leicestershire, UK).
Qunipirole, a DA D2  receptor agonist and CGS 21680, an adenosine A2 A receptor 
agonist were dissolved in deionised water, and sulpiride, a DA D2  antagonist was 
dissolved in dimethylsulphoxide (DMSO), the working concentration of sulpiride 
contained <0.001% DMSO. Less than 0.1% of DMSO alone has been shown to have 
no effect on the firing rate of DAergic neurons in the VTA (Bowery et a l 1994). All 
drugs were stored at various concentrations in 25-60 pi aliquots at -25°C until 
required. Working concentrations were prepared by diluting the drug 1000 fold in 
aCSF. All drugs used were perfused in aCSF when applied to the brain slice. 
Quinpirole was purchased from Tocris Bioscience (Bristol, Somerset, UK) and CGS
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21680 and sulpiride were supplied by Sigma-Aldrich Company Ltd (Gillingham, 
Dorset, UK).
2.2.4 Data Analysis
Cellular depolarisations were recorded as spikes and divided into 10 s bins. The 
frequency of spikes before drug application and after the washes, were taken as the 
baseline mean frequency. Baseline data from wildtype and knockout mice were 
analysed using a Student’s t-test and compared. The remaining data were analysed 
using a two-way analysis of variance (ANOVA) followed by a Newman Kewls post- 
hoc analysis. In some cases the data were normalised prior to analysis.
2.3 Results
The baseline firing frequency in wildtype and adenosine A2A receptor knockout mice 
was not significantly different (P>0.05; Student’s t-test) (Fig. 2.2). Various 
concentrations o f the DA D% receptor agonist, quinpirole, were applied to the 
perfusate for 5 min in a cumulative manner. With increasing concentrations o f 
quinpirole, a decrease in firing frequency of VTA DA cells, in wildtype and 
adenosine A2A receptor knockout mice was observed (Fig. 2.3). Complete inhibition 
of cell firing was achieved at IpM  quinpirole in wildtype mice but complete 
inhibition was not achieved in adenosine A2 A receptor knockout mice even at a 
concentration up to 50 pM of quinpirole (Fig. 2.3). Quinpirole induced a lower 
maximal response in adenosine A2 A receptor knockout mice compared to wildtype 
mice (Fig. 2.3). There was a significant difference in the inhibition of cell firing 
between the genotypes (P<0.001, two-way repeated measures ANOVA) (Fig. 2.4).
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The DA D2 antagonist, sulpiride, was able to reverse quinpirole-induced complete 
inhibition of cell firing seen in wildtype mice, back to baseline frequency (Fig. 2.5).
Flaving established that the firing rate o f VTA DA cells, in response to quinpirole, 
differed in CDl wildtype and adenosine A2 A receptor knockout mice, the effect of the 
adenosine A2A receptor agonist, CGS 21680 was investigated in wildtype mice. No 
change in the firing frequency of VTA DA cells in response to various doses of CGS 
21680 was observed (Fig. 2.6).
Li.
?
■c
II
W ildtype A2 A k n ock ou t
Figure 2.2: Baseline firing frequency in wildtype and adenosine A2A receptor 
knockout mice. Bars represent mean (± SEM) firing frequency. There was no 
significant difference between genotypes (Student’s t-test; n=14-20).
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Figure 2.3: Representative traces illustrating VTA DA cell firing in a CDl 
wildtype and adenosine A2A receptor knockout mouse following addition of 
quinpirole. Quinpirole was added in the concentrations and the times indicated by the 
arrows.
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Figure 2.4: The firing rate of DAergic neurons in the VTA in response to 
quinpirole in wildtype and adenosine A2A receptor knockout mice. Values 
represent the mean ± SEM (n=9-ll). There was a significant genotype and 
concentration effect (P<0.001, two-way repeated measures ANOVA).
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Figure 2.5: Representative trace illustrating the inhibition of VTA DA cell firing 
in CDl wildtype mouse by quinpirole and the reversal of this effect by sulpiride.
Drugs were added at the times indicated by arrows, representative of 6 experiments.
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Figure 2.6: VTA DA cell firing in wildtype mice following addition of the 
adenosine Ajx  receptor agonist CGS 21680. Two concentrations of CGS 21680 
were added as indicated by the arrows with a wash period in between, representative 
of 5 experiments.
2.4 Discussion
Using in vitro electrophysiological recordings, this study compared the ability of DA 
D] receptors to inhibit firing of DAergic neurons within the VTA of wildtype and 
adenosine A2 A receptor knockout mice. No difference in the baseline firing frequency 
in the wildtype compared to the adenosine A ja receptor knockout mice was observed, 
which suggests that in the absence of adenosine A2 A receptors, the cell physiology 
was unaltered.
The cumulative addition of quinpirole (0.01-1.0 pM) almost completely abolished the 
firing frequency of VTA DA neurons in wildtype mice (Fig. 2.3 and 2.4). Mercuri et
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al. (1997) and Centonze et al. (2002) also previously reported that the application of 
0.1-30 pM quinpirole for 3-5 min caused a reversible inhibition of firing activity on 
the DAergic neurons of the VTA in inbred mouse strains. In addition, Bowery et al. 
(1994) demonstrated that in rats the cumulative addition of 0.003-0.1 pM quinpirole 
caused inhibition in firing in DAergic neurons in the VTA with almost complete 
inhibition at 0.1 pM. Microdialysis studies involving the perfusion o f quinpirole into 
the VTA show a reduction in the efflux of DA and in VTA DA cell firing, which 
suggests that DA D] receptors inhibit the local release o f DA (Kalivas et al. 1989; 
Chen et al. 2000b). The specific involvement of the DA D% receptors in the VTA was 
confirmed by the addition of the DA D2  receptor antagonist, sulpiride, which reversed 
the inhibitory effect of quinpirole in VTA DA cells (Fig. 2.5), as shown by others 
(Bemardini et al. 1991; Bowery et al. 1994; Mercuri et al. 1997; Centonze et al. 
2002).
In the adenosine A2 A receptor mice, however, the firing frequency o f VTA DA 
neurons was not reduced to the same extent as shovm in wildtype mice, even when the 
concentration of quinpirole was increased to 50 pM (Fig. 2.3 and 2.4). A significant 
genotype effect was revealed upon comparison of the percentage inhibition in 
response to quinpirole in the wildtype and adenosine A2A receptor knockout mice 
(Fig. 2.4). A decrease in the maximal response was seen in the adenosine A2 A receptor 
knockout mice compared to wildtype mice although there was no change in EC50 (Fig. 
2.4).
In more recent unpublished studies from our research group the effect o f single rather 
than cumulative applications of different concentrations of quinpirole on DA cell
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firing in the VTA in wildtype and adenosine A2 A receptor knockout mice, creating a 
concentration response curve, have been investigated. In these experiments both 
genotypes showed a similar maximal reduction in DA cell firing in the VTA in 
comparison to the reduced maximal response in the inhibition of VTA DA cell firing 
(shown here) following cumulative applications in the adenosine A2A receptor 
knockout mice. During the single applications of quinpirole the brain sections were 
exposed to quinpirole for 15 min whereas during the cumulative concentration 
response, presented here, the brain sections were exposed to each concentration of 
quinpirole for 5 min before the addition of the next concentration. The concentration- 
response curve following individual dosing (not shown here) shifted to the left; an 
increase in the inhibition of DAergic firing was seen at lower doses (0.001-1 pM, 
EC$o=9 nM) in comparison to cumulative dosing (0.01-30 pM, EC5o=0.04 pM), 
which suggests that perhaps cumulative dosing did not allow for a full effect to be 
reached at each concentration. These results suggest that the extent o f quinpirole- 
induced inhibition of DA cell firing may be time dependent. Bemardini et al. (1991) 
looked at various strains of wildtype inbred mice and also demonstrated that 
individual dosing of lower concentrations of quinpirole (0.001-1 pM, EC$o=9nM) 
resulted in complete inhibition in DAergic firing in the VTA. In the individual dose 
study the inhibition in DAergic firing was reduced in adenosine A 2A receptor 
knockout mice, with a significant difference achieved at 3 nM.
The findings from this study suggest a possible alteration in the behaviour o f the DA 
D2  receptors in the VTA in adenosine A2A receptor knockout mice. However, the 
hypothesised alteration in DA D2 receptor function cannot be directly attributed to the 
loss of interaction between DA D2  and adenosine A2 A receptors in the VTA as there
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was no functional evidence for adenosine A%A receptors in the VTA, shown in this 
study and through autoradiographic binding studies and immuohistochemistry 
(Sebastiao et al. 1996; Moreau et al. 1999). Therefore, altered DA D2  receptor 
function may be due to adaptive changes in adenosine A2A receptor knockout mice.
There is evidence to support the presence of heteromeric complexes containing 
adenosine A2A and metabotropic glutamate 5 receptors (mGlu5), as well as adenosine 
A2A and DA D2  receptors, in striatal neurons (Ferre et al. 2002; Fuxe et al. 2003). It 
has been shown that adenosine A2A and DA D2  receptors may play a major role in 
mGlu5 receptor modulation of striatal function (Popoli et al. 2001; Nishi et al. 2003; 
Domenici et al. 2004; Rodrigues et al. 2005), which is likely to be disrupted in 
adenosine A2 A receptor knockout mice. Moreover, electrophysiological experiments 
have also provided evidence that the dendritic release of DA may regulate the firing 
rate of DAergic neurons in the VTA through DA D2  receptors located in 
glutamatergic terminals (Koga et al. 2000) which may be altered in adenosine A2 A 
receptor knockout mice.
It has also been postulated that the somatodendritic release of DA in the VTA 
modulates cell firing by the interaction with local DA D2  receptors (Adell et al. 2004). 
However, endogenous DA, via DA D2  receptors, does not appear to have an effect on 
the firing rate o f DAergic neurons in the VTA as no change in the firing frequency o f 
DAergic neurons was observed following exposure to the DA D2 antagonist, sulpiride 
(data not shown).
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The mechanism underlying the alteration in DA D] receptor function in adenosine 
A2A receptor knockout mice is still unclear. Neuronal circuitries are absent in such in 
vitro studies therefore the potential influence of neuronal circuitries is absent. The 
absence o f adenosine A2 A receptors may influence the GABAergic feedback loop of 
the mesolimbic pathway, projecting from the NAc to the VTA. Further studies would 
be required to examine these effects on DA D2  receptors in the VTA.
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Chapter 3
Morphine and cocaine-induced conditioned place preference, 
extinction and reinstatement in CDl wildtype and adenosine A2A 
receptor knockout mice and C57BL/6 wildtype mice
3.1 Introduction
Relapse following abstinence from drug use still remains the primary problem in 
treating drug addiction and as a result much research has been targeted into this area. 
The animal model most widely used to study extinction and reinstatement to drugs of 
abuse is the self-administration paradigm. In this model the animals are initially 
trained to associate a particular response such as a lever press or nose poke with the 
administration of a drug and after the extinction of this learned behaviour, the initial 
response is reinstated by the test drug, a cue, or the induction of stress (Shaham et al. 
2003). There is much literature on the use o f extinction and reinstatement in self­
administration studies. For comprehensive reviews see Shaham et al. (2003) and 
Epstein et al. (2006), which identify the validity of self administration paradigms in 
understanding why humans, who have abstained from drug use, relapse. The costly 
and labour intensive nature of the self administration paradigm has encouraged the 
adaptation of the place conditioning model to provide an alternative model for 
extinction and reinstatement.
The place-conditioning or CPP paradigm is one of the most widely used techniques to 
measure drug reward in animals, as reviewed by Tzschentke (2007). It is based on 
Pavlovian conditioning principles where preference for a specific context develops 
following an association between the context and a drug-associated stimulus. The
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advantages of CPP are numerous and include the ability to show reward and aversion 
in response to a drug, to test animals in a drug dependant and drug-free state and also 
to simultaneously determine locomotor activity.
In a CPP paradigm, the conditioning boxes consist o f either two or three chambers, 
two chambers for conditioning purposes and if  a third is present it serves as a neutral 
area, connecting the two chambers. The two conditioning chambers are of equal size 
but have different tactile and visual stimuli. Animals are trained by receiving vehicle 
injections in one chamber and drug injections in the other. If the drug is rewarding, 
the mouse is likely to spend more time in the chamber in which they received that 
drug, as a result o f the pairing. The time spent in both chambers and the centre area is 
measured over a period of time, usually 15 min. If significantly more time is spent in 
the chamber paired with the drug in comparison to the other chamber and the centre 
area, the animal is said to be conditioned and CPP is established (Fattore et a l 2005; 
Tzschentke 2007).
Many different CPP protocols exist and extensive studies have identified how specific 
conditions greatly affect the potential outcome; for a review see Tzschentke (2007). 
An important and widely debated issue is that of the biased V5. unbiased design. CPP 
apparatus can be designed in such a way so naïve animals either show no significant 
preference for either o f the conditioning chambers following an initial pre-test 
(unbiased design) or show a significant preference for one of the chambers (biased 
design). In the case of an unbiased design the animals can be randomly assigned to 
their prospective conditioning chamber. In a biased situation however, either all 
animals can be conditioned to the preferred or non-preferred chamber, maintaining the
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biased situation, or half the mice can be conditioned to their preferred chamber and 
the other half to their non-preferred chamber, thereby creating an unbiased situation.
Extensive work has been done highlighting the importance of the unbiased vs. biased 
approach to CPP. For example, it was shown that in an unbiased situation, significant 
CPP could be induced when mice were conditioned to their preferred or non-preferred 
chamber as opposed to the standard procedure o f randomly assigning them to either 
chamber (Cunningham et al. 2003). This is unlike the biased situation where CPP 
could only be achieved when the drug was paired with the initially non-preferred side 
(Cunningham et al. 2003). However, it was also shown that in a biased design where 
the animals were paired with their non-preferred side, they showed conditioned place 
aversion (CPA), spending more time away from the paired chamber, the opposite of 
the desired CPP effect (Marchand et a l 2006). These different responses highlight the 
importance and influence a biased or unbiased design can have on the outcome o f an 
experiment.
The biased nature of CPP apparatus can be manipulated by altering the visual and 
tactile stimuli in the chambers. Roma et al. (2005) show that the presence or absence 
of visual stimuli, such as light or dark conditions and tactile stimuli, such as textured 
flooring allow the animals to discriminate between chambers. The majority of 
researchers prefer to use an unbiased protocol as it eliminates potential discrepancies 
with regards to the formation of false-positive results (Tzschentke 2007).
There is limited and conflicting evidence regarding the effect of the route of 
administration of the drug upon CPP. One group demonstrated that only
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intraperitoneal (i.p.) rather than subcutaneous (s.c.) administration of cocaine could 
induce CPP (Mayer et al. 1993). In contrast, another group were able to induce CPP 
following both i.p. and s.c. administration of cocaine, but a higher dose of cocaine 
was required to induce CPP following i.p. administration (Durazzo et al. 1994).
The time of drug administration in relation to conditioning has also been shown to 
determine whether CPP is achieved. Administration of a drug immediately before 
conditioning caused CPA but a delay between administration and conditioning 
induced CPP (Ettenberg et al. 1999; Cunningham et al. 2002). There is also evidence 
to suggest that the length of the conditioning procedure is critical in the formation of 
CPP when using a number of drugs o f abuse. In DBA/2J mice, increased cocaine- 
induced CPP occurred as the duration o f the conditioning phase increased 
(Cunningham et al. 1999). A long period of conditioning was also shown to produce a 
clear CPP response in mice exposed to A9-tetrahydrocannabinol (THC), as it avoided 
the possible dysphoric consequences o f the initial drug exposure (Valjent et al. 2000). 
In contrast to this, Ikemoto et al. (2005) demonstrated that rats who experienced a five 
minute conditioning trial showed CPP in response to cocaine, while those that 
conditioned for fifteen minutes did not. Furthermore, Cunningham et al. (2002) 
demonstrated that the infusion of ethanol, via intragastric catheter, immediately before 
the conditioning session produced CPA whereas a five minute delay between drug 
infusion and the conditioning session induced CPP.
The number and time frame of the conditioning sessions have an influential effect on 
the overall conditioning trial but this is also highly dependent on the drug. For 
example, when using buprenorphine, CPP could not be induced using higher doses
76
under standard conditions of a single conditioning trial each day. A delay o f one or 
two days between conditioning trials resulted in CPP. In the case of buprenorphine, 
the lack of CPP at higher doses is likely to be due to the long duration of its action 
and slow receptor kinetics resulting in the drug effect being carried over to the vehicle 
session thereby preventing CPP (Tzschentke 2004; 2007). It is important therefore to 
take into account that both the period of conditioning and the route of administration 
are strongly influenced by the pharmacokinetics of the drug in use.
The individual or group housing of mice has been shown to affect the acquisition of 
CPP. For example, morphine could not induce CPP in mice that had been isolated for 
up to thirty days but could in mice that had been socially housed. Upon the re­
grouping of the isolated mice with other mice, the previously isolated mice showed 
place preference to morphine (Coudereau et al. 1997). The mechanisms that influence 
this difference in CPP between isolated and socially-housed mice remain unclear but 
it has been suggested that social isolation may alter the rewarding properties of 
morphine (Coudereau et al. 1999).
Despite the variability in the potential conditions that can be used in a CPP paradigm 
many studies, using rodents, show that the conditioning response can be extinguished 
with repeated exposure to the saline or vehicle, the unconditioned stimuli. 
Furthermore, the initial expression of CPP can also be reinstated using a drug-priming 
injection, stress or a conditioned cue; this has been shown using morphine (Mueller 
et al. 2002; Ribeiro Do Couto et al. 2003; Zhou et al. 2006) or cocaine (Mueller et al. 
2000). Reinstatement was also shown to be induced by foot-shock stress following 
morphine- (Wang et al. 2001) and cocaine- (Lu et al. 2001) induced CPP and
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extinction. Ribeiro Do Couto et al. (2006) also demonstrated that morphine-induced 
CPP could be reinstated by physical stressors such as restraint, tail pinch and social 
stressors.
The majority o f studies using the place conditioning paradigm to study extinction and 
reinstatement to drugs of abuse have been performed in rats. In 2003, however, 
Ribeiro Do Couto et al. (2003) did the first experiment investigating conditioning, 
extinction and reinstatement in mice. This was an essential first step, as the mouse is 
the only species in which transgenic techniques are well established. Only a few 
studies have used the place conditioning paradigm to look at extinction and 
reinstatement, in mice and even less so in the CDl strain of mice, the strain in which 
the adenosine A2 A receptor was first genetically deleted (Ledent et al. 1997). The 
studies that have been conducted in the CDl strain of mouse are described in more 
detail in section 1.7 and 1.8 o f the introduction.
The initial aim of this chapter was to investigate addictive responses to morphine and 
cocaine in CDl wildtype and adenosine A2 A receptor knockout mice using the place 
conditioning paradigm of extinction and reinstatement, as adenosine A 2 A receptor 
knockout mice show alterations in addictive behaviours. These include reduced 
cocaine self-administration, the abolition of cannabinoid and morphine reward, 
increased signs of morphine withdrawal, an increase in functional activity o f MOP 
receptors and a reduction in DA D2  function in the ventral tegmental area (Berrendero 
et al. 2003; Bailey et al. 2004; Soria et al. 2006; Castane et al. 2008; Brown et al. 
2009). The overall aim was, however, modified in light of the results, which showed
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that CPP could not be reliably induced to either morphine or cocaine in this strain of
mouse.
3.2 Materials and methods 
3.2.1 Animals
Male CDl wildtype and adenosine A2 A receptor knockout mice aged 8-12 weeks and 
male C57BL/6 wildtype mice also aged 8-12 weeks were used in this study. The 
maintenance o f the CDl wildtype and adenosine A2 A receptor knockout colony has 
been described in section 2.2.1.
3.2.2 Apparatus
CPP was carried out in four identical PVC boxes measuring 16.5" length (8.25" per 
side), 10.5" height and 8.5" width (Columbus instruments, OH, USA) (Fig. 3.1). The 
boxes comprised of two chambers, separated by a removable divider. One chamber 
had black walls and floor, while the other had white walls and floor; both had 
transparent ceilings (these were modified for each individual study). Sixteen equally 
spaced infra-red beams monitored side to side motion and communicated to a 
computer ten times per second through an interface. This data was then collected and 
analysed with Auto-Track software (Columbus instruments, USA).
3.2.3 Drugs
Animals were injected with morphine sulphate or cocaine hydrochloride (s.c.) (Sigma 
Aldrich, Dorset, UK) in a volume of 0.1-0.2 ml. Control groups were injected with 
physiological saline (NaCl 0.9%). Saline was also used to dissolve morphine sulphate 
and cocaine hydrochloride.
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chamber
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Infra-red
beams
Mouse
Figure 3.1: Contextual place preference box from Columbus instruments, USA
3.2.4 Procedures
Each mouse was individually housed and handled once a day for seven days, prior to 
the start of the experiment. This was necessary in order to habituate the mice to 
human handling. Before each experimental day the mice were placed in the procedure 
room for an hour to habituate to their surroundings.
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The CPP, extinction and reinstatement paradigm was made up of a number of phases, 
detailed below:
Habituation phase (1 day)
Each mouse was placed in the CPP chamber, without the divide in place, for 20 min 
in the morning to habituate to the chamber and the time spent in each chamber was 
recorded.
Pre-conditionins vhase ( 1  day)
This phase was identical to the habituation phase, however only data from the final 15 
min of activity in the chambers was analysed. The time spent in each chamber was 
recorded and any remaining time, which accounted for the time spent in the small area 
between the chambers where no beams are present, was labelled as centre. In addition, 
all mice were weighed in preparation for the conditioning phase.
The aim was to follow an unbiased protocol. In some experiments any individual 
mouse that showed a preference for one chamber, defined as less than 30% or more 
than 70% of the total time spent in either chamber, was excluded from the experiment 
(Manzanedo et al 2001). In the situation where the mice showed no overall 
significant preference to either chamber, the mice were randomly assigned to either 
chambers. However, in some cases the majority o f mice showed a preference for one 
chamber or the other and in these experiments half the mice were conditioned to their 
preferred chamber and the other half to their non-preferred chamber to create an 
unbiased situation. In one experiment, shown as experiment 6 , a biased protocol was
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followed in which the administration of the drug was associated with the preferred 
chamber.
Conditionins vhase (4 days)
For this phase the perspex divide was placed in the centre of the box creating two 
separate chambers for conditioning. The conditioning phase consisted o f a morning 
phase and an afternoon phase. In the morning each mouse was injected (s.c) with 
saline and immediately placed in the saline-paired chamber. The time spent in the 
chamber varied depending on the experiment. In the afternoon each animal was 
injected with the drug and immediately placed in the drug-paired chamber for the 
same period of time as in the morning phase. The concentration of the drug and the 
volume of the drug and saline varied between individual experiments. Ambulatory 
activity was recorded throughout.
Post-conditionins vhase (1 day)
The perspex divide was removed and the protocol for the pre-conditioning phase was 
repeated for this phase. The time spent in the drug-paired chamber and saline-paired 
(unpaired) chamber in the post-conditioning phase was analysed using a Student’s 
paired t-test. This identified whether the mice had conditioned to drug and determined 
whether the experiment continued to the extinction phase.
Extinction vhase (5-14 days)
The same procedure as stated in the conditioning phase was followed but the mice 
were injected (s.c) with saline both in the morning and afternoon. Ambulatory activity 
was recorded throughout.
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Post-extinction vhase (1 day)
The protocol for the pre-conditioning phase was repeated for this phase. The time 
spent in the drug-paired chamber and saline-paired (unpaired) chamber post­
extinction was analysed using a Student’s paired t-test. This identified whether the 
CPP response in the mice had been extinguished and if  not the extinction phase was 
continued.
Reinstatement vhase (1 day)
Each animal was injected (s.c) with half the concentration of drug used for the 
conditioning phase and placed in the CPP chamber for 20 minutes. Only time spent in 
the chambers over the final 15 min was analysed.
Day 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Hab Pre  ------------------------   Post   ' Post Rein.
Cond. Conditioning Cond. Extinction Ext.
Figure 3.2: Summary of the CPP, extinction and reinstatement protocol
The extinction phase is shown here as 5 days but in some experiments this was 
extended up to 14 days.
Brain sample Collection
Immediately after reinstatement the animals were killed and the brains were dissected, 
frozen in iso-pentane, cooled to -20 to -30°C and stored at -80°C until required.
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3.2.5 Statistical Analysis
Differences in the time spent between the chambers following conditioning, 
extinction and reinstatement were analysed using a Student’s paired t-test or two-way 
repeated measures ANOVA. Ambulatory activity was also analysed using a two-way 
repeated measures ANOVA.
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3.3 Results
Morphine- and cocaine-induced CPP was studied in CDl wildtype and adenosine A2 A 
receptor knockout mice and C57BL/6 mice under a variety of conditions summarised 
in table 3.1.
3.3.1 Morphine-induced CPP in CDl wildtype and adenosine A2A receptor 
knockout mice
In all experiments using morphine, straub tail was observed, which is a characteristic 
reaction mediated through the release of DA in the CNS (Gupta et a l 1988). In 
addition, there was an observable decrease in faecal matter following morphine 
injections, which is a common side effect o f morphine treatment (Matthes et a l 
1996).
Experiment 1
Following four days of conditioning, 5 mg/kg of morphine failed to induce CPP in 
CDl wildtype mice. There was no significant treatment or condition effect between 
the chambers pre- or post-conditioning (P>0.05, two-way repeated measures 
ANOVA, Fig. 3.3).
Ambulatory activity was recorded on day 1 through to day 4 of conditioning (Fig. 3.4) 
and analysed on day 1 and day 4. On day 1 there were no significant differences 
between saline and morphine treatment over 45 min (two-way repeated measures 
ANOVA, Fig. 3.4A). On day 4, however, a significant treatment effect (P<0.001) and 
a significant interaction effect between treatment and time (P<0.001) was shown 
(two-way repeated measures ANOVA, Fig. 3.4D), identifying an increase in
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ambulatory activity following morphine treatment over the 45 min period. Despite the 
significant increase in ambulatory activity following morphine treatment for four days 
the mice did not show CPP. In the initial experiment, it was thought that the lack of 
conditioning could be due to a conditioning time of 45 min being too long. The mice 
may have associated the negative effects or the ‘come down’ of morphine with the 
chamber rather than the euphoric and stimulatory sensation. It is clear from the results 
shown in figure 3.4 that the increase in ambulatory activity begins at approximately 
2 0  min, and accordingly the duration of conditioning was reduced to 2 0  min in the 
following experiment, and modifications were also made to the chambers.
Experiment 2
The conditions were altered for this experiment in a number of ways. The colours and 
tactile stimuli within the chambers were altered, the conditioning time was set at 2 0  
min instead of 45 min and the injection volume was decreased to 0.1-0.2 ml (see table 
3.1). The administration of 5 mg/kg of morphine induced CPP in CDl wildtype mice 
(Fig. 3.5). A significant choice of chamber and condition interaction were observed 
(P<0.001 and P<0.001, respectively, two-way repeated measures ANOVA, Fig. 3.5). 
A significant increase in the time spent in the drug-paired chamber compared to the 
unpaired chamber post-conditioning was also shown, (P<0.01, Newman-Keuls post- 
hoc comparison. Fig. 3.5). There were no significant differences in the time spent 
between the paired and unpaired chamber following extinction and reinstatement.
The analysis of ambulatory activity on day 1 and day 4 of conditioning to morphine 
over a 2 0  min period, revealed a significant treatment and time effect on day 1 
(P<0.05) and (P<0.001) respectively, but no interaction effect (two-way repeated
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measures ANOVA, Fig. 3.6A). On day 4 there was a significant treatment effect 
(P<0.01) but no significant interaction between treatment and time (P>0.05, two-way 
repeated measures ANOVA, Fig. 3.6D). Importantly, ambulatory activity in response 
to saline was higher than morphine at 5 mg/kg over 20 minutes. Despite the fact that 
the mice appeared to condition, reinstatement could not be induced at a dose o f 2.5 
mg/kg (half the conditioning dose). The lack of any increase in ambulatory activity in 
response to morphine and the lack of morphine-induced reinstatement may have been 
due to the dose o f 5 mg/kg being too low, therefore the dose in the following 
experiment was increased to 10 mg/kg for conditioning and 5 mg/kg for 
reinstatement.
Experiment 3
The dose of morphine used for this experiment was increased to 10 mg/kg and the 
CDl adenosine A2 A receptor knockout mice were also used, in addition to the 
wildtype mice (see Table 3.1). 10 mg/kg of morphine failed to induce CPP in both 
CDl wildtype and adenosine A2A receptor knockout mice (Fig. 3.7A and 3.7B). A 
significant choice of chamber in both the wildtype and knockout was shown (P<0.001 
and P<0.01, respectively) but no significant interaction between choice o f chamber 
and condition was observed (two-way repeated measures ANOVA, Fig. 3.7A and 
3.7B). No other significant changes were shown.
The analysis of ambulatory activity on day 1 and day 4 of conditioning to morphine in 
wildtype mice, revealed a significant interaction between treatment and time on day 1 
and day 4 (two-way repeated measures ANOVA, Fig. 3.8A and 3.8D). There was an 
increase in ambulatory activity following treatment with morphine over 20 min. In the
adenosine A2 A receptor knockout mice there were no significant differences in 
ambulatory activity on day 1 but on day 4 there was a significant treatment effect 
(P<0.05, two-way repeated measures ANOVA, Fig. 3.9A and 3.9D). To summarise, 
by day 4 there was an increase in ambulatory activity in response to morphine over 20 
min in both genotypes, however, neither group of mice exhibited CPP. The results of 
this experiment show that the increase in the dose of morphine from 5 mg/kg to 10 
mg/kg produced robust increases in ambulatory activity within 2 0  min, however the 
lack of CPP suggests that perhaps 20 min is not long enough for the animals to 
establish CPP, therefore in the following experiment the conditioning time was 
increased to 40 min.
Experiment 4
The only alteration in this experiment was the increase of the conditioning time from 
20 min to 40 min. Both the wildtype and adenosine A2A reecptor knockout mice 
showed a significant choice of chamber and condition effect (P<0.01 and P<0.001, 
respectively) but no significant interaction effect (two-way repeated measures 
ANOVA, Fig. 3.10A and 3.1 OB). No other significant changes were observed.
Analysis of ambulatory activity on day 1 and day 4 o f conditioning to morphine 
identified a significant treatment effect in both wildtype and adenosine A 2 A receptor 
knockout mice (P<0.001) on day 1 and day 4 (two-way repeated measures ANOVA, 
Fig. 3.11 A, 3.1 ID, 3.12A and 3.12D). A significant interaction was shown between 
treatment and time on day 1 and day 4 in the wildtype mice (P<0.05, Fig. 3.11A and 
3.11D). This was also evident in the adenosine A2 A receptor knockout mice on day 1 
and day 4 (P<0.001 and P<0.001) respectively (two-way repeated measures ANOVA, 
Fig. 3.12A and 3.12D). Despite the significant increase in ambulatory activity over 4
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days following treatment with 10 mg/kg morphine over 40 min, CPP could not be 
induced. The dose of drug, the length of conditioning time and the conditions within 
the chambers had all been altered in the previous experiments to try and identify the 
cause for the lack of conditioning. In the following experiment, therefore, cocaine was 
used instead of morphine to determine whether CPP could be induced by another drug 
recognised to produce robust conditioning in mice and rats (Mueller et al. 2000; 
Houchi et al. 2005; Soria et al. 2006).
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Figure 3.3: Morphine induced CPP in GDI mice: Experiment 1
A) Effects of 5 mg/kg of morphine on the acquisition of CPP in CDl wildtype mice.
Bars represent mean (± SEM) time spent in drug-paired, saline-paired (unpaired)
chamber and centre pre-conditioning and post-conditioning; No significant 
differences (two-way repeated measures ANOVA, n=7).
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Figure 3.5: Morphine induced C P P  in C D l mice: Experiment 2
Effects of 5 mg/kg of morphine on the acquisition, extinction and reinstatement o f
CPP in CDl wildtype mice. Bars represent mean (± SEM) time spent in drug-paired,
saline-paired (unpaired) chamber and centre pre-conditioning, post-conditioning, post­
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3.3.2 Cocaine-induced CPP in GDI wildtype mice 
Experiment 5
The conditions in the chambers remained the same as experiment 4 but cocaine was 
used instead of morphine, the conditioning time was reduced from 40 min to 30 min, 
the dose was 20 mg/kg. Cocaine failed to induce CPP in CDl wildtype mice (Fig. 
3.13). A significant difference in the choice of chamber (P<0.001) was observed but 
no significant interaction effect between choice and condition was shown (two-way 
repeated measures ANOVA, Fig. 3.13).
Analysis of ambulatory activity on day 1 and day 4 of conditioning to cocaine, 
identified a significant treatment effect on day 1 and day 4 (P<0.001, two-way 
repeated measures ANOVA, Fig. 3.14A and 3.14D). Despite the fact that ambulatory 
activity increased following treatment with cocaine over 4 days of conditioning, CPP 
could not be induced. To identify whether conditions in the chamber were not strong 
enough to induce an association between the drug and chamber a biased protocol was 
employed in the following experiment.
Experiment 6
The conditions of the chambers were altered for this experiment to create a biased 
situation; cocaine was therefore paired with the preferred chamber. 2 0  mg/kg of 
cocaine was again unable to induce CPP. A significant choice o f chamber and 
interaction between choice and conditioning was revealed (P<0.001 and P<0.05) 
respectively (two-way repeated measures ANOVA, Fig. 3.15). A significant 
difference in time spent in the paired chamber compared to the unpaired chamber pre-
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conditioning (P<0.01) was also shown (Newman-Keuls post-hoc comparison, Fig. 
3.15).
Analysis o f ambulatory activity during conditioning on day 1 and 4 identified a 
significant time and treatment effect on day 1 (P<0.001) and a significant treatment 
effect on day 4 (P<0.001) (two way repeated measures ANOVA, Fig. 3.16A and 
3.16D). The increase in ambulatory activity following cocaine treatment fi*om day 1 
though to day 4 clearly shows that cocaine is having a stimulatory effect on the mice 
but despite this the use o f the biased protocol, CPP could not be established. At this 
point, having explored many experimental angles, the probability o f strain 
insensitivity was considered for this type of behavioural protocol and therefore 
C57BL/6 mice were tested in the CPP protocol following treatment with either 
morphine or cocaine.
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Figure 3.13: Cocaine induced CPP in CDl mice: Experiment 5
Effects of 20 mg/kg of cocaine on the acquisition of CPP in CDl wildtype mice. Bars
represent mean (± SEM) time spent in drug-paired, saline-paired (unpaired) chamber
and centre pre-conditioning and post-conditioning. No significant changes (two-way 
repeated measures ANOVA, n=12).
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Figure 3.15: Cocaine induced CPP in CDl mice: Experiment 6
Effects of 20 mg/kg of cocaine on the acquisition of CPP in CDl wildtype mice.
Bars represent mean (± SEM) time spent in drug-paired, saline-paired (unpaired) 
chamber and centre pre-conditioning and post-conditioning (n= 1 2 ).
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3.3.3 Morphine and cocaine-induced CPP in C57BL/6 mice 
Experiment 7
The conditions in the chambers were altered upon use of the C57BL/6 mice, to match 
conditions previously shown to induce CPP in C57BL/6 mice (Bailey et a l 
manuscript in preparation) (see Table 3.1). The administration o f 10 mg/kg of 
morphine induced CPP in C57BL/6 mice (Fig. 3.17). A significant choice effect 
(P<0.001) and interaction effect between the choice of chamber and the various 
conditions (pre-conditioning, post-conditioning, extinction and reinstatement) 
(P<0.001), were revealed (two-way repeated measures ANOVA, Fig. 3.17). There 
was a significant increase (P<0.01) in the time spent in the drug-paired chamber 
compared to the unpaired chamber post-conditioning (Fig. 3.17). There was also a 
significant increase (P<0.001) in the time spent in the drug-paired chamber following 
reinstatement in comparison with the drug paired chamber pre-, post-conditioning, 
post-extinction and the unpaired chamber following reinstatement (Newman-Keuls 
post-hoc comparison, Fig. 3.17).
The comparison of ambulatory activity on day 1 and day 4 of conditioning to 
morphine, revealed a significant treatment effect (P<0.001) and a significant 
interaction between treatment and time (P<0.001) on day 1 (two-way repeated 
measures ANOVA, Fig. 3.18A). On day 4 a significant treatment, time and treatment 
and time interaction was shown (P<0.001, two-way repeated measures ANOVA, Fig. 
3.18D).
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Experiment 8:
20 mg/kg of cocaine induced CPP in C57BL/6 mice (Fig. 3.19). A comparison of time 
spent in the drug-paired chamber, unpaired chamber pre- and post-conditioning 
revealed a significant choice effect (P<0.001) (two-way repeated measures ANOVA, 
Fig. 3.19) and a significant interaction effect between the choice o f chamber and 
conditions (P<0.001, two-way repeated measures ANOVA, Fig. 3.19). A significant 
increase (P<0.01) in the time spent in the drug-paired chamber compared to the 
unpaired chamber post-conditioning was shown (Newman-Keuls post-hoc 
comparison, Fig. 3.19).There was also a significant increase (P<0.001) in the time 
spent in the drug-paired chamber following reinstatement in comparison with the 
drug-paired chamber pre-conditioning, post-extinction and the unpaired chamber 
following reinstatement (Newman-Keuls post-hoc test, Fig. 3.19).
A comparison of ambulatory activity on day 1 and day 4 of conditioning to cocaine, 
revealed a significant treatment effect (P<0.001) and a significant treatment and time 
interaction (P<0.01) on day 1 (two-way repeated measures ANOVA, Fig. 3.20A). On 
day 4, a significant treatment effect and time effect was shown (P<0.001, two-way 
repeated measures ANOVA, Fig. 3.20D).
To summarise, in the C57BL/6 mice both cocaine and morphine induced CPP which 
could be extinguished and reinstated. Furthermore, morphine and cocaine had a 
significant effect on ambulatory activity.
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Figure 3.17: Morphine induced CPP in C57BL/6 mice: Experiment 7
Effects of 10 mg/kg of morphine on the acquisition, extinction and reinstatement of
CPP. Bars represent mean (± SEM) time spent in drug-paired, saline-paired
(unpaired) chamber and centre pre-conditioning and post-conditioning, post­
extinction and following reinstatement; * P<0.01, significant difference increase in 
the time spent in the morphine-paired ehamber v .^ unpaired chamber post­
conditioning and a significant increase ** P<0.001 in the time spent in the paired 
ehamber following reinstatement eompared to the time spent in the paired chamber 
pre-conditioning, post-conditioning, post-extinction and in the unpaired chamber upon 
reinstatement (two-way repeated measures ANOVA followed by Newman-Keuls 
post-hoe analysis; n=2 0 ).
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Figure 3.19: Cocaine induced CPP in C57BL/6 mice: Experiment 8
Effects of 20 mg/kg of cocaine on the acquisition, extinction and reinstatement of
CPP. Bars represent mean (± SEM) time spent in drug-paired, saline-paired
(unpaired) ehamber and eentre pre-conditioning and post-conditioning, post- 
extinetion and following reinstatement; * P<0.01, significant difference increase in 
the time spent in the cocaine-paired chamber vs. unpaired ehamber post-conditioning 
and a significant increase, **P<0.001, in the time spent in the paired ehamber 
following reinstatement compared to the time spent in the paired chamber pre­
conditioning, post-extinction and in the unpaired chamber upon reinstatement (two- 
way repeated measures followed by a Newman-Keuls post-hoc comparison, n=20).
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3.4 Discussion
The original aim of this chapter was to investigate further addictive responses to 
cocaine and morphine in the CDl adenosine A%A receptor knockout mice using the 
place conditioning model of extinction and reinstatement. However, consistent CPP 
could not be induced by either morphine or cocaine in the CDl strain of mice despite 
the numerous modifications made. For example, the conditions within each chamber 
were modified to include different visual and tactile stimuli in order to maintain an 
unbiased protocol, but also induce CPP. The injection volume was reduced in an 
attempt to minimise any possible discomfort to the mice. A number o f different doses 
of drug were used throughout the experiments. The conditioning time course was also 
altered to ensure that the mice were associating the positive effects of the drug with 
the chamber (see table 3.1 for a summary). The final aim was therefore to compare 
the effects o f morphine and cocaine in CDl mice and C57BL/6 mice in a CPP 
paradigm.
3.4.1 Response to morphine in CDl mice
Overall, morphine produced a stimulatory effect in mice; ambulatory activity 
increased in response to morphine from day 1 through to day 4. On day 1 there was a 
reduced ambulatory response to morphine compared to day 4, probably due to an 
injection effect. Mice treated with saline showed an initial increase in ambulatory 
activity as they responded to the novel experience o f an injection, which was lost by 
day 4. Mice were treated with both 5 mg/kg and 10 mg/kg of morphine and over a 45 
min conditioning period 5 mg/kg caused a stimulatory response but this was not seen 
within 20 min. This suggests that 5 mg/kg morphine is not a high enough dose to 
cause an increase in ambulatory activity within 20 min. This was further confirmed as
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10 mg/kg morphine caused an increase in ambulatory activity at both 20 min and 40 
min, although a larger increase in locomotor activity was seen 40 min after drug 
administration.
These ambulatory results agree with the work of Castane et ah (2008) and Brown et 
al (2009), who showed an increase in ambulatory movements following treatment 
with 10 mg/kg over 30 and 40 min, respectively. 5 mg/kg of morphine was also 
shown to induce an ambulatory response but was reduced compared to the response 
following 10 mg/kg morphine. In addition to the increase in ambulatory activity in 
response to morphine, shown in the present study, the mice all produced a straub tail 
response, which is a characteristic reaction mediated through the release of DA in the 
CNS (Gupta et a l 1988). Both the increase in ambulatory activity and straub tail 
response illustrate that morphine-induced a stimulatory response but despite this 
morphine was unable to induce consistent CPP.
3.4.2 Response of CDl mice to cocaine
Cocaine also produced a stimulatory response in CDl mice. Unlike morphine, where 
a gradual increase in ambulatory activity was seen over the 40 min conditioning 
period, from day 1 through to day 4; cocaine immediately induced a high ambulatory 
response, which was maintained throughout the 30 min and for the four days o f 
conditioning. There was very little change in ambulatory activity in response to 
cocaine over the four days. In the first 5 min the saline treated mice showed increased 
ambulatory activity but this was likely to be in response to the injection. On day 4 
Soria et a l  (2006) also showed a treatment effect with an increase in ambulatory 
activity compared to saline after 20 mg/kg cocaine. However, cocaine was also unable
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to induce CPP in CDl wildtype mice, in contrast to the results of other groups who 
have been able to show cocaine-induced CPP in CDl wildtype mice (Houchi et al. 
2005; Castane et al. 2006).
3.4.3 Potential reasons for inconsistent CPP
There are limited studies o f the behavioural effects of morphine in the CDl strain of 
mice but Castane et al. (2008) and Brown et al. (2009) reported morphine-induced 
CPP in this strain. It is difficult to identify whether the experiment reported by 
Castane et al. (2008) and Brown et al. (2009) would produce the same results if  
repeated. For example, one o f the four morphine experiments carried out in CDl mice 
in the present study produced significant conditioning but when this was repeated 
CPP was not reproducible.
The discrepancies between the present study and the study reported by Castane et al. 
(2008) could also be attributed to the differences in the CPP conditions. The 
conditioning schedules as well as the conditions of the chambers differed between the 
two experiments. Castane et al. (2008) based the conditions on those of Maldonado et 
al. (1997). The main difference was the use of different conditioning apparatus, 
Castane et al. (2008) and Brown et al. (2009) used a two-chamber apparatus with an 
additional central area whereas a two-chamber apparatus without a central chamber 
was used for the work in this chapter. The area labelled as centre in this study refers to 
the area between the two chambers without beams to measure activity.
Despite the use of different chambers the conditions for this study were based, as far 
as possible on the methods of Castane et al. (2008). Some of the conditions such as
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the use of 30 lux lighting (Castane et al. 2008) could not be used in the current 
experiments, as it induced jumping and escape behaviour in the CDl mice so 40-45 
lux lighting, the normal lighting level in the room, was used. The conditioning 
schedule also differed; in the current study the mice received saline injections in the 
morning and morphine in the afternoon during the four days of conditioning (Ribeiro 
Do Couto et al. 2003; Houchi et al. 2005; Popik et al. 2006; Ribeiro Do Couto et al. 
2006) whereas Castane et al. (2008) and Brown et al. (2009) injected saline and 
morphine on alternate days (Maldonado et al. 1997; Belzung et al. 2000; Sakoori et 
al. 2005; Szumlinski et al. 2005). These differences in conditions may affect the 
outcome of the studies, although there is no published data to suggest that such 
differences in the conditioning schedule can affect CPP.
A critical difference between the CPP experiments is the method of data analysis and 
what is considered a measurement of conditioning. Castane et al. (2008) considered a 
significant difference between the time spent in the paired chamber pre-conditioning 
with the time spent in the paired chamber post-conditioning, as conditioning. It could 
be argued that this type of analysis may not be a good indication of conditioning; the 
time spent in the paired chamber post-conditioning may be more than the time spent 
in the paired chamber pre-conditioning, but how does it compare to the time spent in 
the unpaired chamber post-conditioning? There is no comparison between the two 
chambers in the post-conditioning phase, so there may be an increase in time spent in 
the paired chamber post-conditioning compared with the time spent in the paired 
chamber pre-conditioning but the time spent in the paired chamber post-conditioning 
may not be different from the time spent in the unpaired chamber post-conditioning.
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Therefore, the mice are not distinguishing between the two chambers and 
conditioning may not really have been established.
Soria et al. (2006) however, subtracted the time spent in the paired chamber pre­
conditioning from the time spent in the paired chamber post-conditioning and 
compared this to the saline treated mice. A significant difference between the cocaine- 
treated and saline-treated mice was considered as conditioning. This method of 
analysis also does not take into account the time spent in the unpaired chamber post­
conditioning. There is no comparison between the data within the experiment; the 
comparison is between two different experiments, which would increase error and 
variability. Furthermore, this type of analysis does not show how much time the 
mouse is spending in each chamber in both the pre- and post-conditioning phase, 
which is vital.
Both these methods of analysis therefore do not take into account time spent in the 
paired chamber compared to the unpaired chamber in both the pre- and post­
conditioning phase. In this chapter conditioning was taken as a significant difference 
between the time spent in the paired chamber compared to the unpaired chamber post­
conditioning, which is a widely used method of analysis (Mueller et al. 2002; Orsini 
et al. 2005; Rizos et al. 2005; Szumlinski et al. 2005). This method of analysis shows 
the time spent in both chambers in every phase so there is no scope for data 
misinterpretation.
Housing and laboratory conditions can also affect behavioural experiments. Mice 
from the same CDl origin (Ledent et al. 1997; Ledent et al. 1999) were used in this
116
chapter and by Houchi et a l (2005); Soria et a l (2006); Castane et a l (2008) and 
Brown et a l (2009), however they were all housed differently. Castane et a l  (2008) 
and Soria et a l  (2006) group-housed their mice, with five in each cage, as did Houchi 
et ah (2005) with ten in each cage. The mice in the present study were individually 
housed, with one mouse per cage to maintain consistency. When the mice were 
weaned they were group housed but once genotyped some mice were eliminated, 
leaving odd numbers in each cage. The mice could not therefore be transferred 
between cages as this caused the mice to fight hence individual housing. Coudereau 
et a l  (1997; 1999) showed that individual and social housing can affect the outcome 
of CPP, and individual housing showed less CPP so this could explain the difference 
in results.
Furthermore, a study was carried out to investigate the effect of group vs. solitary 
housing on the behaviour o f mice in two different strains o f mice (Voikar et a l 2005) 
This identified that solitary housing has strong-strain and test-specific effects on 
emotional behaviour and impairs memory in certain tasks, such as novel object 
recognition and fear conditioning. A study also investigated the effect o f housing 
conditions on behaviour of mice, in which the same experiment under the same 
experimental conditions was carried in two different laboratories (Lewejohann et a l 
2006). Significant differences were observed between different laboratories in the 
barrier test, which tested spontaneous exploratory behaviour and the elevated plus- 
maze, which measured anxiety-related behaviour. However, no difference was 
observed in the open-field test. These results highlight how different housing and 
laboratory conditions can cause variation in behavioural results in different 
behavioural experiments. This may help explain differences between the CPP studies
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using the same CDl strain but in a number of different laboratories under different 
housing conditions. In addition, there is evidence to show that stress influences CPP 
and reinstatement (Erb et a l 1998; Koob 1999; Stewart 2000; Lu et a l 2001; Ribeiro 
Do Couto et a l 2006) and the level of stress may pre-dispose mice to conditioning 
and relapse. Therefore, mice in different laboratories under different housing and 
experimental conditions may be under different levels o f stress and as a result respond 
differently to the same drug.
3.4.4 Response of C57BL/6 mice to morphine and cocaine
Due to the failure to reproduce the reported cocaine- and morphine- induced CPP in 
CDl mice, cocaine- and morphine- induced CPP was studied in C57BL/6 mice, as 
heroin CPP had already been successfully carried out in our laboratory using the same 
conditioning apparatus (results not shown). Both morphine and cocaine were able to 
induce conditioning and show extinction and reinstatement in the C57BL/6 mice in 
accordance with a number of studies (Belzung et a l 2000; Itzhak et a l 2002; Ribeiro 
Do Couto et a l 2003; Orsini et a l 2005; Sakoori et a l 2005; Popik et a l 2006; Orsini 
et a l 2008). Ambulatory activity in response to 10 mg/kg morphine in the C57BL/6 
mice showed a similar profile to that seen in the CDl mice; by day 4 morphine had 
induced behavioural sensitisation (Orsini et a l 2005; Brown et a l 2009). 20 mg/kg 
of cocaine induced a reduction in ambulatory activity from day 1 through to day 4, as 
shown by Orsini et a l  (2005), which was also similar to the response seen in CDl 
mice.
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3.4.5 Conclusion
This study highlighted that conditioning to morphine and cocaine can be achieved in 
C57BL/6 mice using the same conditions and conditioning schedule as those used for 
CDl mice. A similar ambulatory response was induced in the CDl and C57BL/6 mice 
to both morphine and cocaine, therefore the lack of conditioning in CDl mice is not 
likely to be due to conditions, such as dose, the pharmacokinetics o f the drug or the 
route of administration.
The reason the CDl mice did not show consistent conditioning whereas the C57BL/6 
mice did maybe due to a difference between the two strains. Many studies have 
compared various strains of mice and have identified that the strain can cause changes 
in behaviour (Testing 1976; Testing 1999) but most studies do not include the CDl 
strain. The CDl strain is an out-bred strain which is one of the reasons why it is not 
included in many strain comparison studies. The fact that the CDl mice are outbred 
could also explain the difference in behaviour as there is an increase in variability 
when compared to inbred strains such as the C57BL/6 mice (Testing 1976; Testing 
1999). This strain difference may explain the inability o f the CDl strain to condition 
reliably to morphine and cocaine and is a fundamental finding in itself. These data 
suggest that either the CDl strain may not be suitable for further research into the 
behavioural aspects o f addiction or it could be argued that CDl mice are an ideal 
strain to use for addiction studies as they appear to be non-vulnerable and can be 
made vulnerable experimentally.
In addition, there is evidence to show that levels o f cocaine in the blood following 
acute and chronic treatment were higher in the C57BL/6 mice than the CDl mice
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although the brain concentration of cocaine did not differ between the two strains 
(McCarthy et al. 2004). This could explain why CPP can be established in C57BL/6 
mice but not the CDl mice. Furthermore, studies looking at inbred strains of mice 
found differences in brain cocaine kinetics (Wiener et al. 1990; Azar et al. 1998). 
These pharmacokinetic differences may be due to differences in cocaine distribution 
among different mouse strains, therefore the same may be true when comparing 
outbred and inbred strains.
The adenosine A%A receptor knockout mice are now also available in a mixed 
C57BL/6 X 129-steel background (Chen et al. 2000a), pure 129-steel background 
(Chen et al. 1999) and a pure C57BL/6 background (Bastia et al. 2005). The 
investigation of the effect of the adenosine A2A receptor in the extinction and relapse 
phase of morphine and cocaine addiction may be facilitated by the use o f the inbred 
strains mentioned above.
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Chapter 4
Autoradiographic studies on MOP receptors and DAergic systems in
relation to CPP studies
4.1 Introduction
The results from the CPP work in chapter 3 led to the conclusion that morphine or 
cocaine could induce CPP in C57BL/6 mice but not in CDl mice. In an attempt to 
understand the possible neurobiological changes that might underlie these different 
behavioural responses, quantitative autoradiography was employed to study the 
distribution and function of specific receptors in the brains o f these mice.
4.1.1 The distribution and function of MOPr in the VTA and SN in C57BL/6 and 
CDl mice
Morphine exerts its action through MOP receptors in the VTA, which is a key region 
involved in the mesocorticolimbic reward pathway. Morphine increases DAergic 
neuronal cell firing in VTA DA neurons, which occurs indirectly through the 
activation of inhibitory MOPr located on GABAergic intemeurons in the VTA 
(Johnson et a l 1992a) or on GABAergic projection neurons (Tepper et a l 1995). 
Under normal conditions these inhibitory GABAergic neurons inhibit DA cell-firing, 
however, upon activation of MOPr the inhibitory GABAergic effect on VTA DA 
neurons is reduced thereby increasing the DA cell firing and the amount o f DA 
released into the NAc (Johnson et a l 1992a).
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Bailey et a l (2002; 2004) investigated MOP receptor distribution and function in 
CDl mice, however, neither the VTA nor SN were included in this analysis. Other 
studies have examined the density o f receptors in order to explain differing 
behavioural responses in different strains of mice; De Waele et al (1997) investigated 
the density of MOPr in C57BL/6 and DBA/2 mice but saw no change in receptor 
density in the brain regions related to the drug reward and reinforcement.
It was hypothesised that there may be a decrease in the density or function o f MOP 
receptors in outbred CDl wildtype mice compared to inbred C57BL/6 wildtype mice. 
A reduction in the density or function o f MOPr in the VTA could cause a decrease in 
the level of DA released in the NAc thereby reducing the rewarding effects of 
morphine which would in turn explain why morphine is unable to induce CPP in CDl 
mice. Receptor levels were examined using quantitative receptor autoradiography.
4.1.2 An investigation into the DAergic system of CDl mice in cocaine-induced 
CPP responders and cocaine-induced CPP non-responders
Overall cocaine-induced CPP was also not observed in CDl mice when expressed as 
mean data. However, following a closer examination into the response o f each animal 
it became apparent that the response was highly variable and, as a result, the animals 
could be divided into responders and non-responders. The responders showed 
conditioning behaviour, spending an increased amount of time in the chamber 
associated with cocaine whereas the non-responders showed no response to cocaine.
Cocaine inhibits monoamine re-uptake transporters leading to the inhibition of DA, 5- 
HT and NA reuptake and a resultant increase of neurotransmitter concentrations in the
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synaptic cleft (Heikkila et a l 1975; Koe 1976; Raiteri et a l 1977; Torres et a l 2003). 
Neuropharmacological studies have established an important role for the DAergic 
system in the reinforcing effects of cocaine (Woolverton 1992), primarily due to the 
increased levels of DA in the NAc and CPu, which are innervated by the 
mesocorticolimbic DAergic pathway. The influence of the individual DAergic 
receptors in the reinforcing effects of cocaine, particularly the DA D2  receptor, is 
uncertain. For example DA D2  receptor antagonists fail to influence cocaine-induced 
CPP whereas DA Di receptor antagonists block cocaine-induced place preference, 
which suggests that DA Di but not DA D2 are involved in the primary rewarding 
properties o f cocaine (Cervo et a l 1995; Pruitt et a l 1995; Liao et al 1998; Nazarian 
et a l 2004). In contrast, the injection o f selective DA D% or DA D2  receptor 
antagonists into the NAc increased cocaine self-administration which suggests 
therefore that both DA D% and DA D2  receptors are involved in mediating the 
reinforcing actions of cocaine (Phillips et a l 1983; Maldonado et a l 1993).
Due to the unknown involvement of DA in cocaine reward and reinforcement it was 
hypothesised that there may be a change in the DAergic profile between the 
responders and non-responders to cocaine-induced CPP in CDl mice. Quantitative 
autoradiography was used to study of DA Di, D2 , DAT and DA D2  receptor- 
stimulated [^^S] GTPyS binding in the brains of responders and non-responders, 
defined from their behavioural profile.
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4.2 Materials and Methods
4.2.1 The cleaning and subbing of the microscope slides
Slides were left to soak in Decon, a water based detergent, overnight. The slides were 
then rinsed in hot running water for approximately 15 min and cold distilled water for 
a ftirther 15 min. The slides were soaked in a solution of 10% HCl/90% ethanol for a 
period of 20 min and rinsed once again in distilled water for 15 min. Following this 
cleaning procedure the slides were immersed in a solution of 1 % gelatine/chome-alum 
solution for 2 min in order the coat the slide. The slides were left to dry before use.
4.2.2 Tissue preparation and sectioning
Naïve 8-12 week old male C57BL/6 and CDl mice were killed by cervical dislocation 
and whole brains removed. The brains were immediately frozen at -25°C in 
isopentane and stored at -80°C until sectioning. Prior to sectioning the brains were 
placed on a mounting stage and fixed using a plastic embedding liquid (O.C.T 
compound, BDH chemicals, Dorset, UK).
20 pm coronal brain sections spanning the whole brain were cut, 300 pm apart, in a - 
21°C cryostat (Zeiss Microm 505E, Hertforshire, U.K) and thaw-mounted onto 
gelatin-coated ice cold microscope slides. Adjacent sections were cut for 
determination of total binding and non-specific binding. The slides were dried using 
anhydrous calcium sulphate (Drierite-BDH Chemicals, Dorset, UK) at 4°C for 2 h, 
preventing the formation of ice-crystals and stored at -20°C for 1 week.
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4.2.3 Selection of responders and non-responders from cocaine-induced CPP
The mice used in the present study were taken from experiments 5 and 6  in chapter 3. 
The pre-conditioning value (time spent in the drug paired chamber in seconds) was 
subtracted from the post-conditioning value to calculate a conditioning score. In 
previous studies using this score, mice that displayed a score of over 1 2 0  were 
regarded as being conditioned to cocaine (Soria et al. 2006), therefore in these 
experiments all animals with a score above 120 were assigned as responders (Fig. 
4.1). Those mice that displayed a score between 10 and -50 were considered non­
responders (Fig. 4.1). Any mice with values lower than -50 were considered to be 
negative conditioners so were excluded from further analysis. In figure 4.1 A a non­
biased protocol was used and in figure 4.1 B a biased protocol was followed. The 
responders and non-responders from the two experiments were pooled together for 
analysis of the results from the autoradiographic analysis.
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Figure 4.1: The responders and non-responders to cocaine-induced CPP. (A)
non-biased CPP protocol was used and (B) a biased CPP protocol was used. In total 
responders (n=6 ) and non-responders (n=6 ).
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4.2.4 Autoradiographic binding
4.2.4.1 MOP receptor binding
For tissue preparation and sectioning see section 4.2.1 and 4.2.2. Autoradiography 
was performed as detailed by Kitchen et a l (1997) and Clarke et ah (2001). The 
radiolabelled ligand [^HJD-Ala^-MePhe'^-Gly-ol^ enkephalin (DAMGO) was used to 
label MOPr in the brains of the C57BL/6 and CDl miee. A concentration o f 3-4 times 
Kd was used to label the MOP receptors; 4 nM of [^H] DAMGO was added to 50 mM 
Tris-HCl incubation buffer (120 mM NaCl, 5 mM KCl, 2 mM CaCl2  and 1 mM 
MgCli), pH 7.4 at room temperature (Sigma Aldrich, Dorset, UK). The MOP receptor 
antagonist naloxone (1 pM) was added to some of the incubation buffer for the 
determination of non-specific binding. This resulted in 2 separate incubation buffers; 
one for total binding and one for non-specific binding.
All slides were pre-incubated at room temperature for 30 min in 50 mM Tris-HCl 
buffer (Sigma Aldrich, Dorset, UK) pH 7.4, to remove endogenous opioids. The 
slides were then placed in binding trays and 1 ml of either the total binding or non­
specific binding incubation buffer was pipetted onto each slide, ensuring complete 
coverage and left for 60 min. The slides were then washed three times in ice cold 
Tris-HCl buffer for a period of 5 min and cool-air dried. The slides were then 
dessicated for a further 3 days in anhydrous calcium sulphate (Drierite-BDH 
Chemicals, Poole, UK)
4.2.4.2 MOP receptor-stimulated [^ S^] GTPyS binding
For tissue preparation and sectioning see section 4.2.1 and 4.2.2. General procedures 
o f MOP receptor-stimulated [^^S] GTPyS binding were performed essentially as
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described by Sim et al. (1996), Kirschke et a l (2002) and Bailey et a l (2004). All 
slides were allowed to defrost for 30 min prior to binding. The sections were initially 
pre-ineubated in a 50 mM Tris-HCl assay buffer containing 3 mM MgCl2 .8 H2 0 , 2.0 
mM ethylene glycol tetraacetic acid (EOTA) and 100 mM NaCl, pH 7.4 at 25°C for 
10 min. This was followed by a further incubation in a guanylyl-diphosphate (GDP) 
buffer made up of the pre-incubation assay buffer plus 1 mM GDP for 15 min. The 
slides were then rinsed in a 50 mM Tris-HCl buffer at pH 7.
MOPr agonist-stimulated activity was determined by incubating the sections in a 
solution containing [^^S]GTPyS (0.08 nM) with the MOPr agonist DAMGO (10 pM) 
in the GDP buffer (mentioned above) for 2 h. Basal G-protein activity was determined 
by incubating the sections in [^^S]GTPyS (0.08 nM in GDP buffer, as above) but in 
the absence of DAMGO. Non-specific binding was measured by incubating the 
sections in a solution containing [^^S]GTPyS (0.08 nM) in assay buffer (without GDP) 
and 10 pM of unlabelled GTPyS. All slides were incubated in the appropriate 
solutions for 2 h and then rinsed twice for 3 min in ice eold 50mM Tris-HCl buffer, 
pH 4. This was followed by a final rinse in de-ionised water and the slides were left to 
dry for 2 h under a cold stream of air. The slides were stored with anhydrous calcium 
sulphate (Drierite-BDH chemicals, Poole, UK) for 2 days for further drying and the 
sections were laid to film for 3 days.
4.2.4.3 DA Di receptor binding
For tissue preparation and sectioning see section 4.2.1 and 4.2.2. Autoradiography 
was performed as described previously by Lena et al. (2004). The slides were pre- 
incubated for 20 min at room temperature in a 50 mM Tris-HCl assay buffer
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containing 120 mM NaCl, 5 mM KCl, 2 mM CaCli and MgCli, pH 7.4. The DA Di 
receptor antagonist [^H] SCH-23390 was used to label DA D% receptors at a 4 nM 
concentration (3-4 times the Kd of the ligand) and 1 pM mianserin was included in 
the incubation mixture, to prevent the antagonist binding to 5 -HT2 and 5-HTic. The 
incubation buffer was made up of the radioligand and mianserin in the assay buffer 
stated above for both specific and non-specific binding. 10 pM of cis-flupenthixol 
(DA Di receptor antagonist) was added to the assay buffer for the determination of 
non-specific binding.
1 ml of incubation buffer for specific and non-specific binding was pipetted over the 
appropriate slides, ensuring all the sections were completely covered and left for 90 
min at room temperature. The slides were then washed six times for 1 min in ice-cold 
rinse buffer (50 mM Tris-HCl, pH 7.4) followed by a dip into ice-cold distilled water. 
The slides were dried under a cold stream of air for 2 h and stored in an airtight box 
with anhydrous calcium sulphate for 7 days for further drying.
4.2.4.4 DA transporter (DAT) receptor binding
The tissue preparation and sectioning was the same as described in section 4.2.1 and 
4.2.2. All procedures were performed as detailed by Javitch et al. (1985) and Bailey et 
al. (2007). All slides were initially allowed to defrost for 30 min prior to binding. The 
whole procedure was carried out in ice to maintain the temperature at 4°C throughout 
the experiment. The slides were pre-incubated for 5 min at room temperature in a 50 
mM Tris-HCl assay buffer containing 300 mM NaCl and 5 mM KCl, pH 7.4 at 4°C. 
[^H] mazindol was used for labelling the DAT at a 4 nM concentration (3-4 times the 
Kd of the ligand) and 0.3 pM desipramine was included to block the binding to
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noradrenaline uptake sites. The incubation buffer was made up of the radioligand and 
desipramine in the assay buffer stated above for both specific and non-specific 
binding. 10 pM of non-tritiated mazindol was added to the assay buffer for the 
determination of non-specific binding.
1 ml of incubation buffer for specific and non-specific binding was pipetted over the 
appropriate slides placed in binding trays on ice, ensuring all the sections were 
completely covered and left at 4°C for 45 min. The slides were rinsed twice for 1 min 
in ice cold rinse buffer (50mM Tris-HCl, pH 7.4). The slides were dried under a eold 
stream of air for 2  h and stored in an airtight box with anhydrous calcium sulphate for 
7 days for further drying.
4.2.4.S DA D] receptor binding
The tissue preparation and sectioning was the same as that described in section 4.2.1 
and 4.2.2. Autoradiography was preformed as detailed by Kitchen et al. (1997) and 
Lena et al. (2004). The slides were pre-incubated for 20 min at room temperature in a 
50 mM Tris-HCl assay buffer containing 120 mM NaCl, 5 mM KCl, 2 mM CaCL and 
MgCli, pH 7.4. The DA Di receptor antagonist [^H] raclopride was used to label DA 
D2  receptors at a 4 nM concentration (3-4 times the Kd of the ligand). The incubation 
buffer was made up of the radioligand in the assay buffer stated above for both 
specific and non-specific binding. 10 pM of sulpiride (DA D2  receptor antagonist) 
was added to the assay buffer for the determination of non-specific binding.
1 ml of incubation buffer for specific and non-specific binding was pipetted over the 
appropriate slides, ensuring all the sections were completely covered for 60 min at
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room temperature. The slides were then washed 6  times for 1 min in ice cold rinse 
buffer (50 mM Tris-HCl, pH 7.4) followed by a dip into ice cold distilled water. The 
slides were dried under a cold stream of air for 2  h and stored in an airtight box with 
anhydrous calcium sulphate for 7 days for further drying.
4.2.4.6 DA D] receptor-stimulated [^ S^] GTPyS binding
The tissue preparation and sectioning was the same as that described in section 4.2.1 
and 4.2.2. General procedures of autoradiography were performed essentially as 
described by Newman-Tancredi et al. (2001) and Bailey et al. (2008). All slides were 
allowed to defrost for 30 min prior to binding. The sections were initially pre- 
incubated in a 50 mM Tris-HCl assay buffer containing 3 mM MgCl2 8 H2 0 , 2.0 mM 
EGTA and 100 mM NaCl, pH 7.4 at 25°C for 10 min. Sections were then incubated in 
an assay buffer made up of pre-incubation buffer plus 1 mM GDP for 15 min. The 
slides were then rinsed in a 50 mM Tris-HCl buffer at pH 7.4.
DA D2  receptor agonist-stimulated activity was determined by incubating the sections 
in a solution containing [^^S]GTPyS (0.04 nM) with the selective DA D2  receptor 
agonist, quinerolane (100 pM), in the assay buffer containing GDP for 2 h. Basal G- 
protein activity was determined by incubating the sections in [^^SJGTPyS (0.04 nM in 
GDP buffer, as above) but in the absence of quinerolane. Non-specific binding was 
measured by incubating the sections in a solution containing [^^S]GTPyS (0.04 nM) in 
assay buffer (without GDP) and 10 pM of unlabelled GTPyS. All slides were 
incubated in the appropriate solutions for 2 h and then rinsed twice for 3 min in ice 
cold 50 mM Tris-HCl buffer, pH 4. This was followed by a final rinse in de-ionised
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water and the slides were left to dry for 2 h under a cold stream of air. The slides were 
stored with anhydrous calcium sulphate for 2  days for further drying.
4.2.5 Autoradiographic film preparation
The slides containing the sections from each group were securely placed in 
Hypercasettes with [^H] microscales, as standards for MOPr, DA Di receptor, DA D% 
receptor and DAT binding, and microscales as standards for MOPr and DA D2  
receptor-stimulated GTPyS binding (Amersham International, Buckinghamshire, 
UK). Sections from each group of mice were laid down against the same film and the 
film was placed emulsion side down, onto the slides. The slides were apposed to MR 
film (Kodak) in a dark room under red filtered light. The hypercassettes were sealed 
preventing any light exposure and stored flat for 3 weeks for MOPr binding, 1 week 
for MOPr-stimulated GTPyS binding, 5 weeks for DA Di receptor binding, 4 weeks 
for DAT binding, 6  weeks for DA D2  binding and 3 weeks for DA D2  receptor- 
stimulated GTPyS binding.
4.2.6 Film development
This process was carried out in a dark room under red filtered light. The films were 
developed using an aqueous solution containing 50% Kodak D19 developer (Sigma 
Aldrich, Dorset, UK) and 50% distilled water for 1 min. The film was then placed in a 
solution of distilled water and glacial acetic acid for 1 min to stop the reaction. The 
images were finally fixed in a Kodak rapid fix solution for 3 min and rinsed in cold 
running water for 2 0  min and left to dry under a fume hood.
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4.2.7 Image analysis
A video-based densitometry MCID image analyser (Imaging research, Ontario, 
Canada) was used to analyse quantitative receptor binding autoradiography. A 
computerised free-hand drawing tool was used to take measurements from the right 
and left hemisphere of the brain, providing a duplicate representation of each structure 
analysed. For central structures one measurement was taken. When analysing larger 
structures such as the cortex a small box sampling tool was used to take 
approximately 10-15 samples within the specific structure and a mean of samples was 
generated. The regions o f interest were identified using the mouse atlas o f Franklin 
and Paxinos (1997).
For MOPr, DA Di receptor, DA Di receptor and DAT binding, specific binding was 
calculated by subtracting the non-specific binding from the total binding in the images 
o f the brain sections. Stimulated [^^S]GTPyS activity was calculated by subtracting 
the optical density in the basal sections from that measured in the stimulated sections. 
With reference to the calibration standards laid down with the slides, specific binding 
was expressed in fmol/mg tissue equivalent.
4.2.8 Data Analysis
For MOPr binding the mean and standard error of the mean for the bound ligand 
(fmol of radioligand bound/mg of tissue) was calculated in the VTA and SN for each 
strain. Comparison of quantitative measures o f autoradiographic binding for the 
ligand was carried out using Student’s t-test.
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The mean and standard error of the mean for the bound ligand (fmol of radioligand 
bound/mg of tissue) was calculated in a number of brain regions in each group 
following DA Di receptor, DA D2 receptor and DAT binding. Comparison of 
quantitative measures of autoradiographic binding for the ligand was carried out using 
a two-way ANOVA (for factors region of brain and strain).
For MOPr and DA D2  receptor-stimulated GTPyS binding, the mean and standard 
error of the mean for the bound ligand (KBq of radioligand bound/mg of tissue) was 
calculated in a number of brain regions for each group. Comparison of quantitative 
measures o f autoradiographic binding for the ligand was carried out using a two-way 
ANOVA (for factors region of brain and strain).
4.2.9 Materials
The following radioligands were all purchased from Amersham International pic 
(Buckinghamshire, UK); [^H] DAMGO (specific activity 1250 Ci/mmol), [^H] 
GTPyS (specific activity 56.0 Ci/mmol), [^H] raclopride (specific activity 56.0 
Ci/mmol), [^H] SCH-23390 (specific activity 85.0 Ci/mmol, [^H] mazindole (specific 
activity 17.8 Ci/mmol). The displacers, naloxone, GDP, mianserin, cis-flupenthixol, 
desipramine, mazindol and sulpiride were all purehased from Sigma Aldrich (Dorset, 
UK).
4.3 Results
4.3.1 MOPr and MOPr-stimulated GTPyS binding in CDl and C57BL/6 mice
The distribution of MOPr in the brains of C57BL/6 and CDl mice was determined 
with 4 nM [^H] DAMGO and the function o f MOPr in the brains of C57BL/6 and
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CDl mice was determined with 10 pM DAMGO and 0.08 nM [^^S]GTPyS. DAMGO 
binding levels were eompared between the 2 strains of mouse in the VTA and SN 
regions of the brain; the qualitative distribution of DAMGO was similar in CDl and 
C57BL/6 in the VTA and SN (Fig. 4.2). This was supported by no signifieant 
difference in DAMGO binding between C57BL/6 and CDl miee in either the VTA or 
the SN (P>0.05, Student’s t-test, Fig. 4.3).
The qualitative distribution o f DAMGO-stimulated GTPyS was similar in all brain 
regions analysed in C57BL/6 and CDl mice (Fig. 4.4). There was also no significant 
difference in any of the brain regions between C57BL/6 and CDl miee (P>0.05, two- 
way ANOVA, Fig. 4.5).
WT c57 W TCDlfmol/mg
Figure 4.2: Computer-enhanced autoradiograms of coronal brain sections from 
CDl and C57BL/6 mice showing MOPr expression. The sections are shown from 
the level of the VTA (Bregma -3.16 mm). The MOPr were labelled with 4 nM of [^H] 
DAMGO. Non-specific binding was determined in the presence of 1 pM naloxone. 
The calibration bar represents a pseudo-colour interpretation derived from the black 
and white film images.
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Figure 4.3: [ H] DAMGO binding in coronal sections from CDl and C57B1/6 
mice. Data are expressed as mean ± SEM (n=5-6). There was no significant genotype 
or region effect (P>0.05, Student’s t-test).
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Figure 4.4: Computer-enhanced autoradiograms of coronal brain sections from 
CDl and C57BL/6 mice showing MOPr G-protein activity. The sections are 
shown from the level of the VTA (Bregma -3.16 mm). The sections were pre- 
ineubated with 1 mM GDP and then incubated for 2 h with either 0.08 nM [^^S] 
GTPyS and 1 mM GDP (basal) or 0.08 nM [ ’^S] GTPyS and 1 mM GDP in the 
presence of 10 pM DAMGO (MOPr-stimulated). Non-specific binding was 
determined in the presence of 10 pM of non-tritiated mazindol. The calibration bar 
represents a pseudo-colour interpretation derived from the black and white film 
images.
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Figure 4.5: DAMGO-stimuiated [^^S]GTPyS binding in coronal brain sections 
from CDl and C57BL/6 mice. Data are expressed as mean ± SEM (n=5-6). There 
was no signifieant genotype or region effect (P>0.05, two-way ANOVA). 
Abbreviations: PAG-Periaqueduetal grey, MM-Medial mammill, Fr-Faseiculus 
retroflexus, RSG + RSA-Retrosplenial granular and retrosplenial agranular cortex, 
Vex-Secondary visual cortex, AuCx-Secondary auditory cortex, LEnt-Lateral 
entorhinal cortex, VTA-Ventral tegmental area, SN-Substantia nigra, IP- 
Intrapeduncular nucleus, SuG-Superfieial grey, ING - Intermediate grey layer, Hip- 
Hippocampal fissure.
4.3.2 DA Di receptor autoradiography in CDl responders and non-responders
The distribution of DA Di receptors in the brains of CDl mice that either responded 
to cocaine-induced CPP or did not respond to cocaine-induced CPP was determined 
with 4 nM [^H] SCH-23390 and 1 pM mianserin. There was regional up-regulation of 
DA Di receptor expression in the CPu of non-responders (Fig. 4.6). This was 
supported by a significant effect of group (P<0.05) and region (P<0.001, two-way 
ANOVA) with a significant increase in binding in the non-responsders vs. responders 
in the rostral CPu (*P<0.001, Duncan’s post-hoc test) (Fig. 4.7).
136
fmol/mg Responders Non-Responders
m
Figure 4.6: Computer-enhanced autoradiograms of coronal brain sections 
showing DA Di receptor expression in CDl mice following cocaine-induced CPP.
The sections are shown from the level of the caudate (Bregma 1.10 mm, shown 
above) and hippocampus (Bregma -1.58, shown below). The DA Di receptors were 
labelled with 4 nM [^H] SCH-23390. Non-specific binding was determined in the 
presence of 10 pM eis-flupenthixol. The calibration bar represents a pseudo-colour 
interpretation derived from the black and white film images.
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Figure 4.7: DA Di receptor binding in coronal brain sections from CDl mice 
following cocaine-induced CPP. Data are expressed as mean ± SEM (n=6 ). A 
significant effect of group (P<0.05) and region (P<0.001) was observed (two-way 
ANOVA) with significantly greater binding in the non-responsders vs. responders, 
*P<0.001 (Duncan’s post-hoe test). Abbreviations: CPuR-eaudate putamen rostral, 
CPuC-caudate putamen caudal, AcbC-nucleus accumbens core, AcbSh-nucleus 
accumbens shell, Tu-olfactory tubercle, CgCx-cingulate cortex. Den-dorsal 
endopiriform nucleus, CL-claustrum, Th-thalamus, Hyp-hypothalamus, Hip- 
hippocampus, Amy-amygdala, SN-substantia nigra, VTA-ventral tegmental area.
4.3.3 DAT autoradiography in CDl responders and non-responders
DAT distribution was also determined with 4 nM [^H] mazindol in the presence of 0.3 
pM desipramine in responders and non-responders. The qualitative distribution of 
DAT was similar in responders and non-responders in all brain regions (Fig. 4.8). A 
significant region effect was revealed (P<0.05, two-way ANOVA) but no significant 
effect of group or individual brain regions showed different levels of binding between 
the responders and non-responders (Fig. 4.9).
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Figure 4.8: DAT receptor expression shown in computer-enhanced
autoradiograms of coronal brain sections from CDl mice following cocaine- 
induced CPP. The sections are shown from the level of the caudate (Bregma 1.10 
mm, shown above) and the hippocampus (Bregma -1.58mm, shown below). The DAT 
receptors were labelled with 4 nM [^H] mazindol in the presence of 0.3 pM 
desipramine. Non-specific binding was determined in the presence of 10 pM of non- 
tritiated mazindol. The calibration bar represents a pseudo-colour interpretation 
derived from the black and white film images.
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Figure 4.9: DAT receptor binding in coronal brain sections from C D l mice 
following cocaine-induced CPP. Data are expressed as mean ± SEM (n=6 ). A 
significant effect of region (P<0.001, two-way ANOVA) was observed. 
(Abbreviations: CPuR-caudate putamen rostral, CPuC-caudate putamen caudal, 
AcbC-nucleus accumbens core, AcbSh-nucleus accumbens shell. Tu- olfactory 
tubercle, SN-substantia nigra, VTA-ventral tegmental area.
4.3.4 DA D] receptor autoradiography in responders and non-responders
The DA D2 receptor distribution in responders and non-responders to cocaine-induced 
CPP was measured with 4 nM [^H] raclopride and showed restricted localisation in 
the NAc, CPu and olfactory tubercle, collectively known as the striatum (Fig. 4.10). 
Binding was low to undetectable in all other brain regions and therefore was not 
quantified. Upregulation o f DA D2 receptor binding was visible in the CPu of the non­
responders (Fig. 4.10). A significant effect of group and region was determined 
(P>0.001, two-way ANOVA, with a significant up-regulation of DA D2 receptor 
expression in the caudal and rostral CPu (P<0.05 and P<0.001, respectively, Duncan’s 
post hoc analysis) (Fig. 4.11).
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Figure 4.10: DA D] receptor expression shown in computer-enhanced 
autoradiograms of coronal brain sections from CDl following cocaine-induced 
CPP. The sections are shown from the level of the caudate (Bregma 1.10 mm). The 
DA D] receptors were labelled with 4 nM [^H] raclopride. Non-specific binding was 
determined in the presence of 10 \xM o f sulpiride. The calibration bar represents a 
pseudo-colour interpretation derived from the black and white film images.
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Figure 4.11: DA D] receptor binding in coronal brain sections from CDl mice 
following cocaine-induced CPP. Data are expressed as mean ± SEM (n=6 ). A 
significant effect of group (P<0.001) and region (P<0.001) was observed (two-way 
ANOVA) with significantly greater binding in the non-responsders vs. responders, 
*P<0.05 and **P<0.001 (Duncan’s post-hoc test). (Abbreviations: CPuR-caudate 
putamen rostral, CPuC-caudate putamen caudal, AcbC-nucleus accumbens core, 
AcbSh-nucleus accumbens shell, Tu-olfaetory tubercle.
4.3.5 DA D% receptor-stimulated [^ S^] GTPyS autoradiography in responders and 
non-responders
The function of DA D2 receptors was determined by 100 pM quinerolane and 0.04 
nM [^^S] GTPyS. The qualitative distribution was similar in the responders and non­
responders (Fig. 4.12); this was supported by no significant differences within the 
groups or brain regions (P<0.05, two-way ANOVA) (Fig. 4.13).
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Basal Non-Responders Stim. Non-Responders NSB Non-Responders
Figure 4.12: DA D] G-protein activity shown in computer-enhanced
autoradiograms of coronal brain sections from CDl mice following cocaine- 
induced CPP. The sections are shown from the level of the caudate (Bregma 1.10 
mm, shown above) and hippoeampus (Bregma-1.58, shown below). The sections were 
pre-ineubated with 1 mM GDP and then incubated for 2 h with either [^^S]GTPyS 
(0.04 nM) and 1 mM GDP (basal) or [^^SJGTPyS (0.04 nM) and 100 pM quinerolane 
(DA D] receptor stimulated). Non-specific binding was determined in the presence of 
10 pM of non-tritiated mazindol. The ealibration bar represents a pseudo-colour 
interpretation derived from the black and white film images.
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Figure 4.13: Quinerolane-stimulated [^^S]GTPyS binding in coronal brain 
sections from CDl responders and non-responders following cocaine-induced
CPP. Data are expressed as mean ± SEM (n=3-5). There was no significant genotype 
or region effect (P>0.05, two-way ANOVA). Abbreviations: CPuR-caudate putamen 
rostral, CPuC-caudate putamen caudal, AcbC-nucleus accumbens core, AcbSh- 
nucleus accumbens shell, Tu-olfactory tubercle, CgCx-cingulate cortex, Hyp- 
hypothalamus, SN-substantia nigra
4.4 Discussion
4.4.1 The density and function of MOPr in C57BL/6 and CDl mice
The aim of this study was to investigate whether the induction of morphine CPP in 
C57BL/6 but not CDl mice could be attributed to a difference in the density and 
function of MOPr in the VTA and SN using quantitative autoradiography. No 
difference in the density or function of MOPr in any areas including the VTA were 
observed in C57BL/6 and CDl mice therefore the induction of CPP by morphine in 
C57BL/6 but not CDl mice is not likely to be due to a redueed density or function of 
MOPr in the VTA or SN of CDl mice. In light of this speculation it must be noted
144
that standard error of the mean following MOPr binding analysis in CDl mice was 
unusually large, with absolute values 50% higher. MOPr quantitative autoradiography 
typically produces standard error of the mean values which are only 1 0 -2 0 % higher 
(Kitchen et al. 1997; Clarke et al. 2001; Bailey et al. 2002). This unusually high 
standard error of the mean could represent the variability apparent in CDl mice and 
could explain why some of the CDl mice responded to behavioural studies while 
others did not. In addition, C57BL/6 mice show a much smaller standard error of the 
mean and they respond reliably to behavioural studies.
Morphine exerts its rewarding effects via the mesolimbic DAergic pathway, 
projecting from the VTA to the NAc. The influence o f the NAc in the action of 
morphine has also been considered; Castane et al. (2008) reported an absence in acute 
morphine-induced increases in extra-cellular DA in the NAc in CDl mice. However, 
numerous studies have previously reported an increase in extracellular DA in the NAc 
in response to morphine using inbred strains of mice such as the C57BL/6, DBA/2 
and 129Sv (Murphy et al. 2001; Chefer et al. 2003; Fadda et al. 2005; Narita et al. 
2006; Ogawa et al. 2007). This study also suggests that the lack o f DA release in the 
NAc of CDl mice is not due to a change in MOPr density or function in the VTA.
The lack of DA release in the NAc and the lack o f morphine-induced CPP in the CDl 
strain could be attributed to the fact that CDl mice are outbred. It has been postulated 
that the outbred CDl strain of mouse, which has more biological variability may have 
a lower addictive potential compared to the inbred strains, which are less variable 
(Short et al. 2006b). This is demonstrated by the work of Short et al. (2006b) who
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demonstrated that CDl mice have reduced ethanol preference in comparison to the 
inbred C57BL/6 strain.
4.4.2 Differences in the DAergic profile of CDl responders and non-responders 
to cocaine-induced CPP
The aim was to identify whether the DAergic profile of the CDl mice differed 
between the mice that responded to cocaine-induced CPP and those that did not. This 
was investigated by studying DA Di receptor, DA D2  receptor, DAT distribution and 
DA D2  receptor function also using quantitative autoradiography. There was no 
difference in DAT distribution and DA D2  receptor function between the responders 
and non-responders.
Interestingly, however, a difference in DA D% receptor density was revealed in the 
rostral CPu between responders and non-responders and a difference in DA D2  
receptor density was measured in the rostral and caudal CPu between responders and 
non-responders. When the CPP experiments were conducted the aim was to try and 
achieve consistent cocaine-induced CPP before introducing a saline control. In this 
case, cocaine-induced CPP could not be achieved and therefore no saline controls 
were generated. In light o f this the binding results presented here on responders and 
non-responders are compared below to the binding results from naïve CDl mice, 
generated by another researcher in the same laboratory but not in conjunction with the 
present binding experiments. This is by no means an ideal control as the mice did not 
undergo CPP but it provides a basal binding level to compare to the responders and 
non-responders.
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DA Di receptor binding in the non-responders was greater than the responders in the 
rostral CPu (Fig. 4.7). However, the level of DA Di receptor binding in the rostral 
CPu in naïve CDl mice was lower than that measured in both the responders and non­
responders; 317.6±10.7 fmol/mg in naïve mice compared to 469.16±27 fmol/mg and 
552.49±22 fmol/mg in responders and non-responders, respectively.
A difference in DA D2  receptor density was also measured in the rostral and caudal 
CPu between responders and non-responders. The non-responders had greater DA D2  
receptor binding than the responders. However, when compared to DA D2  receptor 
binding levels in the CPu in naïve CDl mice the levels of DA D2  receptor binding are 
lower in both the responders and non-responders; 90.6±6.6 fmol/mg in naïve mice 
compared to 38.38±4.91 fmol/mg and 53.05±4.06 fmol/mg in the rostral CPu in 
responders and non-responders respectively, and 33.71^3.38 fmol/mg and 47.07±1.86 
fmol/mg in the caudal CPu in responders and non-responders, respectively.
The majority of research has focused on the involvement of DA Di and D 2  following 
chronic or chronic ‘binge’ induced sensitisation to cocaine. There is no information 
on the involvement or receptor density of DA Di and D2  receptors following cocaine- 
induced CPP, making direct comparisons between the results presented here and 
current literature difficult. However, it has been shown that the activation of DA Di 
receptors and cAMP activity using DA or a DA D% agonist following chronic cocaine 
administration was greater in the CPu (Unterwald et ah 1994; Unterwald et a l 1996); 
a region identified in the present results to have greater DA Di receptor density 
following cocaine treatment. In addition, DA Di receptor density was increased in the 
rostral CPu of C57BL/6 mice and 129/J mice following a ‘binge’ cocaine protocol
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(Schlussman et a l 2003). DA Di densities were also increased in the rostral CPu of 
monkeys following chronic self-administration, an effect that was not observed 
following 5 days of self-administration (Nader et al 2002). Alburges et a l  (1993) 
observed an increase in DA Di receptor density in striatal tissue in rats following 
cocaine treatment on day 3, 7 ,14  and 21.
The mechanism behind the upregulation of DA Di receptors following cocaine 
treatment is unclear. It has been suggested, however, that the upregulation and 
increased sensitivity of DA Di receptors following exposure to cocaine maybe due to 
enhanced DA Di receptor stimulation by endogenous DA secondary to cocaine 
inhibition of DA re-uptake (Unterwald et al 1996). This is supported by evidence to 
show that repeated administration of the selective DA Di receptor agonist, SKF 
38393, enhanced the sensitivity of CPu neurons to DA Di receptor agonists (Henry et 
al 1991). It has been postulated that the increased neuronal response to DA Di 
receptor agonists may be mediated by increases in DA Di receptor-stimulated cAMP 
production (Unterwald et al 1996). It has also been suggested that the upregulation of 
DA Di receptors may be a secondary response in the postsynaptic DAergic system 
due to the cocaine-induced depletion of DA (Dackis et a l 1985; Alburges et a l 
1993). The greater DA Di receptor density observed in the non-responders compared 
to the responders is therefore unexpected and further experimental work is required to 
elucidate an explanation.
The study of DA D% receptor density following exposure to cocaine has been studied 
and it has been reported that DA D] receptor densities were significantly decreased 
throughout the striatum of rhesus monkeys following cocaine self-administration
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(Moore et al. 1998; Nader et a l 2002). In addition, human PET studies have 
demonstrated persistently low striatal DA D2  receptor availability in cocaine abusers 
(Volkow et al. 1999a; Voikow et al. 1999b; Martinez et al. 2004). These findings 
support the apparent decrease in DA D2 receptor density in the CPu following cocaine 
administration shown in the present results. Moreover, no significant difference in DA 
D2  receptor binding density was visible in any portion of the VTA and SN in rats and 
primates after cocaine administration, in agreement with the present results (Moore et 
al. 1998; Stefanski ar aZ. 2007).
It was hypothesised that the reduced striatal DA D2  receptor availability may be 
involved in the initiation or maintenance of cocaine abuse, particularly as low striatal 
DA D2 availability was observed in detoxified chronic cocaine abusers (Volkow et al 
1993; Stefanski et a l 2007). This supports the present results where the responders 
have lower DA D2  receptor upregulation compared to the non-responders. The 
responders conditioned following cocaine treatment, which is equivalent to the 
initiation of drug abuse in humans and is reflected in the greater reduction in the level 
of DA D2  receptors compared to the non-responders.
In the striatum DA Di and DA D2  are found on different populations of medium spiny 
neurons. DA Di receptors facilitate neuronal firing and DA D2  receptors inhibit 
neuronal firing. The global increase in DA levels, as is caused by cocaine, correlates 
with the downregulation of inhibitory DA D2  receptors. The reason for the 
upregulation of DA Di following cocaine administration is not so clear. One 
hypothesis for the increase in DA Di receptor density is that DA Di receptor density 
is differentially regulated over time with continued exposure to cocaine, therefore the
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initial increase in DA Di receptor density that precedes a later decrease may represent 
two distinct mechanisms for DA Di receptor regulation (Nader et a l 2002). This is 
supported by the work of Farfel et a l (1992) in which two weeks o f cocaine 
administration followed by two weeks of withdrawal resulted in a decrease in DA Di 
receptor density. The differences in DA Di and DA D2  receptor binding between mice 
responding and non-responding to cocaine-induced CPP suggest that the ability of 
cocaine to induce a rewarding effect may depend on DA Di and D2  receptor density 
and/or Di and D2  receptor regulation by cocaine. This might provide an important 
insight on the role of the dopaminergic system in the vulnerability to develop cocaine 
addiction.
150
Chapter 5
In vivo dopamine release and locomotor activity in GDI wildtype and 
adenosine A%A receptor knockout mice following chronic ‘binge’
cocaine administration
5.1 Introduction
Cocaine acts upon the brain as a non-selective inhibitor of monoamine reuptake 
transporters to block the re-uptake of DA, NA and 5-HT into pre-synaptic neurons, 
thereby increasing synaptic concentrations of DA, NA and 5-HT which acutely 
increases activity at DAergic, adrenergic and 5-HT receptors (Heikkila et al. 1975; 
Koe 1976; Raiteri et al. 1977; Torres et al. 2003).
The ability of cocaine to block DAT results in an increase in DA, which is an 
important factor in the behavioural and reinforcing effects of cocaine and is related to 
its addictive properties (De Wit et al. 1977; Wise 1996; Anderson et al. 2005). 
Neuropharmacological studies have established an important role for the DAergic 
system in the reinforcing effects of cocaine (Woolverton et al. 1992), primarily due to 
the increased levels of DA in the NAc. Evidence to support the role of the NAc in 
cocaine reinforcement shows that the destruction of DAergic neurons, using 6 - 
OHDA, in the NAc (Roberts et al. 1980; Pettit et al. 1984; Zito et al. 1985; Caine et 
al. 1994) and in the VTA (Roberts et al. 1982) disrupts cocaine self-administration. In 
addition, self-administration studies have shown that the i.v. infusion of cocaine 
causes an increase in extracellular DA in the NAc, measured using in vivo 
microdialysis (Pettit et al. 1989; Czoty et al. 2000). Cocaine-induced locomotion and
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stereotypic behaviours are also disrupted following lesions of the NAc and CPu 
(Kelly et a l 1976). Locomotor activity is increased after intra-accumbens 
administration of cocaine (Delfs et al 1990). It has, therefore, been postulated that the 
locomotor response to cocaine may be mediated in part through the mesolimbic DA 
pathway.
Major roles have been established for DAergic and glutamatergic transmission in 
psychostimulant-induced behavioural sensitisation (Wolf 1998). The adenosine A2 A 
receptor has been considered as a potential modulator o f psychostimulant sensitisation 
partly due to the fact that brain expression of the adenosine A2 A receptor is restricted 
to the striatum. Moreover, the activation of adenosine A2A receptors enhances the 
release of several brain neurotransmitters including DA and glutamate (Quarta et a l 
2004).
The generation o f the adenosine A2A receptor knockout mouse has enabled the 
investigation of the role of the adenosine A2A receptor in the behavioural and 
reinforcing properties of cocaine. Chen et a l  (2000a) showed that the acute 
administration of psychostimulants cocaine and amphetamine attenuated locomotor 
activity in adenosine A2 A receptor knockout mice generated on a C57BL/6/129-Steel 
and pure 129-Steel genetic background compared to wildtype mice. The inactivation 
of adenosine A2 A receptors in mice with a 129-steel background, and a conditional 
knockout on a C57BL/6 background, also attenuated amphetamine-induced 
behavioural sensitisation (Chen et a l 2003; Bastia et a l 2005). At a cellular level 
dynorphin mRNA is predominantly co-expressed with DA Di receptor mRNA in 
striatonigral neurons o f the ‘direct’ striatal output pathway (Gerfen et a l 1990; Le
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Moine et al. 1991) and has been implicated in neuroadaptive responses to 
psychostimulants (Xu et al. 1994a; Xu et al. 1994b; Moratalla et al. 1996). Chen et al. 
(2003) demonstrated that repeated amphetamine treatment caused an increase in 
dynorphin mRNA in wildtype but not adenosine A2A receptor knockout mice, 
suggesting that the activation of adenosine A2 A receptors required for behavioural 
sensitisation is induced by repeated exposure to psychostimulants. Interestingly, 
studies using the adenosine A2 A receptor knockout model generated on a CD-I 
background revealed that the deletion of the adenosine A2A receptor did not modify 
the acute effects of cocaine and that locomotor sensitisation was observed in both 
genotypes (Soria et al. 2006).
The work of Wells (2008), within our laboratory, investigated the role o f the 
adenosine A2 A receptor in modulating the effect of acute cocaine administration on 
extracellular DA release in the NAc, locomotor behaviour and small local movements 
using the CDl strain of adenosine A2A receptor knockout mice. Following an initial 
increase in the concentration of DA levels in both genotypes, a significant reduction 
in DA levels was observed in adenosine A2 A receptor knockout mice 100 min after the 
administration of cocaine. In addition, acute cocaine administration induced a 
significantly greater increase in locomotor activity and a significantly greater decrease 
in small local movements in adenosine A2A receptor knockout mice compared to 
wildtype mice. These results and the observations of Soria et al. (2006) conflict both 
with the findings o f Chen et al. (2000), where acute cocaine-induced locomotion was 
reduced in adenosine A2A receptor knockout mice, and the findings of Chen et al. 
(2000) and Bastia et al. (2005) who observed an attenuation in locomotor sensitisation
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in adenosine A2 A receptor knockout mice following the administration of a similar 
psychostimulant, amphetamine.
Therefore, the aim of this study was to further investigate the role o f adenosine A2 A 
receptors in the modulation of cocaine sensitisation in the CDl strain o f adenosine 
A2 A receptor knockout mice (Ledent et al. 1997). The effect of chronic ‘binge’ 
cocaine administration on extra-cellular DA in the NAc was evaluated using in vivo 
microdialysis in wildtype and adenosine A2 A receptor knockout mice. In addition 
ambulatory activity and small local movements were measured throughout the chronic 
‘binge’ administration of cocaine and during the dialysis procedure.
High performance liquid chromatography (HPLC) with electrochemical detection 
(EC) was used to measure levels of DA in the dialysate. This was a method of 
detection previously used to measure catecholamines, such as DA (Hjemdahl 1984) 
and in conjunction with freely-moving microdialysis can be used to measure 
extracelluar levels of accumbal DA (Baumann et al. 2000; Zhang et al. 2001; Zhang 
et al. 2003; Castane et al. 2008).
5.2 Methods
Animals and general experimental details
Male, 12-15 week old CDl wildtype and adenosine A2A receptor knockout mice were 
used for this study. The generation and maintenance of the mice used has been 
previously described in section 2.2.1. The mice were allowed to habituate to the 
locomotor chambers for 1 h prior to any experimentation. They were then injected 
with 20 mg/kg cocaine or 0.9% saline (5 ml/mg, s.c.) 3 times daily (11.00, 12.00 and
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13.00) for 13 days, prior to the insertion of a cannulae for microdialysis 
measurements, and on day 14 following the insertion of the cannulae and probe. 
Ambulatory activity, small local movements and resting behaviours were recorded 
during cocaine treatment on each day.
5.2.1 Monitoring of locomotor activity
Ambulatory activity, small local movements and resting behaviours were measured 
by TruScan photobeam activity system (TruScan, Bilaney Consultants, Kent, UK). 
The system contained a locomotor chamber with 2 sensor rings, each ring had 32x32 
photobeams set 0.76 cm apart with a 100 ms sampling interval. One sensor ring was 
set 2  cm above the floor to measure horizontal activity and one 6  cm above the floor 
to measure vertical activity.
On days 1-13 locomotor activity was measured for 20 min prior to cocaine 
administration to obtain baseline data and during the 3 h period o f cocaine 
administration. On day 14, following the insertion o f the microdialysis probe, the 
mice were allowed to habituate to the chambers for 2  h, during which time they 
resumed normal exploratory and sleeping behaviours. Each animal’s accumulated 
basal activity was then measured for 100 min (bins 1-5, each bin consisting o f 20 min 
accumulated data). Cocaine or saline injections were administered as described for 
days 1-13, 3 times at 11.00, 12.00 and 13.00; treatment-induced movements were 
recorded throughout (bin 6-14) as was movement during post-treatment high 
potassium evoked DA release (bins 15-18) (Fig. 5.1). High potassium aCSF was 
infused following treatment to release all extracellular DA in the NAc and to assess 
whether cocaine had an effect on extracellular DA levels following cocaine treatment
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between the wildtype and adenosine A2 A receptor knockout mice. Locomotor activity,
small movements and rest time were calculated by changes in the coordinates o f the 
body centre; these were determined by the scanning photobeams finding the weighted
shadow centre of the mice and analysing the location of new coordinates in relation to 
time.
Bin 1 2 3 4 5
i
6 7 8
i
9  1 0 1 1
1
1 2  13 1 4 15 16 17 18 19
100 min INJ 1 INJ 2 INJ 3 High K+ conc. aCSF
collected
baseline
Figure 5.1: Representation of experimental procedure on day 14. Each bin 
represents a 20 min period. Basal activity was measured from bin 1-5. The arrows 
represent time of cocaine injection at the start o f bin 6 , 9 and 12; locomotor activity 
was recorded following each injection. Locomotor activity was also measured 
following the infusion of high aCSF between bin 15 and 19.
5.2.2 Im plantation of the cannulae for microdialysis
All surgical tools were sterilised prior to surgery; pointed-dissecting scissors, straight 
graefe forceps, #3 scalpel handle with a #10 scalpel blade, 2 mm flat-head screw 
driver and needle holders (World Precision Instruments Ltd, FL. USA) were placed in 
a bead steriliser. The drill, 4 mm x 0.75 jaw vessel clips and 2 mm M l anchor screws 
(Royem Scientific, Bedfordshire, UK) were swabbed or placed in 100% ethanol and 
disposable items such as cotton buds were autoclaved.
On the day of the experiment a mouse was anaesthetised with a volatile isofluorane 
anaesthetic (3.5%-4.5%) (Isoflo, Abbott Laboratories Ltd, Kent, UK) vaporised in 
95% O2 / 5% CO2 gas, with a flow rate of -450 ml/min and delivered by a U400 
anaesthetic unit (Univentor, Royem Scientific, UK). The mouse was placed in the
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anaesthetic chamber for 3-4 min until all righting reflex was lost, ensuring the mouse 
was anaesthetised. The mouse was weighed before transfer to the stereotaxic frame 
and anaesthesia was maintained while in the stereotaxic frame and throughout surgery 
by mask for approximately 45 min using (3.5-4.5%) isofluorane at a flow rate o f -360 
ml/min).
The mouse was placed on a homeothermic blanket with a rectal probe (CMA/150, 
CMA microdilaysis, Sweden) to maintain the mouse’s core body temperature at 
37.5°C. The upper incisors o f the mouse were hooked into the tooth-bar allowing the 
anaesthetic mask to be placed over the face. The tooth-bar was adjusted so the dorsal 
surface of the skull was horizontal to the bench, ensuring accuracy and a paw pinch 
was administered to check that the required depth of anaesthesia was maintained.
The head o f the mouse was supported in the stereotaxic frame by the gentle insertion 
of ear bars into the ear canals either side of the mouse’s head. No less than 3.5 mm 
was left on either side of the head to ensure stability whilst avoiding haemorrhage or 
strangulation due to increased pressure from the ear bars.
The eyes of the mouse were protected throughout surgery using tissue dampened with 
sterile water. The head of the mouse was then shaved, the fur was removed and the 
scalp was swabbed with disinfectant to remove any remaining fur and to sterilise the 
area. EMLA cream (5% lidocaine and prilocaine) (Vet-tech solutions limited, 
Cheshire, UK) was also applied to the scalp to mildly anaesthetise the area. A 6-10 
mm saggital-midline incision was made in the scalp 'with one stroke through the skin 
exposing the coronal and transverse (saggital) sutures of the skull and their point o f
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intersection, the bregma. The periosteum was cleared using sterile cotton buds, 
allowing the bregma point to be clearly visible (Fig. 5.3).
The skin surrounding the incision was secured back using vessel clips and a small 
mark was made above the bregma point. The tip of the drill bit was then positioned 
slightly above the bregma mark by use of the stereotaxic arms. This established the 
reference point from which ‘zero’ coordinates were ascertained.
optic lamp homeothermic unit
stereotaxic 
frame
probe clip
U400 anaesthetic unit
drill
anaesthetic mask
heat mat
Figure 5.2: Surgical set-up for cannulae implantation
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Figure 5.3: A midline-saggital incision illustrating the bregma and surrounding 
sutures
The right stereotaxic arm allows the drill to be moved in the direction of three planes, 
the anterior-posterior plane, the lateral plane and the vertical plane. The co-ordinates 
of the position of the drill tip were read from the vernier scales on the anterior- 
posterior and lateral arms of the stereotaxic frame. Vernier scales allow positioning to 
an accuracy of 0.1 mm. Once the bregma co-ordinates were determined it was 
possible to target the region of interest, the NAc, at the coordinates calculated from a 
mouse brain atlas (Franklin and Paxinos 1997) (Fig. 5.4). The drill was repositioned at 
the calculated coordinates above NAc and a small borehole was drilled through the 
skull to the level of the dura. The drill tip was then moved to a clear area of the skull 
well below the bore hole and used to create a small furrow into which an anchor 
screw was placed, ensuring that the screw did not penetrate the depth of the skull.
The microdialysis MAB4 probe was placed into the probe clip positioned on the left 
stereotaxic arm (Fig. 5.2). The probe was aligned with the bregma point, the 
coordinates were recalculated from the bregma using the left stereotaxic arm and the 
probe was placed over the target area. The probe was then lowered to the level o f the
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dura, the depth was read from the vertical plane and the probe was lowered to the 
required depth. The probe and anchor screws were fixed to the skull using dental 
acrylic cement (Royem scientific, UK) and once set the probe was carefully released 
from the clip and a further layer of cement was placed around the probe to secure it. 
The skin surrounding the probe was then pulled over the cement and sutured if 
necessary.
Upon the completion of the surgical procedure the ear bars were released and the level 
of anaesthesia reduced (-2.1%  isofluorane, 215 ml/min air flow). The mouse was 
allowed to recover in a heated recovery chamber until its righting reflex returned. The 
mouse was closely monitored post-surgery and microdialysis did not commence until 
the following day, ensuring the mouse was fully reeovered.
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Figure 5.4: An image from the brain atlas of Franklin and Paxinos (1997) at the 
level of the CPu and NAc. The blue line indicates the desired position of the probe, 
which is +1.54 mm from the bregma (anterior-posterior plane), -0.9 mm laterally 
from the midline (lateral plane) and at a depth of -4  mm from dura (vertical plane).
5.2.3 Preparation of reagents and experimental equipment
aCSF containing NaCl, 145 mM; KCl, 2.8 mM; CaCl], 1.3 mM; MgC^, 1.2 mM was 
prepared and filtered with a 0.2 pM syringe filter. A further solution of aCSF was 
adjusted to contain a high concentration of potassium (K^aCSF), which contained the 
following: NaCl, 77.5 mM; KCl, 50 mM; CaCl], 1.3 mM; MgCli, 1.2 mM and was 
also filtered with a 0.2 pM syringe filter. Both solutions were prepared in advance of 
experimentation, aliquoted into 10 ml vials and stored at -80°C.
On the morning of experimentation a vial of aCSF and K^aCSF were defrosted and 
degassed by sonification for 15 min. Two 1 ml gas-tight microdialysis syringes
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(Royem Scientific, UK) were fiushed three times with aCSF and one 1 ml gas-tight 
microdialysis syringe was fiushed three times with K^aCSF. The appropriate amount 
of aCSF was drawn up into a syringe and all visible air bubbles expelled. The syringes 
were then mounted on a microinjection pump (CMA/100, CMA microdialysis, 
Stockholm, Sweden) and one syringe of aCSF was used to flush the fluorinated 
ethylene propylene (FEP) tubing and a liquid switch (Microbiotech, Royem Scientific, 
UK) at a flow rate of 1 pl/min to remove any debris or air bubbles. Using FEP tubing, 
the liquid switch was connected via one outlet to the second syringe containing aCSF 
and via another outlet to the syringe containing K^aCSF ready to deliver either 
solution when appropriate (Fig. 5.5).
FEP tubing was also connected to the inlet of a MAB4 probe (1 mm cuprophane 
membrane with a 6 KDa cut-off and outer diameter of 0.24mm) (Microbiotech, 
Royem Scientific, UK) the membrane of which was submerged in a vial containing 
ethanol at a high flow rate (5-10 pl/min) for 5 min, to remove the protective glycerol 
coating. The vial o f ethanol was replaced with a vial o f filtered aCSF and perfused 
with aCSF at a flow rate of 1 pl/min for 20 min to further remove any traces of 
glycerol and air. The probe remained submerged until needed. Additional sections o f 
FEP tubing were prepared to connect the liquid switch to the swivel on the freely 
moving arm for the transport o f aCSF to the mouse and to connect the probe to the 
swivel and then from the swivel to a microfraction collector (CMA/140, CMA 
microdialysis, Sweden) (Fig. 5.5).
The mouse was briefly anaesthetised with isofluorane anaesthesia (3.5-4.5% in 95% 
0 2 /5 % CO2  gas mix, for 3-4 min) so the probe could be inserted into the guide
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cannulae. The animal was placed back in the locomotor chamber and attached to the 
freely-moving arm via their collar and all FEP tubing was connected accordingly. The 
probe was perfused with aCSF at a flow rate of 1 pl/min; dialysate was collected for 2 
h and discarded to ensure a stable basal DA level. Five consecutive dialysate fractions 
(1-5) were then collected at intervals of 20 min to monitor basal DA release. The 
animal was injected with 20 mg/kg cocaine at 11.00, 12.00 and 13.00 while in the 
locomotor chamber. Sample fractions were collected at 20 min intervals throughout 
(bin 6-14) (Fig. 5.1). The liquid switch was then set to deliver high aCSF and a 
further 5 sample fractions were collected (bin 15-19) (Fig. 5.1). All dialysate fractions 
were collected into polypropene sample vials that contained 35 pi o f mobile phase 
and frozen immediately in dry ice. The samples were kept frozen at -80°C until 
analysed by HPLC-EC.
Upon completion of the experiment the mouse was killed by cervical dislocation and 
trypan blue solution (0.4%, Sigma-Aldrich, Dorset, UK) was immediately flushed 
through the probe to aid the location o f the guide cannula and probe tracts. The brain 
was removed and frozen in isopentane with dry ice (-20 to -30°C) for verification of 
probe placement. All components o f the freely moving microdialysis equipment were 
flushed with sterile water and dried with a bolus o f air.
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CMA/140 
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Figure 5.5: Representation of the setup used for freely moving microdialysis in 
mice. Broken line represents FEP tubing carrying perfusion fluid, arrows indicate 
direction of flow. Perfusion fluid A=aCSF and B=k^aCSF. In this example the liquid 
switch is set to deliver aCSF (A). Liquid perfuses to the mouse through channel 1 
(blue boxes) and to the fraction collector via channel 2 (red boxes).
5.2.4 Analysis of dopamine levels in microdialysis dialysate by high performance 
liquid chromatography with electrochemical detection (HPLC-EC)
HPLC-EC was used to measure the concentration of DA in the dialysate samples 
collected during freely-moving microdialysis. The HPLC system consisted of a pump, 
refrigerated automatie autosampler (set a 4°C, injection volume 50 pi) supplied by 
JASCO (Essex, UK). The pulse dampener and dual potential couloumetric 
microdialysis cell were housed in a separate unit supplied by Presearch (Hampshire, 
UK) along with a GeminiNX C l8 5 pm x 100 mm x 4.6 mm analytical column 
(Phenomenex, Cheshire, UK) and a guard column (Phenomenex, Cheshire, UK).
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The mobile phase was made up of NaH2 P0 4 , 0.05 M; octyl sodium sulphate (OSA), 
0.8 mM; EDTA, 0.1 mM; methanol 10% (v/v), adjusted to pH 3.3 with 
orthophosphoric acid, filtered through a 0.2 pm nylon membrane and degassed with 
helium before use. The pH of the mobile phase was low as DA is easily oxidised in 
solution. All reagents used for mobile phase were o f analytical or electrochemical 
grade (Fisher Scientific, Leicestershire, UK). The mobile phase was allowed to 
circulate through the HPLC machine at a flow rate o f 0.2 mPmin for 2 days prior to 
use. DA was detected on a dual porous graphite electrode system.
Preparation and calibration o f standards
External DA standards were used to calibrate the HPLC-EC application. DA 
hydrochloride (Sigma-Aldrich, Dorset, UK) was dissolved in 10 ml 0.1 M HCl to 
make a 5 mM solution. The flask was protected from light with aluminium foil, 
vortexed and left to stand at 4°C over night. The stock solution was filtered through a 
0.2 pm membrane and divided into 1 ml aliquots which were also protected from light 
with foil and frozen at -80°C until required. Further dilutions were made in ice-cold 
mobile phase when preparing the standard curve. Current-voltage curves were used to 
determine the optimal potential to be applied across the cell to produce a maximal 
response from DA oxidation.
5.2.5 Histology
Frozen coronal brain sections including the NAc area where the guide cannula tract 
could be identified were cut using a cryostat (Zeiss Microm 505E, Hertforshire, U.K) 
and thaw mounted onto pre-cleaned and gelatine subbed ice-cold microscope slides. 
The slides were placed in a staining tray and submerged in Clarke’s solution (3:1 v/v
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absolute alcohol: glacial acetic acid) for 2 min. The slides were removed and allowed 
to dry under a fume hood for 10-15 min, fixing the tissue in preparation for staining.
The slides were then placed in haematoxylin for 15 min and rinsed with fresh de­
ionised water for 1 min. This was followed by a brief immersion in 1% acetic acid 
alcohol for 5-10 s. The slides were once again rinsed with fresh deionised water, 
submerged in eosin (aqueous 1 %) for 2  min and briefly rinsed with de-ionised water. 
The slides were finally dehydrated in 3 alcohol solutions (85%, 100%, 100%) for 30 s 
each and cleared twice with xylene (30 s). The slides were allowed to dry before a 
coverslip was placed over each section, avoiding the introduction of air bubbles. The 
reagents for haematoxylin and eosin (H&E) stain were purchased from Raymond A. 
Lamb (Thermo Fisher, Leistershire, UK). The correct probe placements were verified 
by observation under a light microscope, using xlO and x40 objectives. Only data 
obtained from animals with correct probe placement were used for analysis.
5.3 Results
5.3.1 Cocaine-induced ambulatory activity in wildtype and adenosine A%A 
receptor knockout mice from day 1 to 13
Mice were exposed to the locomotor chambers for 30 min before the start o f any 
experimentation. The mice were injected 3 times daily at hourly intervals for 13 days 
and locomotor activity was recorded throughout. Due to an irretrievable software 
failure several o f the locomotor files were lost during analysis. Accordingly, some o f 
these data sets are incomplete and statistical comparisons were not possible. As a 
consequence only qualitative statements can be made with respect to this data.
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Basal levels in all parameters measured (rest time, small local moves and ambulatory 
activity) appeared to be similar in both genotypes and in all experimental groups 
during all the days measured (Fig. 5.6-5.11). Overall the rest time of saline-treated 
wildtype and saline-treated adenosine A 2 A receptor knockout mice increased on day 3, 
7 and 13 compared to day 1 (Fig. 5.6 A-D and 5.7 A-D). This is likely to be due to the 
mice becoming familiar with the locomotor chambers and the injection procedure. 
There was an overall decrease in the number of small local moves following the 
second and third injections compared to the first injection in saline-treated mice in 
both genotypes (Fig. 5.8 A-D and 5.9 A-D. Ambulatory activity remained the same 
throughout all the days measured in saline-treated mice in both genotypes (Fig. 5.10 
A-D and 5.11 A-D).
On day 1 cocaine administration (20 mg/kg s.c.) did not have a great effect on 
ambulatory activity in wildtype mice following all 3 injections of cocaine (Fig. 5.10 
E) but a very slight increase in small local moves was observed (Fig. 5.8 E). The same 
response was observed in adenosine A2A receptor knockout mice on day 1 until the 
final injection where a large increase in ambulatory activity was observed (Fig. 5.11 
E), which was mirrored by a decrease in small local moves (Fig. 5.9 E). On days 3, 7 
and 13 cocaine induced an increase in ambulatory activity compared to baseline 
ambulatory activity in both genotypes following the first injection (Fig. 5.10 F, G and 
H and 5.11 F, G and H). This was accompanied by a decrease in rest time in both 
genotypes following cocaine treatment compared to the saline treatment (Fig. 5.6 and 
5.7). On day 7 an increase in ambulatory activity was observed following all three 
injections of cocaine in both genotypes (Fig. 5.10 G and 5.11 G). By day 13 there was 
a large increase in ambulatory activity in both genotypes following cocaine treatment
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compared to day 1 and day 3 (Fig. 5.10 H and 5.11 H). These results suggest that 
chronic ‘binge’ cocaine treatment induced a sensitisation response in the wildtype and 
perhaps the adensosine A2A receptor knockout mice (Fig. 5.10 E-H and 5.11 E-H). 
Ambulatory activity appears to be greater in wildtype mice compared to the adenosine 
A2A receptor knockout, which therefore suggests that the absence of adenosine A 2 A 
receptor may reduce cocaine-induced sensitisation.
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Figure 5.6: Rest time (sec) of wildtype mice treated with saline (5 ml/kg s.c.) on 
day 1 (A), day 3 (B), day 7 (C) and day 13 (D) and wildtype mice treated with 
cocaine (20 mg/kg s.c.) on day 1 (E), day 3 (F), day 7 (G) and day 13 (H), 3 times 
daily for 13 days. Data are shown as mean ± SEM, where possible (n=l-5).
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Figure 5.7: Rest time (sec) of adenosine A2A knockout mice treated by saline (5 
ml/kg s.c.) on day 1 (A), day 3 (B), day 7 (C) and day 13 (D) and adenosine A2A 
knockout mice treated with cocaine (20 mg/kg s.c.) on day 1 (E), day 3 (F), day 7 
(G), day 13 (H), 3 times daily for 13 days. Data are shown as mean ± SEM (n=l-3).
170
Day 3Day 1
1500-, 1500-
100 0 - 1 0 0 0 -
500- 500-
M in u te s  
Day 7
I IN J  2  I I IN J  3  I
M in u te s
Day 13
I IN J  1 I [ M J 3  I
1500-,1500-
1 0 0 0 -g 1000-
5 0 0 -% 500
20
M in u te sM in u te s
Day 3Day 1
1500-, 1500-
100 0 -
500- 5 0 0 -
20 40 60 80 100 120 140 160 180
M in u te sM in u te s
Day 7 Day 13
1500-1500-
1000 -1 0 0 0 -
500-500-
M in u te s M in u te s
Figure 5.8; Small local movements of wildtype mice treated with saline (5 ml/kg 
s.c.) on day 1 (A), day 3 (B), day 7 (C) and day 13 (D) and wildtype mice treated 
with cocaine (20 mg/kg s.c.) on day 1 (E), day 3 (F), day 7 (G) and day 13 (H), 3 
times daily for 13 days. Data are shown as mean ± SEM (n=l-5).
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Figure 5.9: Small local movements (sec) of adenosine A%A knockout mice treated 
with saline (5 ml/kg s.c.) on day 1 (A), day 3 (B), day 7 (C) and day 13 (D) and 
adenosine A%A knockout mice treated with cocaine (20 mg/kg s.c.) on day 1 (E), 
day 3 (F), day 7 (G), day 13 (H), 3 times daily for 13 days. Data are shown as mean 
± SEM (n=l-3).
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Figure 5.10: Ambulatory activity of wildtype mice treated with saline (5 ml/kg 
s.c.) on day 1 (A), day 3 (B), day 7 (C) and day 13 (D) and wildtype mice treated 
with cocaine (20 mg/kg s.c.) on day 1 (E), day 3 (F), day 7 (G) and day 13 (H), 3 
times daily for 13 days. Data are shown as mean ± SEM (n=l-5).
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Figure 5.11: Ambulatory activity of adenosine À2a knockout mice treated by 
saline (5 ml/kg s.c.) on day 1 (A), day 3 (B), day 7 (C) and day 13 (D) and 
adenosine A2A knockout mice treated with cocaine (20 mg/kg s.c.) day 1 (E), day 
3 (F), day 7 (G), day 13 (H), 3 times daily for 13 days. Data are shown as mean ± 
SEM (n=l-3).
174
5.3.2 Cocaine-induced ambulatory activity in wildtype and adenosine A2A 
receptor knockout mice on day 14
A cannula was surgically implanted on the afternoon of day 13, the probe was inserted 
on the morning o f day 14 and the mouse was attached to the freely moving arm. All 
mice received 3 cocaine injections regardless of treatment with cocaine or saline 
throughout the previous thirteen days. Locomotor activity was recorded as before. 
Due to the irretrievable software failure mentioned earlier some data sets collected on 
day 14 were also incomplete and statistical comparisons were not possible. As before 
only qualitative statements can be made with respect to this data.
The basal readings for rest time, small local movements and ambulatory activity were 
similar in both genotypes and all experimental groups (Fig. 5.12-5.15 A-C). They 
were also similar to the previous results obtained from day 1 to 13 (Fig. 5.6-5.11 A- 
H). The wildtype mouse previously treated with saline exhibited an increase in small 
local moves following the first two injections of cocaine (Fig. 5.12 B), accompanied 
by a smaller increase in ambulatory activity following all three injections (Fig. 5.12 
C). This also corresponds with the rest time which decreased as activity increased and 
visa versa (Fig. 5.12 A). In addition, the ambulatory activity and small local moves 
decreased following the final injection of cocaine and the subsequent infusion of high 
K-^aCSF (Fig. 5.12 B, C).
In wildtype mice previously treated with cocaine an increase in ambulatory activity 
and small local movements was observed following all three injections of cocaine 
(Fig. 5.13 B and C). This was mirrored by a reduction in rest time (Fig. 5.13 A). Both 
ambulatory activity and small local moves decreased following the termination of
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cocaine treatment, which was followed by the subsequent infusion of high aCSF to 
release the remaining DA (Fig. 5.13 B and C).
In the adenosine A2A receptor knockout mouse previously treated with saline an 
increase in both ambulatory activity and small local moves was observed following 
the first injection o f cocaine (Fig. 5.14 B and C). The second injection induced a drop 
in both ambulatory activity and small local moves, which increased following the 
final injection (Fig. 5.14 B and C). Overall, cocaine induced a greater increase in 
small local moves compared to ambulatory activity (Fig. 5.14 B and C). There was 
little change in ambulatory activity after cocaine treatment and upon the infusion of 
high aCSF (Fig. 5.14 C) but a slight increase in small local movements was 
observed (Fig. 5.14 B).
The adenosine A2 A receptor knockout mice previously treated with cocaine showed an 
increase in ambulatory activity (Fig. 5.15 C) but no increase in small local moves 
(Fig. 5.15 B) following the first cocaine injection. An increase in small local moves 
was observed following the second and third injection (Fig. 5.15 B), which was 
accompanied by a decrease in ambulatory activity (Fig. 5.15 C). As with the previous 
two groups a reduction in both ambulatory activity and small local moves was 
observed following the final cocaine injection and subsequent infusion of high 
aCSF (Fig. 5.15 B, C).
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5.3.3 Extracellular DA in the NAc of coeaine treated wildtype and adenosine A%A 
receptor knockout mice on day 14
Major failure o f HPLC EC analysis in two institutions, the University o f Surrey and 
the University of Roehampton, led to substantial delays in the analysis o f DA 
samples. Unforeseen problems with the HPLC equipment made the analysis o f the 
DA samples extremely difficult. The experiments were carried out over a period o f 18 
months and could not immediately be analysed so were stored in the -80°C freezer. 
Due to the sensitive nature of DA, the samples degraded while stored so those stored 
for longer degraded more than others. Therefore samples from this study could not be 
compared between animals despite the fact that the analysis was carried out at the 
same time points. A higher DA concentration may be due to the fact that the 
experiment was more recent and the sample did not degrade to the same extent as the 
others. These factors limit the interpretation of the results and consequent discussion.
In all experimental groups it appears that cocaine treatment increased the 
concentration o f DA in the NAc but the effect was very small and inconsistent (Fig. 
5.16). A large increase in the concentration of DA in the NAc was also observed in all 
groups following the infusion of high aCSF (Fig. 5.16). There does not appear to 
be any difference in basal DA concentration in the NAc between the genotypes or 
groups. The effect of cocaine on DA release after each injection of cocaine was 
particularly pronounced in wildtype mice previously treated with cocaine (Fig. 5.16 
B) and the adenosine A 2 A receptor knockout mouse previously treated with saline 
(Fig. 5.16 C).
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Figure 5.12: Rest time (sec) (A), number of small local moves (B) and ambulatory 
distance (mm) (C) on day 14, measured in a wildtype mouse treated with saline 
(5 ml/kg s.c.) on day 1-13 and cocaine (20 mg/kg s.c.) on day 14. Data are shown 
for a single mouse.
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Figure 5.13; Rest time (see) (A), number of small local moves (B) and ambulatory 
distance (mm) (C) on day 14, measured in wildtype mice treated with cocaine (20 
mg/kg s.c.) on day 1 -14. Data are shown as mean ± SEM (n=3).
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Figure 5.14: Rest time (sec) (A), number of small local moves (B) and ambulatory 
distance (mm) (C) on day 14, measured in an adenosine Aia receptor knockout 
mouse treated with saline (5 ml/kg s.c.) on day 1-13 and cocaine (20 mg/kg s.c.)
on day 14. Data are shown for a single mouse.
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5.4 Discussion
The aim o f this study was to investigate the neurochemical and behavioural response 
of accumbal DA in wildtype and adenosine A2 A receptor knockout mice following the 
chronic ‘binge’ administration of cocaine. Behavioural responses were studied by 
measuring ambulatory activity, small local moves and rest-time. There appears to be 
no difference in the basal activity (ambulatory activity and small local moves) 
between wildtype and adenosine A%A receptor knockout mice, which is similar to 
results reported in recent studies in the same strain o f mouse (Castane et al. 2008). 
These results are in contrast with that observed by Ledent et a l (1997) and Soria et al. 
(2006) who both observed hypolocomotor activity in adenosine A ia receptor 
knockout mice. In the present study mice of both genotypes displayed normal 
exploratory and sleep behaviours, which suggests that the increase in basal activity in 
adenosine A2 A receptor knockout mice when compared to the observations by Ledent 
et a l (1997) and Soria et al. (2006) is not likely to be due to stress and anxiety but the 
difference may be due to the different experimental conditions employed.
The chronic ‘binge’ administration of cocaine induced an increase in ambulatory 
activity in wildtype and adenosine A2 A receptor knockout mice. The increase in 
cocaine-induced ambulatory activity over thirteen days appeared to be greater in 
wildtype compared to adenosine A2 A receptor knockout mice with little change in the 
number of small local moves. On day 14 the wildtype mice exhibited greater 
ambulatory activity compared to the adenosine A%A receptor knockout mice however 
cocaine treated wildtype mice showed a greater increase in ambulatory activity as 
seen by day 13, which suggest that these mice sensitised to the effects o f cocaine by 
day 14. The chronic ‘binge’ procedure of cocaine administration has not been
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previously performed on the GDI strain of mouse or in the adenosine A2 A receptor 
knockout model so it is difficult to make direct comparisons with current literature. 
However, a chronic study in the GDI strain of adenosine A2A receptor knockout mice 
was performed by Soria et al. (2006). These authors chronically administered 10 
mg/kg cocaine once daily for 1 2  days and, in contrast to the present results, a similar 
locomotor sensitisation was observed in both wildtype and adenosine A%A receptor 
knockout mice. An acute cocaine study carried out by our research group showed that 
the administration of 2 0  mg/kg cocaine induced a significantly greater increase in 
ambulatory activity in adenosine A2 A receptor knockout mice compared to wildtype 
mice (Wells 2008). This was accompanied by a significant attenuation of small local 
moves in cocaine-treated adenosine A2 A receptor knockout mice. These results are 
opposite to the indicative results o f the present study but this is likely to be due the 
comparison between a chronic and acute study.
Ghen et al. (2000) also studied the ambulatory response following the administration 
of acute cocaine but in the 129-steel and 129-steel x G57BL/6 strains of adenosine 
A2 A receptor knockout mice. In both strains ambulatory responses to acute cocaine 
administration were attenuated in adenosine A2A receptor knockout mice. This 
conflicts with the results o f Wells (2008) which showed a significant increase in 
ambulatory activity in the adenosine A 2A receptor knockout mice compared with the 
wildtype mice. The discrepancy between these results may be due to the difference in 
the background strains of the mice. Genetic strain differences have been identified as 
a major factor of consideration in the modification of behavioural responses and drug- 
induced neurochemistry (Parmigiani et al. 1999; He et al. 2000; Murphy et al. 2001; 
Short et al. 2006a). The variation in genetic background of these mice may explain
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the discrepancies in locomotor responses following acute and chronic administration 
of cocaine. For example Schlussman et al. (2003) conducted the same chronic ‘binge’ 
cocaine protocol as described in the present study but with C57BL/6 and 129-J 
wildtype mice. In C57BL/6 mice cocaine-induced locomotor activity was 
significantly lower on day 13 compared to day 1 , demonstrating tolerance, whereas in 
129-J mice no locomotor response was evident on any day. In light of this it would 
seem that chronic ‘binge’ cocaine administration induces sensitisation in GDI 
wildtype mice and tolerance in G57BL/6 mice highlighting the importance of genetic 
variation in drug-induced behavioural studies.
A chronic ‘binge’ cocaine study in rats which followed the same procedure as the 
present study identified that the final dose of cocaine in rats, chronically pre-treated 
with cocaine, resulted in extra-cellular DA levels lower that the corresponding values 
in saline pre-treated rats in the ventromedial striatum, which included the NAc 
(Maisonneuve et al. 1995). Due to the fact that in the current study these samples 
were collected at different time points and therefore degraded to different extremes it 
is not possible to compare the pre-treated with the treated groups.
The lack of any apparent difference in basal accumbal DA release between all the 
genotypes and experimental groups was however observed and is in agreement with 
the studies o f Wells (2008) and Gastane et al. (2006; 2008) who also observed no 
significant difference in basal accumbal DA release in the GDI wildtype and 
adenosine A2 A receptor knockout mice. The acute cocaine study of Wells (2008) 
identified that the increase in ambulatory activity in adenosine A2 A receptor knockout 
mice did not correlate with a change in measured DA release and this may also be the
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case in the chronic ‘binge’ cocaine study. This, however, does not mean that altered 
ambulatory activity is not due to DAergic influences. The NAc has been shown to 
play a role in cocaine-induced locomotor activity. Lesions of the NAc disrupt 
cocaine-induced locomotion and stereotypic behaviours (Kelly et ah 1976). The 
activity o f NAc neurons is markedly inhibited by cocaine; NAc neurons become 
supersensitive to these inhibitory effects following chronic cocaine administration 
(Delfs et a l 1990). Significant increases in the inhibitory responses o f NAc neurons 
have been identified in response to DA Di receptor agonists rather than DA D2  
receptor agonists (Henry et al. 1991; Henry et al. 1995). This is thought to be due to 
the supersensitivity of DA Di receptors (Henry et al. 1991; Xu e/ al. 1994b; Henry et 
al. 1998; Beurrier et al. 2002), which may participate in the development of 
behavioural sensitisation following chronic cocaine exposure (Henry et al. 1991). The 
mechanism which causes the supersensitivity of DA Di receptors is unclear but it has 
been hypothesised that the supersensitivity may be due to the prolonged stimulation o f 
DA Di by endogenous DA, subsequent to uptake inhibition (Henry et al. 1991). It 
may be possible that DA Di supersensitivity results from alterations in DA Di 
receptor coupled transduction mechanisms (Henry et al. 1991).
The selective adenosine A 2A receptor agonist, CGS 21680 reverses cocaine-induced 
locomotion (Poleszak et al. 2002b). This is thought to be due to the involvement of 
DA D% receptors in cocaine-induced responses (Ushijima et al. 1995; Kita et al. 1999; 
Adams et al. 2001; Schindler et al. 2002) and by the existence of adenosine A 2 a/DA 
D2  heterodimeric complexes in which adenosine A2 A receptor activation inhibits DA 
D2  receptor signalling by a reduction in the affinity o f DA D2  receptors and G-protein 
coupling (Fuxe et al. 1998; Hillion et al. 2002; Canals et al. 2003; Fuxe et al. 2003).
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Adenosine A2A receptors are also thought to be involved in the process of cocaine- 
induced receptor sensitisation, as CGS 21680 was found to attenuate both the 
development and expression of sensitisation (Filip et a l 2006). However, these results 
conflict with the present indicative results, as the absence of adenosine A2 A receptors 
attenuated the expression of sensitisation. This may be due to the different 
experimental protocols; Filip et a l (2006) administered cocaine once a day for a 
period o f 5 days, the mice remained drug-free for the following 4 days and on the 
final day received a challenge dose of cocaine. In the present study cocaine was 
administered following a chronic ‘binge’ protocol so the mice were injected with 
cocaine three times daily for 13 days.
To conclude, these studies have confirmed that there is no difference in the basal 
activity o f GDI wildtype mice compared to adenosine A2 A receptor knockout mice, as 
previously reported by Castane et a l (2006, 2008). They also show that GDI WT 
mice sensitise to the effects of cocaine, as shown by an increase in ambulatory 
activity.
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Chapter 6 
Final discussion and future work
The nucleoside purine, adenosine, has been identified to play an important role in 
both opioid and cocaine addiction. The adenosine A2A receptors have been 
specifically identified as playing a key role in the behavioural and reinforcing effects 
of morphine and cocaine. At a molecular level, functional interactions have been 
identified between the adenosinergic and DAergic system, the pathways of which are 
highly involved in addictive processes. The co-expression of adenosine A2A and DA 
D2  receptors in striatopallidal neurons and their antagonistic interactions are thought 
to mediate different phases of morphine and cocaine-induced addictive responses. The 
mechanisms underlying the modulation of these systems is still uncertain, however, 
the generation of the adenosine A2A receptor knockout model in mice has enabled 
more specific investigations into the role o f the adenosine A2 A receptor in these 
neurological pathways and therefore morphine and cocaine addiction. This thesis 
aimed to further investigate the links between adenosine A2 A and DA D2  receptors 
and their involvement in morphine and cocaine addiction using the CDl strain of 
adenosine A2 A receptor knockout mice.
The VTA is a key brain region involved in the processes of addiction as the 
mesolimbic and mesocortical DAergic pathways originate from the DAergic neurons 
in the VTA. DA D2  receptors are involved in DAergic neuronal firing in the VTA and 
are also known to be involved in addictive processes in both morphine and cocaine 
addiction. The activation of DA D2  receptors in the VTA has been shown to 
reversibly inhibit the firing activity on DAergic neurons of the VTA (Bowery et ah
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1994; Mercuri et a l 1997; Centonze et a l 2002). Electrophysiological recordings 
from this thesis confirm that the activation of DA D2  receptors following the 
cumulative addition o f the agonist, quinpirole, also reversibly inhibits the firing 
activity on DAergic neurons of the VTA in CDl wildtype mice. A significant 
genotype difference was shown as the firing frequency was not reduced to the same 
extent in adenosine A2 A receptor knockout mice following the addition of quinpirole. 
The single/non-cummulative addition of quinpirole did not result in a genotype 
difference and a similar maximal response was observed in wildtype and adenosine 
A2 A receptor knockout mice. The increase in the inhibition of DAergic cell firing was 
also seen at a lower concentration in both genotypes.
There appears to be some alteration in the action of DA D2  receptors in the VTA of 
adenosine A2 A receptor knockout mice. These studies suggest that the action of DA 
D2  receptors may be dependent on the length o f stimulation. However, the alteration 
in the action of DA D2  receptors cannot be directly attributed to the loss of interaction 
between DA D2  and adenosine A2 A receptors in the VTA as there is no functional 
evidence for adenosine A2A receptors in the VTA, shown in this study, by the lack of 
any response following the addition of an adenosine A2 A agonist, and others 
(Sebastiao et a l 1996; Moreau et a l 1999). Therefore, altered DA D2  receptor 
function may be due to adaptive changes in adenosine A2A receptor knockout mice. 
There may, for example, be changes in the glutamatergic system; there is evidence to 
show the formation of heteromeric complexes between adenosine A2 A and mGlu5 
receptors as well as adenosine A2A and DA D2 receptors in striatal neurons (Ferre et 
al 2002; Fuxe et a l 2003). The release of DA may regulate the firing rate o f DAergic 
neurons in the VTA through DA D2 receptors located in glutamatergic terminals
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(Koga et a l 2000) and this may be altered in adenosine A2 A receptor knockout mice. 
The changes observed in the firing rate of DAergic neurons in the VTA of adenosine 
A2A receptor knockout mice may also be due to a change in the GABAergic feedback 
loop of the mesolimbic pathway, projecting from the NAc to the VTA. These 
electrophysiological studies suggest that the activation of DA D2  receptors influence 
the firing of DAergic neurons in the VTA of adenosine A2 A receptor knockout mice 
but that this is not directly to due the absence of the adenosine A2A receptors. In order 
to directly link these findings to morphine and cocaine addiction it would be of 
interest to carry out the same in vitro studies, under the same conditions and in the 
same strain o f mice but following both acute and chronic treatment with morphine or 
cocaine. This would enable the investigation into how the activation of DA D2  
receptors affects DAergic neuronal firing in the VTA when the mice are in a non- 
addictive and addictive state in both wildtype compared to the adenosine A 2 A receptor 
knockout mice.
A number of studies have identified alterations in addictive processes in adenosine 
A2 A receptor knockout mice following morphine and cocaine administration. For 
example, cocaine self-administration was reduced, morphine reward was abolished, 
signs of morphine withdrawal were augmented and an increase in the functional 
activity of MOP receptors was observed (Berrendero et a l 2003; Bailey et a l 2004; 
Soria et a l 2004; Soria et a l 2006; Castane et a l 2008; Brown et a l 2009). In light of 
these findings this thesis studied conditioning, extinction and reinstatement following 
morphine and cocaine treatment. The main finding from these studies was that 
consistent CPF could not be induced by either morphine or cocaine in the CDl strain 
of mouse despite numerous modifications and attempts.
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There are a limited number of studies which have investigated the behavioural effects 
of morphine and cocaine in CDl mice; Castane et a l (2008) and Brown et a l (2009) 
reported morphine-induced CPP and Soria et a l (2006) reported cocaine-induced 
CPP, and there are many methodological differences between these studies and the 
CPP studies in this thesis. The conditioning apparatus and the conditioning schedule 
differed between the studies. An important difference between the afore mentioned 
CPP studies and the studies in this thesis is the method of data analysis; each study 
used a different method of analysis to measure conditioning making comparisons 
between studies difficult.
The same CDl strain of mouse was used in the cited studies and in this thesis, 
however, housing and the laboratory conditions differed. A study in which different 
laboratories conducted the same experiment revealed how the different housing and 
laboratory conditions can cause variation in the results of behavioural studies 
(Lewejohann et a l 2006). In addition, Coudereau et a l  (1997; 1999) demonstrated 
that individual and social housing can affect the outcome of CPP. Individually housed 
animals exhibited less CPP than those that were socially (group) housed, which may 
explain the lack of CPP in CDl mice in this thesis as the mice were individually 
housed whereas the mice in other studies that showed CPP were group housed. This is 
a hugely important factor that could explain the discrepancies between studies but is 
difficult to avoid.
In addition, there is evidence to show that stress influences CPP and reinstatement 
(Erb et a l 1998; Koob 1999; Stewart 2000; Lu et a l 2001; Ribeiro Do Couto et a l
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2006) and the level o f stress may pre-dispose mice to conditioning and relapse. 
Therefore, mice in different laboratories under different housing and experimental 
conditions may be under different levels of stress and as a result respond differently to 
the same drug.
Due to inconsistent morphine- or cocaine-induced CPP in CDl mice, morphine- and 
cocaine-induced CPP was conducted in C57BL/6 mice, as heroin-induced CPP had 
been successfully carried out in our laboratory. Morphine and cocaine did induce 
CPP, extinction and reinstatement in C57BL/6 mice, in accordance with a number of 
previous studies (Belzung et a l 2000; Itzhak et a l 2002; Ribeiro Do Couto et a l 
2003; Orsini et a l 2005; Sakoori et a l 2005; Popik et a l 2006; Orsini et a l 2008). 
The same conditioning schedule was used for the CDl mice and the C57BL/6 mice 
and a similar ambulatory response was observed in both strains of mice following 
morphine or cocaine treatment. The lack o f conditioning in CDl mice was therefore 
not due to conditions such as dose, route o f administration and drug 
pharmacokinetics. These studies identified that the difference in behavioural 
responses may be due to the strain difference. It has been documented that strain can 
cause differences in behavioural responses (Testing 1976; 1999). The CDl mice are 
an outbred strain whereas the C57BL/6 mice are inbred. It could be argued that CDl 
strain of mice may not be suitable for such behavioural studies or alternatively it 
could be argued that CDl mice are a non-vulnerable strain and can be made 
vulnerable experimentally. It would be of interest to study whether vulnerability to 
addiction through the induction o f stress affects conditioning to morphine and 
cocaine. It would also be of interest to conduct the same CPP experiments under the 
same conditions using the adenosine A2 A receptor knockout mice of different strains.
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such as the pure C57BL/6, C57BL/6 x 129-Steel and pure Steel to identify whether 
consistent CPP can be achieved and whether the absence of the adenosine A%A 
receptor affects conditioning, extinction and reinstatement.
As a consequence o f the CPP results and in an attempt to understand the different 
behavioural responses observed in CDl and C57BL/6 mice quantitative 
autoradiography binding studies were performed. Morphine exerts its rewarding 
action through MOPr by indirectly increasing DAergic neuronal firing in the VTA, a 
key region involved in mesocorticolimbic reward pathways. This thesis studied the 
distribution and function o f MOP in the VTA and SN in CDl and C57BL/6 mice. It 
was hypothesised that the distribution of MOPr in CDl mice may be reduced 
compared to C57BL/6 due to the lack o f conditioning.
No significant difference in the density or function of MOPr in the VTA and SN were 
observed in C57BL/6 and CDl mice therefore the induction of CPP in C57BL/6 but 
not CDl mice was not due a difference in the density or function of MOPr between 
the two strains. The standard error of the mean following MOPr binding analysis in 
CDl mice were unusually large when compared to the standard error o f the mean 
values typically produced following MOPr quantitative autoradiography. This large 
variability may represent the increased variability in the outbred CDl mice and would 
explain why some mice responded to behavioural studies while others did not.
The mesolimbic DAergic pathway projects from the VTA to the NAc therefore the 
influence of NAc has been considered. Acute morphine administration was unable to 
induce increases in extra-cellular DA in the NAc (Castane et a l 2008), previously
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reported to occur in inbred strains o f mice following morphine treatment (Murphy et 
al 2001; Fadda et a l 2005; Narita et a l 2006; Ogawa et a l 2007). The lack of DA 
release in the NAc and CPP following morphine administration may be due to the fact 
that CDl mice are outbred and are more biologically variable. This in turn may result 
in a lower addictive potential compared to C57BL/6 mice (Short et a l 2006a). One 
possible way to study this would be to identify genes that are involved in the addictive 
response of CDl mice to morphine and cocaine by doing a whole genome analysis 
comparing the mice that become addicted to those that do not. It would also be 
interesting to identify whether the variability in response to morphine and cocaine, 
which both target DAergic pathways, would be the same following treatment with 
alcohol for example, which targets the GABAergic pathway. This would identify if 
the variability in CDl is specific to drugs of abuse predominantly involve the 
DAergic pathway.
Following the closer examination of cocaine-induced CPP in CDl mice it became 
apparent that the mice could be divided into responders and non-responders. 
Responders showed conditioning behaviour and the non-responders showed no 
response to cocaine. An important role for the DAergic system in the reinforcing 
effects of cocaine has been established due to the increase in DA in NAc and CPu 
which is innervated by the mesocorticolimbic pathway (Woolverton et a l 1992). This 
thesis therefore investigated whether the DAergic profile was altered between 
responders and non-responders to cocaine conditioning using quantitative 
autoradiography.
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DA Di receptor, DA D2  receptor and DAT distribution and DA D2  receptor function 
using quantitative autoradiography were investigated. No difference was observed in 
DAT distribution and DA D2 receptor function. However, a difference in DA Di 
receptor density was revealed in the rostral CPu between responders and non­
responders and a difference in DA D2  receptor density was measured in the rostral and 
caudal CPu between responders and non-responders.
DA Di receptor binding in the rostral CPu of and non-responders was greater than in 
the rostral CPu of responders. This is in agreement with evidence which also shows 
an increase in DA Di receptor density in the CPu following chronic ‘binge’ 
administration and self-administration o f cocaine (Alburges et a l 1993; Unterwald et 
al 1994; Unterwald et al 1996; Nader et a l 2002; Schlussman et a l 2003). The 
mechanism behind the upregulation of DA Di following cocaine treatment is unclear 
but it has been suggested that it may be due to enhanced DA Di receptor stimulation 
by endogenous DA secondary to cocaine inhibition of DA re-uptake (Unterwald et a l 
1996). A further theory is that the upregulation of DA Di receptors may be a 
secondary response in the postsynaptic DAergic system due to the cocaine-induced 
depletion of DA (Dackis et a l 1985; Alburges et a l 1993).
A difference in DA D2  receptor density was also measured in the rostral and caudal 
CPu between responders and non-responders. The non-responders showed greater DA 
D2  receptor binding than the responders. It was postulated that the reduction of striatal 
DA D2  receptor availability may be involved in the initiation or maintenance of 
cocaine abuse, particularly due to the fact that low striatal DA D2 availability was 
observed in detoxified chronic cocaine abusers (Voikow et a l 1993; Stefanski et a l
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2007). The differences in DA Di and DA D% receptor binding between mice 
responding and non-responding to cocaine-induced CPP suggests that the ability of 
cocaine to induce a rewarding effect may depend on DA Di and D% receptor density 
and/or Di and D2 receptor regulation by cocaine. This might provide an important 
insight on the role of the DAergic system in the vulnerability to develop cocaine 
addiction. Furthermore, the difference between the responders and non-responders to 
cocaine or morphine may be due to genetic differences in a downstream pathway. One 
way to identify this would be to compare allele frequencies o f polymorphisms in 
responders and non-responders.
The generation of the adenosine A2 A receptor knockout mouse has assisted in the 
investigation of the role of the adenosine A2A receptor in the behavioural and 
reinforcing properties of cocaine. Previous work within our laboratory has 
investigated the role of the adenosine A2A receptor in modulating the effect o f acute 
cocaine administration on extracellular DA release in the NAc, locomotor behaviour 
and small local movements using the CDl strain of adenosine A2 A receptor knockout 
mice (Wells. 2008). In this thesis the same method has been used to study the 
neurochemical and behavioural response of accumbal DA in wildtype and adenosine 
A2A receptor knockout mice following the chronic ‘binge’ administration. There were 
a number of problems with data and sample analysis which made the interpretation of 
the results difficult and the complete statistical analysis impossible. However, no 
change in basal activity between the genotypes was observed, which is in agreement 
with the work of Castane et al. (2008), who used a chronic cocaine paradigm. Chronic 
‘binge’ cocaine administration also induced an increase in ambulatory activity
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accompanied by a decrease in small local moves in wildtype mice compared to 
adenosine A2 A receptor knockout mice.
The studies in this thesis support evidence for the existence of an antagonistic 
relationship between DA D2  and adenosine A 2A receptors, as the absence o f the 
adenosine A2A receptors reduce DA D2 receptor response. The work from this thesis 
also identifies that CDl mice are insensitive to the rewarding effects o f morphine and 
cocaine and highlights the importance of strain difference in the behavioural 
responses to drugs of abuse.
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